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 Summary 
Nonribosomal peptide synthetases (NRPS) are multi-domain megaenzymes which are 
involved in the biosynthesis of structurally diverse natural peptides with broad biological 
activities. Recent NRPS research concentrates on protein reengineering of this machinery to 
alter product outcome. For these efforts, knowledge of the NRPS protein architecture is 
important which has been subject of speculations so far. In this work the monomeric structure 
of several NRPS systems was demonstrated by a set of techniques. Biophysical methods such 
as analytical ultracentrifugation, gel filtration and chemical cross-linking gave clear evidence 
for a monomeric architecture. In turn biochemical methods like mutant in trans 
complementation and a two affinity tag system revealed no indication for a dimeric state. All 
together, the results clearly show that in contrast to polyketide and fatty acid synthases, 
NRPSs work as monomers. 
The second and predominant part of this work is dedicated to the chemoenzymatic 
engineering of NRPS products. A key determent of nonribosomal peptide product activity is 
the cyclic structure of many compounds. In this work the principles of enzymatic peptide 
cyclization were first investigated on the example of the lactone forming surfactin thioesterase 
(Srf TE). To evaluate recognition elements in the lipoheptapeptide chain by Srf TE, 
alterations to the fatty acyl group, the heptapeptide, and the thioester leaving group were 
made. Analysis of substrate tolerance with diaminopropionic acid and ε-aminohexanoic acid 
spacer substrates revealed an enzyme specific recognition of C- and N-terminal residues of 
the peptide sequence, leaving space for side chain replacements. Utilizing the recently solved 
crystal structure, the active site nucleophile, Ser80, was changed to Cys, and the other 
components of the catalytic triad, Asp107 and His207, were substituted by Ala, with the 
resulting mutants lacking detectable activity. Two cationic side chains in the active site, 
Lys111 and Arg120 that potentially coordinate the substrate, were altered to Ala, causing 
increased substrate hydrolysis, as did a Pro26 to Gly mutant, mimicking the behavior of 
lipases. To broaden the catalytic tool set, also fengycin (lipodecapeptide lactone), 
mycosubtilin (lipoheptapeptide lactam) and syringomycin (lipononapeptide lactone) TEs, 
which employ different cyclization strategies were cloned and overexpressed during the 
course of these studies. Surprisingly, neither cyclization nor hydrolysis activity with 
conventional peptidyl-SNAC substrates was observed. For a better substrate presentation, a 
new strategy was developed that took advantage of the promiscuity of the 4´-
phosphopantetheine (ppan) transferase Sfp, which allowed to load synthetic peptidyl-CoA 
substrates onto the didomainal fengycin PCP-TE enzyme. The precise natural interaction of 
the TE with the lipodecapeptidyl fengycin substrate attached to the carrier domain PCP 
revealed regioselective cyclization activity with various substrate analogues. However, a 
limitation of this approach was the single turnover reaction. In order to overcome this 
limitation peptidyl thiophenol substrates were synthesized to force multiple turnover via 
transesterification with the free ppan thiol. Surprisingly, the new thiophenol substrates did 
already show activity with the TE domain alone which indicated a rapid direct acyclation of 
the TE active site serine. With this new approach it was possible to characterize previously 
SNAC-inactive fengycin, syringomycin and mycosubstilin TEs. Moreover, a protein 
evolution method was employed to develop “custom made” catalytic cyclization tools. Initial 
results of a mass screen of about 1700 mutant enzymes, derived from tyrocidine TE (252 
residues), revealed 6 new enzyme variants which displayed altered activities. Due to stop 
codons within the mutant enzyme sequences (located in residues 141-178) these enzymes 
lacked 74 to 111 residues (30 – 44 %). Biochemical data with various substrate analogues 
indicated that the N-terminal part of Tyc TE is sufficient for catalysis. 
In conclusion, a tool set of several efficient enzymes capable of stereo- and regioselective 
cyclization of various linear peptides is now available without the need of side chain 
protecting groups, overcoming limitations of chemical synthesis. 
 Zusammenfassung 
Nichtribosomale Peptidsynthetasen (NRPS) sind multifunktionelle Enzymkomplexe, die für 
die Biosynthese einer Reihe strukturell diverser Peptide mit außerordentlichen biologischen 
Eigenschaften verantwortlich sind. In dieser Arbeit konnte mit einer Reihe von Techniken die 
monomere Struktur dieser Multienzymkomplexe gezeigt werden. Biophysikalische Methoden, 
wie z. B. analytische Ultrazentrifugation, Gel-Filtration und chemisches „cross-linking“ 
gaben den Beweis für eine monomere Organisation. Zusätzlich haben biochemische 
Methoden, wie z. B. das „in trans Complementations“ System und das Zwei-Affinitätstag 
System keinen Hinweis auf eine dimere Organisation ergeben. Zusammengenommen zeigen 
die Ergebnisse im Gegensatz zu den verwandten dimeren Polyketid- und Fettsäuresynthetasen 
eine monomere Architektur für NRPS Enzyme. 
Im zweiten Teil der Arbeit wurden die Grundzüge der enzymatischen Peptidzyklisierung am 
Beispiel der lactonbildenden Surfactin Thioesterase (Srf TE) mit Hilfe artifizieller SNAC-
Thioester Substrate untersucht. Um Erkennungssequenzen in der Lipoheptapeptidkette durch 
Srf TE herauszufinden, wurden systematische Veränderungen in der Fettsäuregruppe, dem 
Peptidrückgrat und in der Abgangsgruppe (SNAC) vorgenommen. Die Analyse der 
Substrattoleranz des Peptidrückgrats durch Austausch einzelner Aminosäurereste mit 
Diaminopropionsäure und ε-Aminohexansäure zeigte eine spezifische Erkennung C- und N-
terminaler Reste der Peptidsequenz. Reste in der Mitte der Peptidsequenz konnten unter 
Erhalt der Zyklisierungsaktivität ausgetauscht werden. Mit Hilfe der Kristallstruktur von Srf 
TE konnten gezielte Mutationen in der aktiven Tasche des Enzyms vorgenommen werden. 
Das vermutliche Nukleophil Ser80 wurde gegen Cys, und alle anderen Reste der katalytischen 
Triade, Asp107 und His207, wurden durch Ala ersetzt. Alle Mutanten zeigten keine Aktivität. 
Zwei positiv geladene Seitengruppen, Lys111 und Arg120, die vermutlich das Substrat für die 
Zyklisierung koordinieren, wurden durch Ala ersetzt und zeigten verstärkt hydrolysiertes 
Produkt. Eine Mutation von Pro26 zu Gly in der Oxyanionentasche wurde basierend auf 
einem Vergleich mit Lipasen eingeführt und erhöhte drastisch die Substrathydrolyse. Um die 
Anwendbarkeit von Thioesterasen in diversen Zyklisierungsreaktionen zu vergrößern, wurden 
die Fengycin TE (Lipodekapeptid Lacton), Mycosubtilin TE (Lipoheptapeptid Lactam) und 
Syringomycin TE (Lipononapeptid Lacton) kloniert und überexpremiert. Überraschender-
weise konnte weder eine Zyklisierungs- noch Hydrolyseaktivität mit herkömmlichen SNAC-
Substraten festgestellt werden. In einem neuen Ansatz wurde die Flexibilität der Phospho-
pantethein (ppan) Transferase Sfp ausgenutzt, die eine direkte Beladung des Transportenzyms 
PCP im Zweidomänensystem PCP-TE mit synthetischen peptidyl-CoA ermöglicht. Durch 
kovalente Bindung des Peptids an das Transportenzym PCP konnte eine Substraterkennung 
erzielt und regioselektive Zyklisierungsaktivität mit dem Fengycin PCP-TE System für viele 
Substrate beobachtet werden. Ein Nachteil des Verfahrens stellt die einfache „turnover“ 
Reaktion mit diesem System dar. Daher wurde in einem neuen Ansatz versucht durch eine 
Transthioesterifikationsreaktion mit Peptidyl-Thiophenolaten die freie Thiol-Gruppe des PCP-
ppan mit neuem Peptidsubstrat zu beladen. Überraschenderweise zeigten die Thiophenol 
Substrate bereits Zyklisierungsaktivität mit der TE allein ohne die freie ppan Thiol Gruppe, 
was die direkte Acylierung des aktiven Zentrums der TE demonstriert. Mit dieser neuen 
Thiophenol-Methode war es dann auch möglich Aktivität für andere zuvor inaktive TEs zu 
erhalten, z. B. Mycosubtilin und Syringomycin TEs. Des weiteren wurde versucht durch 
Protein-Evolution maßgeschneiderte Zyklisierungsenzyme zu erhalten. Vorläufige Ergebnisse 
eines Massenscreens von 1700 zufällig mutierten Enzymen, die sich von der Tyrocidin TE 
(252 Reste) ableiten, zeigten 6 Mutanten mit veränderten Aktivitäten. Wegen Stop-Codons 
inmitten der Enzymsequenz (Reste 141-178) fehlten allen Enzymen etwa 30 – 40 % ihrer 
ursprünglichen Sequenz. Biochemische Untersuchungen mit verschiedenen Substratanaloga 
zeigten, dass der N-terminale Teil der TE ausreichend ist für eine katalytische 
Zyklisierungsaktivität, was nun rationale Veränderungen im C-terminalen Bereich ermöglicht. 
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1 Abbreviations 
ACP   acyl carrier protein 
ACV   δ-(α-aminoadipyl)-cysteinyl-D-valine 
A-domain  adenylation domain 
Amp   ampicillin 
ATP   adenosine-5’-triphosphate 
BMH   bismaleimidohexane 
bp   base pairs 
C-domain  condensation domain 
CLP   cyclosporin linear precursor 
CoA   coenzyme A 
Cy-domain  heterocyclization domain 
Da   dalton 
DBP   dibromopropanone 
DCC   dicyclohexylcarbodiimide 
DCM   dichlormethane 
DEBS   desoxyerythronolid-B-synthase 
DHB   dihydroxybenzoyl 
DIPEA  diisopropylethylamine 
DKP   D-Phe-L-Pro diketopiperazine 
DMF   N,N-dimethylformamide 
dNTP   2‘-desoxynucleosid-5‘-triphosphate 
E-domain  epimerisation domain 
EDTA   ethylene diamino tetra acedic acid 
epPCR   error prone polymerase chain reaction 
FAS fatty acid synthase 
Fen PCP-TE  PCP-TE didomain from the fengycin NRPS 
FLP   fengycin linear precursor 
HBTU 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium 
hexaflurophosphate 
HOBt   1-hydroxybenzotriazole 
HPLC   high performance liquid chromatography 
IMAC   immobilized metal ion affinity chromatography 
IPTG   isopropyl-β-D-thiogalactoside 
Kan   kanamycin 
LC/MS  liquid chromatography/mass spectrometry 
MALDI-TOF  matrix assisted laser desorption ionization-time of flight 
MCS   multiple cloning site 
MIC   minimal inhibitory concentration 
min   minutes 
MLP   mycosubtilin linear precursor 
Abbreviations 
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mRNA  messenger RNA 
Myc PCP-TE  PCP-TE didomain from the mycosubtilin NRPS 
n.d.   not detected 
N-Mt-domain  N-methylation domain 
NRPS   nonribosomal peptide synthetase 
NTA   nitrilotriacetate 
OD   optical density 
ONAC   N-acetylethanolamine 
Ox-domain  oxidation domain 
PAGE   polyacrylamide gelelectrophoresis 
PCP   peptidyl carrier protein or thiolation domain 
PCR   polymerase chain reaction 
PKS polyketide synthase 
ppan   4’-phosphopantetheine 
PPi   inorganic pyrophosphate 
PyBOP benzotriazole-1-yl-oxy-tris-pyrrolidino-phosphonium 
hexaflourophosphate 
RBS   ribosomal binding site 
R-domain  reductase domain 
rpm   rounds per minute 
RT    room temperature 
SDS   sodiumdodecylsulfate 
SLP   surfactin linear precursor 
SNAC   N-acetylcysteamine 
SPPS   solid phase peptide synthesis 
Srf TE   TE domain from the tyrocidine NRPS 
SyLP   syringomycin linear precursor 
Syr TE   TE domain from the syringomycin NRPS 
T-domain  thiolation domain PCP 
TE-domain  thioesterase domain 
TFA   triflouroacedic acid 
TFE   triflourethanol 
THF   terahydrofuran 
TLP   tyrocidine linear precursor 
Tyc TE  TE domain from the tyrocidine NRPS 
v/v   volume per volume 
w/v   weight per volume 
wt   wild type 
Abbreviations 
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Tab. 1.1 Amino acids: Abbreviations and molecular weights 
Amino acid 3- 1- MW [g/mol] 
        Letter code  
Alanine Ala A   89 
Arginine Arg R 174 
Asparagine Asn N 132 
Aspartate Asp D 133 
Cysteine 
Glutamate 
Cys 
Glu 
C 
E 
121 
147 
Glutamine Gln Q 146 
Glycine Gly G   75 
Histidine His H 155 
Isoleucine Ile I 131 
Leucine Leu L 131 
Lysine Lys K 146 
Methionine Met M 149 
Ornithine Orn O 132 
Phenylalanine Phe F 165 
Proline Pro P 115 
Serine Ser S 105 
Threonine Thr T 119 
Tryptophane Trp W 204 
Tyrosine Tyr Y 181 
Valine Val V 117 
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2 Introduction 
Research on bioactive natural products was strongly inspired by A. Flemming´s exceptional 
discovery of the antibiotic activity of the peptidic molecule penicillin from the fungal host 
organism Penicillium notatum[1]. Since then microorganisms attracted considerable attention 
as a new source for pharmaceutical agents and screening of microbial extracts revealed a very 
large number of new compounds with antimicrobial, antiviral, immunosuppressive, and 
antitumor activities. These secondary metabolites have been optimised for their dedicated 
function during generations of evolution and now represent promising scaffolds for the 
development of new drug leads.  
Within these substances small peptide molecules represent a large subclass of bioactive 
natural products, which comprise unique structural features like heterocyclic elements, D-
amino acids, and glycosylated as well as N-methylated residues. Moreover, contrary to 
ribosomal protein synthesis, small peptide products contain not only the common 20 amino 
acids, but hundreds of different building blocks, suggesting a nonribosomal origin of 
biosynthesis. In the 1970s Lipmann et al. reported a nucleic acid independent synthesis of the 
peptide antibiotics gramicidin S and tyrocidine A from Bacillus sp. through the use of large 
enzyme complexes similar to fatty acid synthases[2]. In the following years more and more 
peptidic natural products were shown to be assembled by such large enzymes, referred to as 
nonribosomal peptide synthetases (NRPS). Significant progress has been made in the past 
decades toward understanding the principles of bioactive peptide synthesis in microorganisms 
and was the subject of recent extensive reviewing[3-6]. While research first focused on the 
principal molecular architecture of the assembled complex molecules and on the identification 
of their biosynthetic gene clusters, more recent biochemical work revealed high resolution 
structures of some of the catalytic core enzymes. Moreover, recent chemoenzymatic 
approaches were developed to reprogram natural peptide sequences by the combined action of 
chemical peptide synthesis and subsequent enzyme catalysis. This introduction chapter aims 
to give a brief overview on the nonribosomal peptide synthesis machinery with the major 
emphasis on recent progress made on chemoenzymatic synthesis of cyclic peptides. 
2.1 Natural Products 
Natural peptide products synthesized by NRPSs can be grouped according to their biological 
activities. A major class comprises antibiotic and antifungal agents, including the peptides 
tyrocidine, bacitracin, surfactin, pristinamycin, vancomycin and fengycin[3, 7-15]. Their 
biological functionality is strictly associated with their chemical structure, which constrains 
2 Introduction 
the peptide sequence in its biologically active conformation and ensures specific interaction 
with a dedicated molecular target. This structural rigidity is achieved either by cyclization or 
oxidative cross-links, which contribute to stability. Moreover, the great diversity of chemical 
modifications like fatty acid chains, D-amino acids, aromatic and aliphatic side chains, 
glycosylated amino acids and heterocyclic elements add much to these specific interactions 
(Fig. 2.1). 
 
Figure 2.1 Natural peptide products. Characteristic structural features are 
highlighted on selected examples. 
For many natural peptide products the relation between structural features and biological 
activities has been investigated. Some of these like bacitracin from B. licheniformis and 
gramicidin S form B. brevis act also non-specifically as membrane-inserting amphiphatic 
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species[16-19]. In addition to the macrocyclic ring, bacitracin contains a small thiazoline ring, 
which complements its antibiotic activity with a specific cation-dependent complexation of 
the phosphate moiety of the C55 lipid phosphate. This complexation leads to the inhibition of 
the lipid cycle[3, 20, 21]. Amphiphilic lipopetides like the surface tension reducing agent 
surfactin and the antifungal mycosubtilin, both produced by B. subtilis, are also thought to 
penetrate and disrupt the cell membrane, a process where the lipo-chain seems to play a key 
role[22-24]. In addition to the exceptional surfactant power provided by its amphiphilic 
sequence, surfactin has been reported to exhibit hemolytic, antivirial, antibacterial, and 
antitumor properties[10]. Also in case of the cytotoxic molecule syringomycin from 
Pseudomonas syringae, which exhibits toxicity against plant tissues, the amphiphatic nature 
of the polar peptide head and hydrophobic fatty acid tail allows insertation into the plant 
plasma membrane and formation of transmembrane pores permitting ions to flow freely 
across the membrane[25, 26]. Moreover, as seen for the Streptomyces lipopetidelactones CDA 
and daptomycin also metal ions like Ca2+ trigger antibiotic activity by stacking molecules[27-
30]. These complexes may exert their antibacterial activity through membrane seeking, 
surface-active behaviour. Another close relationship between peptide structure and function is 
observed for the glycopeptide antibiotic vancomycin produced by Streptomyces orientalis. 
Vancomycin is a linear heptapeptide, whose backbone is constrained by oxidative cross-
linking. This unique structure sequesters substrate peptidoglycan-D-Ala-D-Ala termini units 
with five hydrogen bonds and shuts down transpeptidation reaction[12]. A different cellular 
target is attacked by the antibiotic pristinamycin from Streptomyces pristinaespiralis, which 
blocks polypeptide translation by binding the 50S subunit of bacterial ribosomes at 23S rRNA 
sites. Investigations revealed interaction with the ribosom via the 3-hydroxy picolinic acid 
residue of pristinamycin emphasizing the importance of non-proteinogenic residues for 
antibiotic activity[31].  
Cyclosporin produced by Tolypocladium niveum exhibits immunosuppressive and toxic 
properties due to the formation of a specific complex with cyclophilin which inhibits the 
protein phosphatase calcineurin, responsible for T-cell activation[32-34]. Cyclosporin is 
highly lipophilic and seven of its eleven amino acids are N-methylated. This high degree of 
methylation protects the peptide from proteolytic digest but also complicates chemical 
synthesis due to low coupling yields and side reactions[35]. In iron deficient environment, 
some bacteria such as E. coli, B. subtilis and Vibrio Cholerae synthesize and secrete iron-
chelating molecules known as siderophores that scavenge Fe3+ with picomolar affinity, 
important for the host survival[36, 37]. Three catechol ligands derived from 2,3-
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dihydroxybenzoyl (DHB) building blocks in bacillibactin, enterobactin and vibriobactin, 
complex iron by forming an intramolecular octahedral.  
Many nonribosomal peptide products presented here show distinct chemical modifications, 
important to specifically interact and inhibit certain cellular functions, which are essential for 
survival. The high toxicity of the peptide products could therefore become a problem for the 
producer organism unless strategies for its own protection and immunity have coevolved with 
antibiotic biosynthesis. This immunity is achieved by several strategies including efflux 
pumps, temporary product inactivation and modifications of the target in the producer 
strain[3]. The latter strategy is used by vancomycin producing streptomycetes by changing the 
D-Ala-D-Ala terminus of the peptidoglycan pentapeptide precursor to a D-Ala-D-lactate 
terminus, which reduces binding affinity to vancomycin 1000-fold[12]. 
Due to their exceptional pharmacological activities many compounds like cyclosporin and 
vancomycin have been synthesized chemically[38, 39]. Regio- and stereoselective reactions 
require the use of protecting groups as well as chiral catalysts. Moreover, macrocyclization 
and coupling of N-methylated peptide bonds is difficult to achieve in satisfying yields, 
indicating an advantage of natural vs. synthetic strategies. Structural peculiarities of these 
complex peptide products suggested early on a nucleic acid independent biosynthesis 
facilitated by multiple catalytic domains expressed as a single multidomain protein. The 
diverse chemical reactions mediated by distinct enzymatic units will be the focus of the 
following section. 
2.2 The NRPS Natural Product Factory 
Although structurally diverse, most of the biologically produced peptides share a common 
mode of synthesis, the multienzyme thiotemplate mechanism[2, 6, 40]. According to this 
model, peptide bond formation takes place on large multienzyme complexes, which represent 
at the same time template and biosynthetic machinery. Sequencing of genes encoding NRPSs 
of bacterial and fungal origin provided insights into the molecular architecture and revealed a 
modular organization[6]. A module is a distinct section of the multienzyme that is responsible 
of the incorporation of one dedicated amino acid into the final product[3, 6, 41]. It is further 
subdivided into a catalytically independent set of domains responsible for substrate 
recognition, activation, binding, modification, elongation and release. Domains can be 
identified at the protein level by characteristic highly conserved sequence motivs. So far 10 
different domains are known, catalysing independent chemical reactions. As an example to 
follow the principles, figure 2.2 shows a prototype NRPS assembly line of the cyclic 
lipoheptapetide surfactin[42]. 
2 Introduction 
 
Figure 2.2. Surfactin assembly line. The multienzyme complex consists of  7 
modules (grey and red) which are specific for the incorporation of 7 amino acids. 24 
domains of 5 different types (C, A, PCP, E, and TE) are responsible for the catalysis of 
24 chemical reactions. 23 reactions are required for peptide elongation while the last 
domain is unique and required for peptide release by cyclization. 
The carboxy group of amino acid building blocks is first activated by ATP hydrolysis to the 
corresponding aminoacyl-adenylate. This reactive intermediate is transferred onto the free 
thiol-group of an enzyme bound 4´-phosphopantetheinyl cofactor (ppan), establishing a 
covalent linkage between enzyme and substrate. At this stage the substrate can undergo 
modifications such as epimerisation or N-methylation. Peptide assembly of the final product 
occurs then by a series of peptide bond formation steps (elongation) between the downstream 
building block with its free amine and the carboxy-acitvated thioester of the upstream 
substrate resulting in an N to C terminal elongation. The ppan cofactor facilitates the ordered 
transfer of thioester substrates between catalytically active units with all intermediates 
covalently tethered to the multienzyme until the product is released by the action of the C-
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terminal TE-domain (termination). This principle minimizes side reactions as well as 
diffusion times, maximizing the catalytic efficiency. Type I polyketide synthases (PKS) and 
fatty acid synthases (FAS) also display a multienzymatic organization and catalyse a repeated 
reaction cycle of decarboxylative condensation of smaller acyl groups[43, 44]. 
2.3 Activation by the Adenylation Domain 
Each nonribosomal peptide synthesis initiates by specific recognition and activation of the 
dedicated amino acid from a pool of substrates by the ca. 550 amino acid comprising  
adenylation domain (A-domain). For example, each of the seven amino acids found in the 
heptapeptide surfactin is respectively selected for incorporation into the growing peptide 
chain by one of the seven A-domains of the surfactin synthetase (Fig. 2.2). Substrate 
activation is achieved in a two-step chemical reaction. First, after binding of the cognate 
amino acid, the enzyme catalyses activation as an aminoacyl adenylate intermediate at the 
expense of Mg2+-ATP and release of PPi (Fig. 2.3). Second, the amino acid-O-AMP oxoester 
is converted into a thioester by a nucleophilic attack of the free thiol-ppan cofactor of the 
adjacent PCP domain, which will be discussed below (Fig. 2.4). This mechanism resembles 
amino acid activation catalysed by aminoacyl-tRNA-synthetases although these enzyme 
families share neither sequence nor structural relations[45]. Many A-domains can be 
heterologously expressed in E. coli and their activity as well as substrate specificity can be 
assayed in vitro by an equilibrium ATP-PPi exchange assay with radiolabeled PPi[46].  
 
Figure 2.3. Amino acid activation. The adenylation domain activates a dedicated 
amino acid as aminoacyl adenylate at the expense of ATP. 
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2.4 Intermediates Transport by the Peptidyl Carrier Protein 
 
Figure 2.4. Thiolation of the activated amino acids.  
The only NRPS domain without autonomous catalytic activity is the peptidyl carrier protein 
(PCP), also referred to as thiolation domain (T). The protein comprises ca. 100 amino acids 
and is located downstream of the A-domain. Within the NRPS assembly line PCP is 
responsible for transportation of substrates and elongation intermediates to the catalytic 
centres. As mentioned in the previous chapter, the A-domain catalyses in the second half-
reaction the transfer of the activated aminoacyl-adenylate substrate onto the terminal 
cysteamine thiol group of the ppan cofactor bound to PCP (Fig. 2.4). In nonribosomal peptide 
synthesis the combination of A-domain and PCP is defined as initiation module, since both 
domains are required to activate and covalently tether the first building block for subsequent 
peptide synthesis. The activity of recombinant A-domains with adjacent holo-PCPs can be 
assayed in vitro by an aminoacylation assay with ATP and radioactive amino acids[46]. In 
contrast to ribosomal protein synthesis with tRNA bound oxo-ester intermediates, 
nonribosomal peptide synthetases use more reactive PCP-thioesters. This difference in 
reactivity is due to the lower mesomeric stabilization of the thioester, which forms less stable 
pπ-pπ double bonds and emphasizes that initial activation energy provided by the A-domain is 
preserved here for subsequent catalytic reactions such as condensation, hydrolysis and 
cyclization (see below)[47].  
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Figure 2.5. Priming of the enzymatic template. The phosphopantheteine moiety of 
coenzyme A is covalently attached onto the invariant serine residue of PCP by 
dedicated phosphopantheteine transferases. 
The 20 Å long prosthetic ppan moiety of coenzyme A is covalently tethered to the side chain 
of a strictly conserved PCP serine residue and serves as a crane for building block 
delivery[48-51]. Transfer of ppan onto apo PCP is catalysed by NRPS specialized 4´-
phosphopantetheinyl transferases such as Sfp and Gsp from B. subtilis and B. brevis, 
respectively[52-54] (Fig. 2.5). The conversion of inactive apo-PCP into its active ppan-PCP 
holo-form was monitored in vitro with recombinant Sfp and PCPs from the surfactin 
synthetase. These studies revealed very low selectivity of Sfp for the carrier proteins[55]. Sfp 
was shown to efficiently phosphopantetheinylate not only apo-PCPs from various NRPS 
systems but also acyl carrier proteins from fatty acid and polyketide synthases[52, 56]. In 
addition, also aminoacyl- and acetyl-CoAs were tolerated[57, 58]. This relaxed specificity of 
Sfp was useful for preparative applications which will be presented in this work[59, 60]. 
Insights into how Sfp mediates binding and protein recognition were provided by a crystal 
structure in complex with its substrate CoA[61] (Fig 2.6). The structure of the 224 amino acid 
comprising Sfp monomer shows a pseudo 2-fold symmetry, which divides the protein into 
two similar folds of almost identical size. The CoA substrate is bound in a bent conformation 
within a pocked formed by the two Sfp halves. The 3´-phospho-5´-ADP moiety of CoA is 
well defined in the electron density map and is coordinated by several Sfp residues and Mg2+, 
while the main part of the ppan arm displays no interactions with Sfp and points out into bulk 
solvent. 
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Figure 2.6. Crystal structure of Sfp. Cocrystal with bound coenzyme A and Mg2+. 
2.4.1 Misacylation and Regeneration 
The promiscuity of Sfp causes also undesired misacylation of PCPs within NRPS assembly 
lines since not only CoA but also acyl-CoAs can serve as cofactor donors. In order to 
regenerate these misprimed NRPS templates (acetyl-ppan), nature has developed specific 
enzymes, which catalyse hydrolysis of the undesired acyl group. These so called thioesterase 
II domains (TEII) were shown to be specific for acyl-PCPs in in vitro assays, while there was 
no hydrolysis observed for acyl-ACPs which are essential in primary fatty acid metabolism. 
Comparison of the catalytic properties of TEII mediated aminoacyl- or peptidyl-PCP 
hydrolysis vs. acetyl-PCP showed a strong preference for the latter substrate which indicates 
that this proofreading enzyme is important for NRPS activity by deblocking misacetylated 
PCPs which was also confirmed by TEII knockout studies[62]. 
2.5 Peptide Elongation by the Condensation Domain 
After activation and covalent binding of the first substrate amino acid by the A-PCP initiation 
module, peptide synthesis proceeds by stepwise condensation with amino acid building blocks 
bound to PCPs of several downstream elongation modules (C-A-PCP)n. Peptide bond 
formation is mediated by a ca. 450 amino acids comprising condensation domain (C-domain). 
The C-domain catalyses the nucleophilic attack of the downstream PCP bound acceptor 
amino acid with its free α-amino group on the activated thioester of the upsteam PCP-bound 
donor amino acid or peptide[57] (Fig. 2.7). In surfactin synthetase, peptide bond formation 
occurs e.g. between modules 1 and 2 by the nucleophilic attack of the α-amino group of 
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leucine on the thioester-activated carboxy group of glutamate to give a dipeptide which is 
translocated to module 2 (Fig. 2.2). 
 
Figure 2.7. Peptide bond formation by the C-domain. Putative donor (d) and 
aceptor (a) sites are marked by circles. 
Biochemical characterization of different C-domains revealed insights into their substrate 
specificities. Probing substrate specificity in the natural synthetase is difficult to achieve 
because the upstream donor and downstream acceptor substrates are defined by restrictive A-
domains. In order to directly evaluate C-domain specificity, various aminoacyl-CoA 
substrates were synthesized and attached to the apo-PCPs of a minimal, bimodular NRPS 
system composed of module 1 from B. brevis gramicidine synthetase and module 2 from 
tyrocidine synthetase under catalysis of Sfp. Mischarging of PCPs from both modules 
revealed in condensation assays that the C-domain of tyrocidine module 2 seems to possess an 
acceptor position for the downstream PCP bound nucleophile, that discriminates against the 
non cognate D-enantiomer, as well as differences in the side chain. By contrast, low side 
chain selectivity was observed for the donor position of the upstream PCP bound electrophile. 
Interestingly, a preference for cognate D-enantiomers were observed[57]. This was confirmed 
by further investigations with the C-domain of tyrocidine elongation module 5 which revealed 
that the donor position exclusively selects a tetrapeptide with the cognate D-configuration of 
the C-terminal residue for condensation reactions[60]. This shows that besides A-domains and 
TEII-domains, C-domains represent a selectivity filter in nonribosomal peptide synthesis. 
Selection of the correct downstream nucleophile by the acceptor position prevents the 
formation of product mixtures and facilitates peptide synthesis in a directed manner. 
Sequence alignments of several C-domains revealed a highly conserved HHXXXDG motif 
that is also found in acyltransferases such as chloramphenicol acetyltransferase (CAT), NRPS 
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epimerisation and heterocyclization domains[63, 64]. Mutations in residues His147 in the 
conserved motif of the C-domain of tyrocidine module 2 and His138 in the motif of 
enterobactin synthetase module F revealed no activity in condensation assays[65, 66] which 
emphasizes the active role of the conserved histidine in catalysis. 
2.6 Editing Domains 
While the amino acid is covalently tethered onto the PCP several editing domains can carry 
out further modifications to increase the diversity of the final product. Structural features like 
D-amino acids and methylated peptide bonds increase the stability of the peptide against 
proteolytic digest and also contribute to unique conformations important for biological 
activity.  
2.6.1 Epimerization 
Almost every nonribosomally synthesized peptide contains D-configurated amino acids to 
various extends. NRPSs realize two different ways for their incorporation. The most common 
way is the epimerisation of L-amino acids by integrated 450 amino acids comprising 
epimerisation domains (E)[67] which racemize the Cα-carbon of the PCP tethered aminoacyl 
substrate to a D/L equilibrium[68] (Fig. 2.8). Racemization can either occur from L to D or 
the opposite way. Rapid quench kinetics revealed that this equilibrium is achieved within 
seconds[69]. Specific incorporation of only the D-amino acid into the growing peptide chain 
is ensured by the enantioselective donor site of the downstream condensation domain[57]. 
This principle is also used in the surfactin synthetase in modules 3 and 6 to incorporate two 
times D-Leu in the final product. The combination of D- and L-amino acids contributes to the 
unique conformation of surfactin that is important for its biological activity[10]. A second 
strategy of D-amino acid incorporation is often observed in fungal systems[32]. The A-
domain of cyclosporin synthetase for example, exclusively incorporates D-Ala at position one 
which is provided by an external racemase[70].  
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Figure 2.8. Epimerisation of the C-terminal amino acid by the E-domain. The 
stereocenter of the shaded residue is epimerised into a D,L equilibrium. 
Biochemical characterization of E-domain substrate specificity revealed that also noncognate 
amino acids were racemized but with lower efficiency[71]. Further studies showed that 
artificial E domain constructs without preceding C-domain (as it would be observed in the 
native initiation module) could epimerise aminoacyl-PCP while in contrast the identical 
constructs with a preceding cognate C-domain (as in an elongation module) did not show 
epimerisation activity for the bound aminoacyl-S-ppan substrate. This led to the conclusion 
that C-domains bind tightly aminoacyl-PCP in the acceptor site until condensation occurs. 
The resulting peptidyl-PCP has a lower binding affinity to the acceptor site and is then 
transferred to the subsequent E-domain or next C-domain[60, 72]. These investigations 
contributed to the understanding of timing and directionality of nonribosomal peptide 
synthesis (Fig. 2.9).  
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Figure 2.9. Directionality of peptide elongation.  
2.6.2 Methylation 
Some nonribosomal peptides such as cyclosporin[73], enniatin[74], actinomycin[75], and 
pristinamycin[11, 76] have N-methylated peptide bonds. This modification is introduced by a 
ca. 420 amino acid comprising N-methylation domain (N-Mt) which is inserted into the 
accompanying A-domain. The N-Mt-domain catalyses the transfer of the S-methyl group of 
S-adenosylmethionine (SAM) to the α-amino group of the thioesterified amino acid releasing 
S-adenosylhomocysteine as a reaction by-product. In comparison to other NRPS domains 
discussed previously less is known about N-Mt-domains. 
2.7 Peptide Release 
All catalytic domains discussed so far are repeating units of the enzymatic template and 
contribute to the synthesis of a linear peptide molecule tethered to the multienzyme. In order 
to reactivate the multienzyme machinery for the next synthesis cycle the mature peptide has to 
be cleaved once it reaches the end of the assembly line. This reaction is usually accomplished 
by a 280 amino acid comprising thioesterase domain (TE-domain) fused to the C-terminal 
module, also referred to as termination module. The peptide can either be released by 
hydrolysis as a linear acid or by an intramolecular reaction with an internal nucleophile to 
give a cyclic peptide (Fig. 2.10). Hydrolytic release is observed e.g. for vancomycin whose 
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peptide backbone is constrained by further postsynthetic oxidative cross linking reactions[12]. 
Alternatively, peptide release can also occur under reduction of the carboxy-group catalysed 
by the NADPH dependent reduction domain (R) to give linear aldehydes or alcohols such as 
in the yeast biosynthetic pathway for the essential amino acid lysine[77] and in the 
biosynthesis of linear gramicidin A in B. brevis[78] or by head to tail condensation mediated 
by the C-domain as seen in cyclosporin synthetase. 
 
Figure 2.10. Release of the linear peptide chain by the TE-domain. Release can 
either be carried out by (A) cyclization or (B) hydrolysis. 
In case of surfactin the peptide backbone is constrained by an intramolecular nucleophilic 
attack of a β-hydroxy group of the fatty acid moiety to give a branched chain 
lipodepsipeptide[79] (Fig. 2.2). Many other cyclization strategies are known so far giving rise 
to a large and diverse set of cyclic or cyclic branched molecules with distinct biological 
activities. Thioesterase domains catalyzing a cyclization reaction are also referred to as 
peptide cyclases and the main emphasis of this chapter is attributed to them. 
2.7.1 Cyclization Strategies: Nature´s Way 
All known NRPS macrocyclization strategies lead to cyclic or cyclic branched chain peptides 
(Fig. 2.11). In macrolactones the branch point can either be a hydroxylated amino acid side 
chain or a hydroxylated fatty acid moiety. In case of the surfactin peptide cyclase the ring 
closure is enzymatically catalysed between a N-terminal β-hydroxyl fatty acid and the C-
terminal peptide end[79]. Cyclization was only observed when the (R)-β-hydroxy fatty acid 
was used while the (S)-enantiomer only showed enzymatic hydrolysis indicating 
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stereoselective recognition[80]. In contrast, syringomycin (P. syringae) and fengycin (B. 
subtilis) lipopeptide cyclases accept serine and tyrosine side chains of the peptide sequence as 
nucleophiles for cyclization, discriminating the N-terminal β-hydroxyl group of the attached 
fatty acid moiety[15, 26, 81](Fig. 2.11). Moreover, these peptide cyclases display a very high 
regioselectivity by selecting only one specific residue of the substrate from a large source of 
nucleophiles for cyclization.  
 
Figure 2.11. Macrocyclization strategies. 
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In addition to macrolactonization, natural product diversity is also increased by various 
enzymatic macrolactamization strategies. Basic head-to-tail peptide macrolactamization is 
observed in the antibiotic tyrocidine from Bacillus brevis and the potent immunosuppressive 
drug cyclosporin A from tolypocladium niveum. In cyclosporin A the final peptide bond is 
formed by a putative condensation domain[82] instead of a peptide cyclase, emphasizing that 
nature developed two different enzyme species capable of catalysing product release by 
cyclization. Recently, a new type of head to tail macrocyclization was reported for 
nostocyclopeptide from the terrestrial cyanobacterium Nostoc sp. The C-terminal residue of 
the linear peptide is reduced by the action of a R-domain to give an aldehyde which is then 
intramolecularly captured by the α-amino group of the N-terminal amino acid residue by an 
unknown mechanism to give a cyclic imine[83].  
Besides head-to-tail cyclized lactams also branched chain lactams are observed. The peptide 
cyclase of the antifungal lipopetide mycosubtilin from B. subtilis forms regioselectively an 
amide bond between a N-terminal β-amino fatty acid and the peptide C-terminal end (Fig. 
2.11). Similar to surfactin also in mycosubtilin a fatty acid chain is involved in the cyclization 
process providing an amine as a nucleophile[23]. While the precursors in both cases seem to 
be β-keto fatty acid residues derived from fatty acid synthases, nature processes these ketones 
in two different ways. They are either reduced to a hydroxyl-group as observed in surfactin or 
they are reductively aminated catalysed by amino transferases as observed in mycosubtilin. In 
both cases nature uses a common precursor motive which is subsequently diversified by the 
application of different synthetic strategies to increase the product outcome. Similar to 
fengycin and syringomycin, enzymatic amide bond formation can also occur between an 
ornithine side chain and the C-terminal peptide end as seen in the antibiotic bacitracin from B. 
licheniformis[17]. The scope of cyclic lactams and lactones can be further broadened by 
oligomerization of peptide monomers. This additional strategy enables the B. brevis 
gramicidin S peptide cyclase to cyclodimerize two linear pentapeptides by catalysing two 
subsequent peptide bond formation steps to form the cyclic antibiotic dilactam gramicidin 
S[80] (Fig. 2.11). Also cyclotrimerization is observed for the siderophore forming peptide 
cyclases of enterobactin and bacillibactin synthetases from E. coli and B. subtilis, 
respectively[84, 85]. Three units of 2,3-dihydroxybenzoyl-serine are fused together by three 
subsequent ester bond formation steps between the serine hydroxyl-group of one molecule 
and the C-terminal end of another molecule to give the cyclic trilactone enterobactin. This 
trilactone displays iron chelating activity which is closely related to its structure. Three 
catechol ligands provide electron donors required for the coordination of iron once more 
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emphasizing the close relationship between cyclic structural organization and biological 
activity. By contrast to enterobactin, it is postulated that the cyclic trimer enniatin is cyclized 
by a PCP-C didomain replacing the TE-domain and allowing the successive build up of 
oligomers on the PCP before C-domain mediated cyclization[86, 87]. 
NRPS peptide cyclases can generate diverse cyclic peptide molecules ranging in size from 
very small as in pristinamycin with seven residues to very large as in syringopeptin with 22 
residues[76, 88]. At the large end of the scale there is also another source of macrocyclic 
molecules observed in nature referred to as naturally occurring circular proteins[89]. These 
proteins are of bacterial origin and have a well folded three dimensional structure. In contrast 
to NRPS they are produced by the translation of genes. Cyclization occurs posttranslationally 
only in a head-to-tail fashion to produce a seamless circle of peptide bonds. Unlike NRPSs 
not much is known about the cyclization mechanism of the linear precursors.  
Cyclization strategies reported here emphasize that nature has developed a large enzymatic 
tool set which allows to introduce diversity into linear peptide sequences by a variety of 
different cyclization steps. The selection from different nucleophiles, epimers and positions in 
the peptide sequence makes peptide cyclases unique enzymatic tools, with very specific 
intrinsic stereo- and regioselective recognition elements. Moreover, to understand the 
catalysis of one, two or three subsequent condensation steps towards cyclization requires 
further studies on structural and mechanistic aspects of these enzymes. 
2.7.2 Chemoenzymatic Cyclization 
The great pharmacological potential of many cyclic peptides emphasizes their role in drug 
discovery, as they show specific interaction with cellular receptors and high resistance to 
proteolytic enzymes. They are therefore most promising scaffolds for phamacophores. So far, 
synthetic chemistry faces several difficulties in the production of cyclic compounds providing 
sufficiently good yields and regioselectivity. Synthetic macrocyclization is difficult to achieve 
since steric repulsion and misalignment of ring residues as well as the use of protecting 
groups to ensure proper regiochemistry decreases yields and makes chemical synthetic 
operations expensive and rather difficult. Since nature developed stereo- and regioselective 
peptide cyclization enzymes, researchers aimed to combine chemical linear peptide synthesis 
with enzymatically catalysed cyclization. This approach allows easy synthesis of linear 
peptide sequences by established solid phase peptide chemistry followed by selective and 
efficient enzymatic cyclization without the use of protecting groups and the formation of 
undesired by-products.  
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Similarities and differences between nonribosomal peptide synthesis and chemical solid phase 
peptide synthesis are highlighted in Figure 2.12. Both methods use a similar way of precursor 
activation and tethering on solid support, which facilitates a rapid and ordered synthesis of 
desired products in high yields. In chemical synthesis chain elongation proceeds from the C- 
to the N-terminal end while it is the opposite direction in enzymatic synthesis. One advantage 
of chemical synthesis is the huge diversity which can be incorporated into the linear peptide 
chain in order to create a variaty of substrate analogues which is desired in biochemical 
studies of excised TE domains.  
 
Figure 2.12. Comparison between nonribosomal peptide synthesis (NRPS) and 
solid phase peptide synthesis (SPPS). Both methods use active ester species for 
amino acid activation and tether these activated species on solid support as thioester 
(NRPS) or oxoester (SPPS) intermediates. While enzymatic peptide synthesis depends 
on the enzymatic specificity of the template, chemical synthesis allows flexibility for 
various amino acid substitutions, required for chemoenzymatic investigations. 
In order to achieve chemoenzymology a translation between the language of chemistry and 
the language of biology has to be established by chemically mimicking the biological 
pathway as close as possible (Fig. 2.13 A and B).  This was first achieved by a cooperation of 
the Walsh and Marahiel groups who cloned and overexpressed excised peptide cyclases (28 
kDa) from the tyrocidine and surfactin synthetase[80, 90]. In order to prove the activity of the 
isolated enzyme vs. the natural enzyme which is embedded in a multienzyme complex, a short 
mimic of the natural cofactor phosphopantetheine, N-acetylcysteamine (SNAC), was attached 
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to the C-terminal end of chemically synthesized linear surfactin and tyrocidine peptides. The 
SNAC represents a link between natural and artificial systems compatible with both. 
Incubation of tyrocidine substrate mimic and excised tyrocidine peptide cyclase revealed 
activity with an observed cyclization to hydrolysis ratio of 6:1 (surfactin cyclization will be 
presented in the results section). The turnover of 59 min-1 indicated a very rapid conversion of 
the linear into the cyclic compound which makes this enzyme as an in vitro biocatalyst 
useful[90]. Follow up studies with various peptidyl-SNAC substrates with varied length, 
stereochemistry and amino acid composition revealed that the tyrocidine peptide cyclase only 
recognizes C- and N-terminal residues of the substrate by identity and stereochemistry, 
leaving space for making longer and shorter substrates as well as for replacements of single 
residues within the peptide backbone[80]. Alteration of backbone parts by replacement of 
three amino acid blocks with a flexible spacer or by replacement of amide bonds with ester 
bonds suggested that during the cyclization reaction the peptide substrate is preorganized by 
intramolecular hydrogen bonds analogous to those in the product tyrocidine. A minimal 
recognition model was postulated[91]. An important feature of cyclic peptides is the β-sheet 
content, which is high for molecules with (4n + 2) residues[80, 91]. A peptide with a high β-
sheet content such as the decapeptide tyrocidine (n = 2) facilitates cyclization through 
substrate preorganization by backbone-to-backbone hydrogen bonds. This intrinsic property 
of tyrocidine facilitates easy cyclization which was also reported to occur un-catalysed but 
less efficiently[92]. A large number of changes in the peptide thioester substrate were 
incorporated for the synthesis of a cyclic integrin inhibitor retaining only the elements in the 
minimal recognition model for tyrocidine cyclization. Although 7 of 10 cognate residues were 
replaced by others with 2 also differing in stereochemistry, tyrocidine cyclase was still 
capable of cyclization but with reduced yield[93]. This method was extended by the synthesis 
of linear novel hybrid polyketide-tyrocidine substrates, which were cyclized in good 
yields[94]. Substrate tolerance of the excised tyrocidine cyclase allowed furthermore the 
synthesis of diverse tyrocidine variants in which position 4 (D-Phe) was replaced by one of 96 
natural and unnatural amino acids. This library of tyrocidine product analogues was 
subsequently screened for improved or altered bioactivity. In contrast to the natural antibiotic 
tyrocidine A which does not discriminate between bacterial and eukaryotic cell membranes, 
the screen revealed that a substitution of D-Phe at position 4 by a positively charged D-amino 
acid led to a 30-fold increase in the selective recognition of bacterial membranes[95]. 
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Figure 2.13. Chemoenzymatic cyclization. The NRPS multienzyme machinery 
required for peptide elongation is replaced by solid phase peptide synthesis and the TE 
domain is excised as a free standing enzyme. Recognition of the artificial substrate by 
the enzyme is ensured by the ppan cofactor mimic SNAC. 
To expand the set of cyclization catalysts also peptide cyclases from other NRPS systems like 
mycosubtilin, fengycin from B. subtilis and syringomycin from P. syringae were recently 
cloned and overexpressed. Contrary to previous characterized cyclases, no activity was 
observed for those of mycosubtilin, fengycin and syringomycin cyclases with synthetically 
made peptidyl-SNAC substrates, which indicates a limitation in the chemoenzymatic potential 
of the latter cyclases. The inability to recognize or bind the SNAC substrates in the active site 
of the excised peptide cyclase could be affected by the way of presenting the short SNAC 
mimic to the enzyme and is subject of investigations presented in this work. 
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2.7.3 Structural and Mechanistic Aspects of NRPS Peptide Cyclases 
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the acyl-O-TE intermediates between cyclization and hydrolysis. A sequence alignment 
between the surfactin peptide cyclase and other members of the α,β-hydrolase enzyme family, 
that catalyse only hydrolysis, revealed a glycine residue, involved in the formation of the 
oxyanion hole to be conserved among lipases. In the surfactin peptide cyclase a rigid proline 
residue is at this position, which might be important for cyclization (Fig. 2.15). 
 
Figure 2.15. Catalytically important residues of Srf TE. (A) The peptide substrate 
and the ppan arm are modelled into a hydrophobic binding pocket and into a substrate 
channel, respectively. (B) Magnification of the binding pocked shows the catalytic 
triad (Ser80, His207 and Asp107) and several hydrophobic residues with the exception 
of Lys111 and Arg120. (C) Proposed oxyanion hole with Pro26 as a rigid gatekeeper. 
In the surfactin assembly line the template modular sequence is collinear with the product 
peptide sequence which is also observed for many other NRPS systems. In these linear type A 
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NRPS assembly lines, TE domains catalyse only one reaction step which is either cyclization 
or hydrolysis of the linear precursor[5]. However, in iterative NRPS type B systems the TE 
domains have an additional function which allows the system to repeat the collinear synthesis 
once or twice. In this case the TE has to count the monomers stalled at the end of the 
assembly line and initiates release by cyclic dimer or trimer formation once the desired 
number is achieved. Less is known about mechanism and structure of iterative cyclases. 
Detailed mass spectrometric analysis was carried out for the last module of the enterobactin 
assembly line (EntF) containing a C-terminal peptide cyclase which catalyses 
cyclotrimerization of  three 2,3-dihydroxybenzoyl serine (DHB-Ser) units to give the cyclic 
trilactone enterobactin[97]. In order to localize acyl-enzyme intermediates an active site 
histidine to alanine mutant enzyme was used with very slow substrate turnover. With this 
approach it was possible to provide evidence for a covalent acyl-O-TE intermediate and 
demonstrate that the peptide cyclase is involved in two reactions: acyl chain growth and 
cyclization. In the first step of acyl chain growth DHB-Ser is transferred to the active site of 
the peptide cyclase by a nucleophilic attack of active site serine onto the acyl-thioester of the 
upstream holo PCP-domain. The second step requires catalytic generation of a DHB-Ser 
alkoxide which in turn allows the nucleophilic attack onto another PCP bound DHB-Ser 
thioester to form a dimeric ester. The elongation step is repeated a third time before the final 
cyclic trilactone is released by an intramolecular nucleophilic attack of serine onto the acyl-O-
TE ester bond. This mechanistic analysis suggests that the enterobactin cyclase serves as a 
waiting room while the phosphopantetheinylated PCP-domain is reacylated, which requires a 
stable ester bond and the exclusion of any water from the active site.  
Insights into the mechanism of cyclization and hydrolysis as well as catalytic capacity of the 
surfactin cyclase are presented in this work. 
2.8 Quaternary Architecture 
Fatty acid synthases (FAS) and polyketide synthases (PKS) use an equivalent assembly line 
strategy with one multi-domain module for each monomeric acyl-CoA incorporated and 
elongated. The acyl chains in each module are tethered as thioesters to 
phosphopantetheinylated carrier protein domains. This is the same logic of a cascade of 
elongating acyl-S-pant-carrier protein intermediates utilized by the NRPS enzymatic 
machinery [44].  
Many enzymes catalyzing sequential metabolic reactions aggregate by non-covalent linking 
of identical or non-identical subunits to form multi-enzyme complexes. The fatty acid 
synthases (FAS) of eucaryotes are examples of an enzyme complex composed of two 
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identical subunits (Fig. 2.16)[98]. Various investigations have unequivocally revealed the 
dimeric organization of multi-modular polyketide synthases [99, 100]. The oligomeric state of 
NRPS enzymatic machinery was unknown. The existence of NRPS-PKS hybrid enzymes in 
nature is well known [101-103] and it would be useful to know if NRPS modules that 
interface with PKS dimeric modules are themselves monomeric or oligomeric. Knowledge of 
the quaternary structure of NRPSs, defined as the spatial geometry of two identical 
neighbouring subunits, is not only important for understanding reactions occurring on or 
between enzymes, but may also be useful for engineering new hybrid enzymes by swapping 
modules or domains. 
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both subunits. The functional interaction between KS and ACP from opposite subunits in a 
dimer has also been supported by cross-linking. This postulated mechanism has been shown 
for both PKS and FAS through product formation catalyzed by a heterodimer [98, 99, 109, 
110]. Recently it was shown by Smith and coworkers that a FAS heterodimer, which consists 
of a wild type subunit and a subunit with mutations in all functional domains, still retains 
activity. This indicates that the quaternary organization of the dimer is required for structural 
integrity since monomers are not active, but in the context of the dimer structure, a monomer 
is self sufficient for catalytic activity.[111]. 
 
Figure 2.17. High resolution crystal structures of NRPS core domains assembled 
as a putative termination module. Shown are the structures of the vibriobactin 
synthetase C-domain VibH, the phenylalanine-activating A domain of gramicidin S 
synthetase PheA, the PCP domain of tyrocidine synthetase module C3 and the TE 
domain of the surfactin synthetase. 
A double-helical structure model for modular PKS was proposed [100]. According to this 
model, the enzyme subunits are orientated head-to-head and folded in an interwound helical 
manner. KS, ACP and AT domains are building the core which is necessary for the observed 
interaction between KS and ACP domains from different strands (Fig. 2.16). Optional 
domains like the KR domain are accommodated in outside loops. The model for FAS 
enzymes considers also functional interactions within each of the two subunits which have 
been observed by cross-linking studies [112] [113]. 
Despite many analogies in the organization and reaction mechanism, in contrast to FAS and 
PKS little is known about the quaternary structure of NRPS. Mainly gel filtration experiments 
are mentioned in literature, e.g. the molecular weight of the enzymes EntB, EntE and EntF of 
the enterobactin synthetase were determined to be monomeric for EntE and EntF and trimeric 
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for EntB [84]. Other NRPS enzymes like the δ-(L-α-aminoadipyl)-L-cysteinyl-D-valine 
synthetase as well as the pipecolate-incorporating enzyme for the biosynthesis of rapamycin 
also showed a monomeric behaviour on gel filtration [114, 115]. One objective of the research 
presented here was therefore to explore the quaternary structure of NRPS.  
2.9 Task 
One aim of this work was to elucidate the quaternary architecture of NRPSs with similar 
strategies to those which have been successfully applied to discover the structure of PKS and 
FAS. In addition to the work which has been started before, analytical ultracentrifugation 
should provide reliable information about protein organization under native conditions. 
Investigations should be carried out with several representative NRPS systems different in 
size and assembly line organization. 
The main task of this work was to investigate the mechanism of peptide cyclization catalysed 
by thioesterase domains in order to evaluate their utility as catalytic cyclization tools. Based 
on a recent crystal structure of surfactin TE the following questions were addressed: 
- Which residues are involved in catalysis? 
- How does the enzyme distinguish between hydrolysis and cyclization? 
- How tolerant is the enzyme for different substrates and what residues are recognized? 
- Is it possible to engineer TE-domain architecture and alter its properties by in vitro 
protein evolution? 
Moreover TE-domains from other NRPS systems should be explored and characterized to 
broaden a putative tool set of cyclization catalysts. 
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3  Materials 
3.1 Chemicals, Enzymes and General Materials 
Chemicals not listed were purchased as standard compounds from other manufacturers in p.a.-
quality. 
Table 3.1. Materials. 
Manufacturer (Location) Product 
Amersham Pharmacia (Freiburg) Source 15Q ion exchange column, Sephadex 200 
16/60 
Amersham/Buchler (Braunschweig) various restriction endonucleases, ampicillin, IPTG, 
kanamycin, yeast extract, coomassie brilliant blue G 
and R250, HiTrapTM desalting columns 
Bachem Nα-Fmoc protected amino acids, Nα-Boc protected 
amino acids 
Biomol Feinchemikalien (Darmstadt) CHAPS 
Böhringer Mannheim (Mannheim) ExpandTM Long Template PCR Kit 
Difco (Detroit, USA) Yeast extract 
Eurogentech (Seraing, Belgien) agarose, electro poration cuvettes 
Fluka (Neu Ulm) SDS, TEMED, fatty acid building blocks, DMF 
Gibco BRL (Karlsruhe) 10 kDa protein molmarker, acrylamide 
IBA (Göttingen) Strep-Tactin sepharose column, Strep-tag HRP 
detection kit 
Millipore (Bedford, USA) dialysis membrane 0,025 µm 
ICN Biomedicals GmbH (Eschwege) DBP (dibromopropanone) cross-linker 
MWG Biotech (Ebersberg), Qiagen 
(Hilden) 
oligonucleotides 
New England Biolabs (Schwalbach) desoxyribonucleotides (dATP, dTTP, dGTP, dCTP), 
restriction endonucleases 
Novabiochem (Darmstadt) Nα-Fmoc protected amino acids, 2-chlorotritylchloride 
resin, HBTU, HOBT, PyBOP 
Oxoid (Wesel) agar Nr.1, trypton 
Pierce (Rockford, USA) BMH (bismaleimidohexane) cross-linker 
Qiagen (Hilden) QIAquick-spin PCR purification kit, Ni2+-NTA-
agarose, QIAexpress vector kit ATG, QIAEXII 
extraction kit 
Qiagen-Operon (Köln)  oligonucleotides 
Roth (Karlsruhe) EtBr, β-mercaptoethanol, acrylamide for SDS-PAGE, 
piperidine 
Schleicher & Schüll (Dassel) Whatman-3MM paper 
Serva (Heidelberg) APS 
Sigma (Deisenhofen) EDTA, coenzyme A, N-acetylcysteamine, thiophenol 
and derivatives 
Stratagene (Heidelberg)  QuikChangeTM Site-Directed Mutagenesis Kit, 
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PfuTurbo DNA polymerase, GeneMorphTM PCR 
Mutagenesis Kit 
Vivascience AG (Hannover) Vivaspin 20 concentrators 10000 MWCO, 
30000MWCO 
Whatmann (Darmstadt) 96-deep well plates 
3.2 Equipment 
Table 3.2. Equipment 
Device Manufacturer 
Autoclave Tuttnauer 5075 ELV 
Bidestilled water supply Seral Seralpur Pro90CN 
DNA-sequenze analyzer Perkin-Elmer/ABI, ABI Prism 310 Genetic Analyzer 
DNA-gel dokumentation Cybertech CS1, thermoprinter Mitsubishi Video Copy 
processor 
Elektroporation-pulse control Bio-Rad Gene Pulser II  
FPLC-System Pharmacia FPLC-Biotechnology FPLC-System 250: 
Gradient-programmer GP-250 
Pump P-500 
Uvicord optical device UV-1 (l = 280 nm) 
Uvicord control element UV-1 
2-channel printer REC-102 
Injection valve V-7 
3-way-valve PSV-100 
Fraction collector FRAC-100 
French Press SLM Aminco; French-Presssure Cell-Version 5.1 
20k Rapid-fill cell (40 mL) 
HPLC-System Agilent series 1100 HPLC-System with DAD-detection, 
vacuum degaser, quaternary pump, autosampler and HP-
chemstation software 
columns: Macherey & Nagel Nucleosil 250/3, pore diameter 
120 Å, particle size 3 µm; Nucleodur, 250/3, pore diameter 
100 Å, particle size 3 µm 
MALDI-TOF Per Septive Biosystems Voyager-DE RP BioSpectrometry, 
Bruker FLEX III 
Peptide synthesis Millipore 9050 Plus 
MS-MS analysis Applied Biosystems, API Qstar Pulsar I 
Shaker New Brunswick Scientific Series 25 Incubator Shaker, New 
Brunswick Scientific Innova 4300 Incubator Shaker 
Photometer Pharmacia Biotech Ultraspec 3000 
Speed-Vac Savant Speed Vac Concentrator, Uniequip Univapo 150 
Thermo-Cycler Perkin-Elmer Thermal Cycler 480, 
Perkin Elmer Gene Amp PCR System 2400, 
Perkin Elmer Gene Amp PCR System 9700 
Centrifugation Heraeus Biofuge pico, 
Sorvall RC26 plus, rotors SS34 and SLA3000, Sorvall RC 
5B Plus 
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3.3 Vector Systems 
3.3.1 pQE60-Vector 
The pQE60 vector system was used for cloning and overexpression of SrfTE active site 
mutants and PCP. The vector allows purification of recombinant proteins by Ni-NTA 
chromatography by fusing a His6-tag to the C-terminal end of the overexpressed protein. This 
His6 codon sequence is attached to the 3´ end of the multiple cloning site (MCS). The pQE60-
vector carries two lac-operators in the promotor region. In the presence of a lac-repressor the 
gene can not be transcribed. After induction with IPTG, repression is abolished and gene 
transcription occurs. This system therefore allows a precise start of protein overexpression. 
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Fig. 3.1 Physical map of the pQE60-vector. 
The vector contains the following components: 
- replication origin from E. coli (ColE1) 
- synthetic ribosomal binding site RBSII 
- T5-promotor from E. coli-phages 
- two lac-operator sequences for expression control by the lac-repressor 
- MCS with recognition sequences for: NcoI (including the ATG-start codon), BamHI 
and BglII 
- Stop codons in all three reading frames 
- codon sequence at the end of the MCS, which codes 6 histidines (C-terminal His6-
tag) 
- two transcription terminators: 
      t0 of an λ-phage 
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      T1 of the rnnB-operon from E. coli 
- β-lactamase-gene bla for ampicillin resistance up to a final concentration of 100µg/mL 
3.3.2 pASK-IBA 2 and pASK-IBA 4 
These vector systems were used for protein evolution of TycTE. Both vectors allow 
purification of recombinant proteins by fusing a strep-tag sequence (WSHPQFEK) to the C-
terminal (pASK-IBA 2) or N-terminal (pASK-IBA 4) end of the overexpressed protein. This 
strep tag sequence has a high affinity to genetically modified streptavidin (Strep-Tactin), 
which is used for affinity purification of the overexpressed proteins. Both vectors also contain 
N-terminal ompA signal peptide, which ensures that premature proteins are segregated into 
the periplasm of the bacterial cell. The signal peptide is cleaved by an E. coli signal peptidase 
while the protein passes trough the cell membrane. 
pASK-IBA 2 and pASK-IBA 4 vectors are tightly regulated by the stringent tet-promotor. 
The tet-promotor is induced by low concentrations of anhydrotetracyclin which are below the 
level of antibiotic activities. The constitutive expression of the vector coded tet-repressor gene 
ensures high repression by the promotor in absence of inductor. There are no further cellular 
regulation mechanisms of the tet-promotor as seen in the lac-promotor.  
The plasmid also contains the following components: 
- origin of replication from pUC plasmids 
- ampicilin-resistance 
- multiple cloning site 
3.3.3 pET37b 
The pET37b (novagen) vector system was used for cloning and overexpression of fen PCP-
TE, syr TE and myc PCP-TE as well as the fen PCP-TE active site mutant. The vector allows 
Ni-NTA chromatography purification of recombinant proteins by fusion of a His8-tag to the 
C-terminal end of the overexpressed protein. In pET vectors, target genes are cloned under 
control of strong bacteriophage T7 transcription and translation signals, and expression is 
induced by providing a source of IPTG inducable T7 RNA polymerase in the host cell. E. coli 
BL21 cells were used for expression (chapter 3.4.2). 
3.3.4 pBAD202/D-TOPO 
The pBAD202/D-TOPO vector (Invitrogen) was used for the expression of the cyclosporin C-
domain gene. The vector is regulated by the araBAD-promotor and is induced by low 
concentrations of arabinose. The His-patch thioredoxin leader increases the efficiency of 
translation and produces more soluble protein.  The vector allows purification of recombinant 
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proteins by Ni-NTA chromatography by fusion of a His6-tag to the C-terminal end of the 
overexpressed protein. 
The plasmid also contains the following components: 
- origin of replication from pUC plasmids 
- rrnB transcription terminator 
- codon sequence coding a V5 epitope 
- CAP-(cAMP binding protein) binding site for transcription enhancement by binding of 
the CAP-cAMP-complex 
- Kanamycin resistance  
 
3.4 Microorganisms 
3.4.1 E. coli XL1-Blue 
This strain was used for cloning and sequencing purposes. The genotype is as follows: recA1, 
endA1, gyrA96, thi-1, hsdR17, supE44, relA1, lac, F'(proAB+, lacIq, lacZDM15, Tn10(Tetr)) 
3.4.2 E. coli BL21(DE3) 
The E. coli strain BL21(DE3) with the genotype  is known as a bacterial host 
for the expression of plasmid DNA. It is characterized by a deficiency of Ion (protease) and 
by the lack of OmpT (protease of the outer membrane). It further contains an IPTG-induceble 
T7 polymerase gene, which is inserted in the chromosome after lacZ and the promotor lacuV5 
on a λ-prophage. This is essential for the IPTG induction of genes under T7-promotor control. 
F-  - -B BompT r m
3.4.3 E. coli M15 
This strain lacks the T7-polymerase. The genotype is as follows: nals, strs, rifs, lac, ara, gal, 
mtl, F-. 
3.5 Media 
E. coli strains were grown in LB-media. To prevent phage infections 20 mM Na+-citrate were 
added. 
 16 g/L bactotrypton 
 10 g/L yeast-extract 
 5 g/L NaCl 
 20 mM Na-citrate 
  
Culure plates: 1.2 % (w/v) of agar no.1 was added to the LB-media and heated at 121°C and 
1,5 bar for 30 min. Antibiotics were added after cooling down to 55 °C in the following 
standard concentrations: 100 µg/mL ampicillin, 50 µg/ml kanamycin. 
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4 Methods 
4.1 Methods of Molecular Biology 
4.1.1 Construction of Plasmids 
Amplification of all DNA gene fragments was carried out by polymerase chain reaction 
(PCR) with Pfu polymerase (Stratagene) according to the manufacturers protocol with 
synthetic oligonucleotides (MWG, Ebersberg or Qiagen-Operon, Köln). Purification of PCR-
fragments was carried out by the “QIAquick-spin PCR purification kit” according to the 
manufacturers protocol (Qiagen, Hilden). All constructs were analyzed by restriction digests 
and DNA-sequencing.  
 
Construction of pET37b[fenPCP-TE] – The fengycin gene fragment encoding Fen PCP-
TE[14] was amplified from chromosomal DNA with the following oligonucleotides: 5´-AAA 
AAA AAC ATA TGC GTC AGG ACC TCA CAC CGC-3´ and 5´-AAA AAA CTC GAG 
ATG CTT ATT TGG CAG CAC TTT TTG-3´. The PCR product of fenPCP-TE was cloned 
into the NdeI/XhoI site of pET37b (Novagen). The plasmid was directly used to produce 
protein with a C-terminal octahistidine tag. 
 
Construction of pQE60[srfPCP] - The surfactin gene fragment encoding Srf PCP (ATCC 
21332) was amplified from chromosomal DNA with the following oligonucleotides: 5´-AAA 
CCA TGG AAT GGA TTG GAC CGC GGA AC-3´ and 5´-AAA GGA TCC GTT TTT CAA 
ATA CGC TGA AAT GC-3´. The PCR product of srf PCP was cloned into the NcoI/BamHI 
site of pQE60 (Qiagen). The plasmids were directly used to produce protein with a C-terminal 
hexahistidine tag. 
 
Construction of pET37b[mycPCP-TE] - The mycosubtilin (ATCC 6633) gene fragment 
encoding Myc PCP-TE was amplified from chromosomal DNA with the following 
oligonucleotides: 5´-AAA AAC ATA TGG CTG CTC CCC GAA CGT TGA TT-3´ and 5`-
AAA AAC TCG AGT GTT CGA TCA GAT TTT GTG CGA CTC-3´. The PCR product of 
myc PCP-TE was cloned into the NdeI/XhoI site of a pET37b vector (Novagene). Escherichia 
coli TOP 10 (Novagen) was used for preparation of recombinant plasmids. The plasmid was 
directly used to produce proteins with a C-terminal octahistidine tag. 
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Construction of pET37b[syrTE] - The syringomycin (DSMZ B-301D) gene fragment 
encoding Syr TE was amplified from chromosomal DNA with the following oligonucleotides: 
5´-AAA AAC ATA TGG GCC AGG CAC GCC CC-3`and 5´-AAA AAC TCG AGC TCA 
GCT GGC GCG GTT ATC-3´. The PCR product of syr TE was cloned into the NdeI/XhoI 
site of a pET37b vector (Novagene). The plasmid was directly used to produce protein with a 
C-terminal octahistidine tag.  
 
Construction of pASK-IBA2[tycTE] – The tycTE gene fragment was amplified from a pQE60 
vector containing tycTE[90] with the following oligonucleotides: 5´-AAA AAG AAT TCG 
CAT AAG CGC TTT GAG AGC AG-3´ and 5´-AAA AAC TGC AGT TTC AGG ATG 
AAC AGT TCT TG-3´. The PCR product of tyc TE was cloned into the EcoRI/PstI site of a 
pASK-IBA2 vector (IBA). The plasmid was directly used to produce protein with a C-
terminal strep-tag. 
 
Construction of pASK-IBA4[tycTE*] – The tycTE gene fragment was amplified from the 
pASK-IBA2 [tycTE*] (chapter 4.1.2) with the following oligonucleotides: 5´-AAA AAG 
AAT TCC ATA AGC GCT TTG AGA GCA G-3´ and 5´-AAA AAC TGC AGT TTC AGG 
ATG AAC AGT TCT TG-3´. The PCR product of tyc TE was cloned into the EcoRI/PstI site 
of a pASK-IBA4 vector (IBA). The plasmid was directly used to produce protein with a N-
terminal strep-tag. 
 
Construction of pBAD202/D-TOPO[cssC]- The cssC gene fragment was amplified from 
chromosomal DNA (ATCC 34921) with the following oligonucleotides: 5´-CAC CCA ACA 
GCA GGG GTT CTC GGG-3´ and 5`-TGT TCT GCT CAA AGC GAG CAT GG-3´. The 
PCR product of cssC containing the sequence 5´-CACC at the 5´-end was incubated with a 
pBAD202/D-TOPO vector (Invitrogen) according to the manufacturers protocol. The plasmid 
was directly used to produce protein with a C-terminal hexahistidine tag. 
4.1.2 Site Directed Mutagenesis 
Construction of Srf TE active site mutants - The mutants were constructed by the 
“QuickChange site directed mutagenesis kit” (Stratagene) according to the manufacturers 
protocol. Constructs were obtained by PCR amplification of the Srf TE-containing pQE60 
plasmid[80] with the following oligonucleotides (modified sequences underlined): P26G, 5´-
ATT TTC GCA TTT CCG GGG GTC TTG GGC TAT GGC CT-3´ and 5´-AGG CCA TAG 
CCC AAG ACC CCC GGA AAT GCG AAA AT-3´; S80C, 5´-CAT TGT TTG GAT ATT 
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GCG CGG GAT GCA GCC TGG CG-3´ and 5´-CGC CAG GCT GCA TCC CGC GCA 
ATA TCC AAA CAA TG-3´; D107A, 5´-GCG GAT CAT CAT GGT CGC TTC CTA TAA 
AAA ACA AGG TGT C-3´ and 5´-GAC ACC TTG TTT TTT ATA GGA AGC GAC CAT 
GAT GAT CCG C-3´; K111A, 5´-GGT CGA TTC CTA TAA AGC ACA AGG TGT CAG 
TGA TCT GG-3´ and 5´-CCA GAT GAC TGA CAC CTT GTG CTT GTG CTT TAT AGG 
AAT CGA CC-3´; R120A, 5´-TGT CAG TGA TCT GGA CGG AGC CAC GGT TGA AAG 
TGA-3´ and 5´-TCA CTT TCA ACC GTG GCT CCG TCC AGA TCA CTG ACA-3´; 
H207A, 5´-AAG AGG CTT CGG AAC AGC CGC AGA AAT GCT GCA GG-3´ and 5´-
CCT GCA TTT CTG CGG CTG TTC CGA AGC CTC TT-3´. E. coli XL1 Blue (Stratagene) 
was used for preparation of recombinant plasmids. Mutagenesis products were confirmed by 
sequencing with an ABI Prism 310 (Applied Biosystems). 
 
Construction of pET37b[fenPCP-TE*] - The gene fragment encoding the Fen PCP-TE site 
directed mutant was constructed using the Quick-Change site directed mutagenesis kit 
(Stratagene) according to the manufacturers protocol. The construct was obtained by PCR 
amplification of Fen PCP-TE containing pET37b plasmid with the following oligonucleotides 
(modified sequences underlined): 5´-CTA TTA GGC TAC GCC GCG GGC GGA ACT T-3´ 
and 5´-TCC GCC CGC GGC GTA GCC TAA TAG AAC GT-3´. E. coli TOP10 (Novagen, 
USA) was used for preparation of recombinant plasmids. All constructs were confirmed by 
sequencing. 
 
Construction of pASK-IBA2[tycTE*] – Two silent point mutations were introduced into the 
TycTE gene fragment by standard PCR amplification of the pASK-IBA2[tycTE] vector with 
the following oligonucleotides: 5´-CGA AAG AAC TCG AGG AGC GGG-3´ and 5´-CGT 
CTG CTT CGA GCT CGG ATT-5´. These silent point mutations give rise to two unique 
restriction sites within the lid region of Tyc TE (XhoI/SacI). The final PCR product was 
cloned into the EcoRI/PstI site of a pASK-IBA2 vector (IBA). The plasmid was directly used 
to produce protein with a C-terminal strep-tag. 
4.1.3 Random Mutagenesis 
Random mutagenesis was carried out with the “GeneMorphTM PCR Mutagenesis Kit” 
(Stratagene) according to the manufacturers protocol. In this kit an error rate is achieved by a 
genetically modified “Mutazyme DNA polymerase”. A low, medium or high mutation 
frequency is produced by adjusting the initial target DNA amounts in the amplification 
reactions. For the same PCR yield, targets amplified from low amounts of target DNA 
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undergo more duplications than targets amplified from high concentrations of DNA. The 
more times a target is replicated, the more errors occur. Mutazyme DNA polymerase makes 
few insertion and deletion mutations (1.1 %) which create frame shifts. 
In this study a mutation rate of 7-16/kb was selected by amplifying 10 ng of DNA template. 
This was repeated 3 times with 10 ng template at each amplification step. The PCR product 
yield must be between 500 ng and 10 µg in a 50 µl reaction in order to obtain the predicted 
mutation frequencies. To ensure sufficient product yield, sample PCR reactions are 
electrophoresed adjacent to a DNA standard. The mutation rate obtained by DNA sequencing 
was about 3-4 per 273 bp corresponding to 1-2 amino acid mutations. The mutated gene 
fragments of the tyc TE lid region were digested with XhoI/SacI and cloned into the pASK-
IBA2[tycTE*] vector containing unique restriction sites in the lid region. 
Table 4.1. PCR protocol for random mutagenesis 
Cycles Temperature [°C] Time [min] 
1 95 1:00 
95 1:00 
50 1:00 
30 
72 1:00 
1 72 10:00 
4.1.4 DNA Sequencing 
Sequence analysis of double stranded DNA was carried out by the method of chain 
termination (147 RF) with the “ABI Prism dRhodamine terminator cycle sequencing ready 
reaction kit (ABI, Foster City (USA))” according to the manufacturers protocol. Sequencing 
reactions were performed with 100 ng of DNA per kbp, 5 pmol primer and 3-4 µl sequence 
mix. After 25-30 rounds of PCR and subsequent purification the sequence analysis was 
carried out on an “ABI Prism 310 Genetic Analyzer (Applied Biosystems, Weiterstadt)”. 
4.2 Protein Techniques 
Standard methods used in protein chemistry like SDS-polyacrylamide-gelelectrophoresis 
(SDS-PAGE) and coomassie-staining have been described elsewhere[46, 116].  
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4.2.1 Gene Expression 
Heterologous expression of TE and PCP-TE proteins was predominantly carried out in the 
pQE60 and pET37b vector systems. For protein evolution of Tyc TE also pASK-IBA and for 
cloning of the cyclosporin A C-domain pBAD202/D-TOPO were used. For this purpose E. 
coli BL21 (DE3) and M15 were transformed with the expression plasmids by electroporation, 
with the exception of tyc TE for protein evolution where E. coli XL1 Blue was transformed 
with expression plasmids. 
4.2.1.1 Expression with the pQE- and pET-Vector Systems 
5 ml overnight culture of the corresponding expression strain in LB-media was inoculated in 
500 ml of LB-media. The culture was incubated at 30-37 °C and 220 rpm until an A600 of 0.5-
0.7 was observed. The expression was induced by adding 1 mM IPTG. The culture was 
further incubated at 30 °C, 220 rpm for 2-3 h. The cells were subsequently harvested by 
centrifugation (5000 upm, 4 °C, 10 min) and the resulting pellet resuspended in Hepes-A 
buffer (50 mM Hepes, 300 mM NaCl (pH 8.0)). The cell suspension was either stored at –20 
°C or immediately used for protein preparation. 
4.2.1.2 Expression with the IBA-Vector Systems 
3 ml overnight culture of the corresponding expression strain in LB-media was inoculated in 
300 ml of LB-media (Amp100). The culture was incubated at 30-37 °C and 220 rpm until an 
A550 of 0.5-0.7 was observed. The expression was induced by adding 3 µL of an 
anhydroteracycline solution in DMF (2 mg/ml) and the culture was further incubated at 30 °C, 
220 rpm for 2-3 h. The cells were subsequently harvested by centrifugation (5000 upm, 4 °C, 
10 min) and the resulting pellet was resuspended in 3 ml buffer P (100 mM Tris/HCl, 1 mM 
ethylendiaminteraactetate (EDTA), 250 mM sucrose (pH 8.0)). The cell suspension was either 
stored at –20 °C or immediately used for protein preparation. 
4.2.1.3 Expression with the pBAD/TOPO-Vector System 
5 ml overnight culture of the corresponding expression strain in LB-media was inoculated in 
500 ml of LB-media (Kan50). The culture was incubated at 22 °C and 220 rpm until an A600 of 
0.5-0.7 was observed. The expression was induced by adding 0.01 % - 0.0005 % arabinose. 
The culture was further incubated at 22 °C, 220 rpm for 3 h. The cells were subsequently 
harvested by centrifugation (5000 upm, 4 °C, 10 min) and the resulting pellet resuspended in 
Hepes-A buffer (50 mM Hepes, 300 mM NaCl (pH 8.0)). The cell suspension was either 
stored at –20 °C or immediately used for protein preparation. 
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4.2.2 Protein Purification 
Protein purification was carried out using Ni-NTA affinity chromatography, Strep-Tactin 
affinity chromatography or periplasmatic extraction for high throughput protein evolution. 
4.2.2.1 Preparation of Cell Extracts 
Preparation of cell extracts from cytoplasmatic expressions was carried out by using a pre-
cooled 40 K French Press cell (SLM Aminco, Urbana, Illinois (USA)). Three cycles of 
compression and decompression were performed with each cell extract. Disrupted cell 
material was separated from the cell extract by centrifugation (17500 upm, 4 °C, 30 min). The 
supernatant was subsequently used for affinity chromatography. 
Preparation of cell extracts from periplasmatic expression was carried out by 30 – 60 min 
incubation on ice with buffer P. Buffer P contains EDTA which destabilises the cell wall by 
complexing Ca2+ and Mg2+ ions. Subsequent centrifugation (17500 upm, 4 °C, 10 min) 
disrupts the outer membrane and releases proteins in solution. For high throughput assays no 
further purification was required. 
4.2.2.2 Purification of His6-tagged Proteins 
His6-tagged proteins can be easily purified by Ni2+-NTA affinity chromatography. In standard 
purifications cell extracts from 500 ml expressions were loaded onto a Ni-NTA superflow 
(Qiagen, Hilden) column (HR 10/2, Amersham Biosciences, Freiburg). The column was 
loaded with a flow rate of 0.8 ml/min in 3 % buffer Hepes B (50 mM Hepes, 300 mM NaCl, 
250 mM imidazole (pH 8.0)) on a “fast performance liquid chromatography” (FPLC) system 
(Amersham Biosciences, Freiburg). Protein binding was monitored at A220. When the A220 
was at baseline again, a 30 min linear gradient up to 50 % Hepes B followed by a 10 min 
gradient to 100 % Hepes B with a flow rate of 1 ml/min was applied. Fractions of 2 ml were 
collected. Proteins were identified by SDS-PAGE. All proteins were dialyzed with standard 
assay buffer (25 mM Hepes, 50 mM NaCl (pH 7.0)) by using “HiTrap Desalting” columns 
(Amersham Biosciences, Freiburg). 
4.2.2.3 Purification of Strep-tagged Proteins 
Strep-tagged proteins can be easily purified by Strep-Tactin affinity columns. 3 ml of 
periplasmatic extract were loaded onto a Step-Tactin gravity flow column (IBA, Göttingen). 
The column was washed 5 times with 1 ml buffer W and eluted with 6 times 0.5 ml buffer E 
(100 mM Tris/HCl, 1 mM EDTA, 2.5 mM Desthiobiotin (pH 8.0)). The column was 
regenerated  with 5 ml buffer R (100 mM Tris/HCl, 1 mM EDTA, 1 mM 4´-hydroxo-
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benzolazo-2-benzoic acid (HABA) (pH 8.0)) followed by equilibration of the column with 4 
ml buffer W. Purity of proteins was evaluated by SDS-PAGE and desalting was carried out as 
described in 4.2.2.2. 
4.2.3 Concentration of Protein Solutions 
Concentrations of the purified proteins were determined photometrically at 280 nm using 
calculated extinction coefficients (table 4.2). Theoretical extinction coefficients were 
calculated by ProtParam (Expasy, Geneva (Switzerland)). 
Table 4.2. Theoretical extinction coefficients 
Protein Theoretical extinction 
coefficient [mg/ml] 
PCP 1.28 
SrfTE and all mutants 0.87  
SyrTE 0.83 
FenPCP-TE 1.09 
MycPCP-TE 0.80 
TycTE 1.34 
JH1 1.15 
10B6 1.10 
9E2 0.86 
 
4.3 Biochemical Methods 
4.3.1 Cyclization Assays with SNAC and Thiophenol Substrates 
Reactions were carried out in standard assay buffer in a total volume of 50 µL. Substrate 
concentration was 100 - 250 µM for standard reactions and varied for kinetic investigations. 
For the cycle opening reactions, 250 mM of SNAC, ONAC, or N-acetylethylenediamine 
(NNAC) were added. Reactions were initiated by addition of enzyme to give final 
concentrations of 5 µM for Fen PCP-TE, 1 and 2.5 µM for Srf TE, 30 µM for Myc PCP-TE 
and 15 µM for Syr TE. Reactions were quenched at various time points by addition of 35 µL 
of 4 % TFA/H2O, and the products were analysed by HPLC-MS on a reversed phase C18 
Nucleodur column (Macherey and Nagel, 250/3, pore diameter 100 Å, particle size:3 µm) 
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with the following gradients: Fen PCP-TE 0-35 min, 30-60 % Acetonitrile/0.1 % TFA in 
water/0.1 % TFA; 0.4 mL/min, 40°C, Srf TE 0-40 min, 20-55 % Acetonitrile/0.1 % TFA in 
water/0.1 % TFA; 0.4 mL/min, 40°C, Myc PCP-TE 0-40 min, 5-50 % Acetonitrile/0.1 % TFA 
in water/0.1 % TFA; 0.4 mL/min, 40°C and Syr TE 0-40 min, 10-50 % Acetonitrile/0.1 % 
TFA in water/0.1 % TFA; 0.4 mL/min, 40°C. Identities of the products were confirmed by 
ESI-MS, and cyclic by-products were additionally verified by MS-MS analysis to confirm 
connection regiospecificity (API Qstar Pulsar i, Applied Biosystems).  
Concentrations of peptidyl-thioesters were calculated using experimentally determined 
extinction coefficients at 220 nm and assumed to be the same for cyclized and hydrolysed 
products. Kinetic characterization of the cyclization and hydrolysis reactions were carried out 
by determining initial rates at 5 – 7 substrate concentrations using two time points at each 
concentration within the linear region of the enzymes determined by time courses. 
The preparative scale synthesis of cyclic SLP-wt (see appendix) was carried out under 
standard assay conditions in a total volume of 10 mL (200-fold increase). After 2.5 hr, the 
reaction was quenched with 500 µL TFA and centrifuged at 2000 rpm for 5 min. The 
supernatant was lyophylized overnight and redissolved in 2 mL 1:1 H2O/Acetonitrile. The 
cycle was isolated by preparative HPLC with a reversed-phase (C18) column (Vydac). Cyclic 
SLP-wt elutes at 24 min (10 mL/min; 0-35 min, 20-100% B; A = H2O, 0.1% TFA; B = 
acetonitrile). 
4.3.2 Loading Peptidyl-CoA onto PCP  
Loading reactions of apo PCPs were carried out in standard assay buffer in a total volume of 
100 µL at room temperature. For the kinetic characterization of the PCP loading reaction the 
concentration of PCP was kept constant at 50 µM (KM = 1.3-1.8 µM)[55]. Initial rates were 
determined at various peptidyl-CoA concentrations ranging from 5 µM to 100 µM using two 
time points (7 min and 14 min) at each concentration. A time course showed that 
modifications were linear up to 30 min. Reactions were initiated by addition of Sfp to give a 
final concentration of 2 µM and quenched by the addition of 30 µL of 4 % TFA/H2O. The 
products were analyzed by analytical HPLC-MS (Agilent 1100) with a reversed phase C18 
Nucleosil (Macherey and Nagel, 250/3, pore diameter:120 Å, particel size:3 µm) column. The 
identities of the products were confirmed by HPLC-MS and MALDI-TOF MS. Different 
gradients were applied according to resolution of the substrates (0-26 min, 55 to 70 % 
Acetonitrile/0.1 % TFA in water/0.1 % TFA, or 0-26 min, 40-57 % Acetonitrile/0.1 % TFA in 
water/0.1 % TFA; 0.9 mL/min, 45°C)[117]. The concentration of apo-PCP was calculated 
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using experimentally determined extinction coefficients at 220 nm which were assumed to be 
the same for the peptidyl holo-PCPs.  
4.3.3 PCP-TE Cyclization Assay 
PCP-TE cyclization assays were carried out in 100 µl standard assay buffer at room 
temperature. The peptidyl-CoA concentration ranged from 20 µM to 60 µM and the PCP-TE 
concentration was 60 µM. Reactions were initiated by addition of Sfp to give a final 
concentration of 5 µM to ensure a fast modification reaction. Reactions were quenched at 
various time points by addition of 40 µL 4 % TFA/H2O and were analyzed by HPLC-MS on a 
reversed phase C18 Nucleodur column (Macherey and Nagel, 250/3, pore diameter:100 Å, 
particle size:3 µm) with the following gradient: 0-35 min, 30-60 % acetonitrile/0.1 % TFA in 
water/0.1 % TFA; 0.4 mL/min, 40°C. Identities of the products were confirmed by ESI-MS 
and MALDI-TOF MS, and the cyclic products were additionally verified by MS-MS analysis 
(API Qstar Pulsar i, Applied Biosystems). Cyclic product hydrolysis assays were carried out 
in 100 µL standard assay buffer under the same conditions as mentioned above with 30 µM 
PCP-TE and 50 µM fengycin cycle. 
4.3.4 Protein Evolution 
After expression of TycTe mutant variants in 96 deep well plates the cells were pelleted by 
centrifugation (4000 upm, 4 °C, 15 min) and resuspended in 50 µl buffer P. The cell 
fragments were pelleted again by centrifugation (4000 upm, 4 °C, 15 min) after 1 h 
incubation. 8 µl of 1 mM TLP-Ala (see appendix) was added to the supernatant and 
incubated for 1 h at room temperature. Reactions were stopped by adding 35 µl 4 % 
TFA/water. The products were analyzed by analytical HPLC-MS (Agilent 1100, API Qstar 
Pulsar I, Applied Biosystems) with a reversed phase C8 Nucleosil (Macherey and Nagel, 30/2, 
pore diameter:120 Å, particle size:3 µm) column with the following method: 5 min, 40 % 
acetonitrile/0.1 % TFA in water/0.1 % TFA; 0.3 mL/min, 40°C. 
4.4 Analytical Methods 
4.4.1 Analytical Ultracentrifugation 
Sedimentation equilibrium experiments were performed with a Beckman Optima XL-A 
ultracentrifuge. Equilibrium and Monte Carlo analyses were performed with UltraScan 
version 5.0 [118]. Hydrodynamic corrections for buffer conditions were made according to 
data published by Laue et al. [119] and as implemented in UltraScan. The partial specific 
volumes of TycB2-3 and EntF were estimated according to the method of Cohn and Edsall 
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[120] and as implemented in UltraScan. TycB2-3 samples were analyzed in a buffer containing 
25mM Hepes pH 7 and 50mM NaCl. EntF samples were analyzed in a buffer containing 
25mM TRIS pH 8, 10mM MgCl2, 5mM DTT and 10% glycerol. Experiments were performed 
at 4°C at speeds ranging between 5,000 and 12,500 rpm for TycB2-3 and between 8,000 and 
17,000 for EntF. Samples were spun in a 6-channel 12mm external fill equilibrium 
centerpiece in an An-60 Ti rotor. 280nm scans were collected at equilibrium in radial step 
mode with 0.001cm steps and 50 point averaging. Loading concentrations were 0.39 and 0.57 
O.D. for TycB2-3 and 0.40 O.D. for EntF. Data exceeding 0.9 O.D. was excluded from the fits. 
Data fitting was performed with a monomer-dimer equilibrium model for TycB2-3 and with a 
one-component (monomer only) model for EntF, as implemented in UltraScan. 
4.4.2 MALDI-MS 
Matrix Assisted Laser Desorption/Ionization-Mass Spectrometry (MALDI-MS) is an 
analytical method to determine the molecular mass of peptides and proteins in high vacuum. 
Samples were prepared by mixing 1 µl of peptide sample with 1 µl DHB-matrix solution 
(Agilent Technologies). 1 µl of this solution was pipetted onto a metallic target probe and 
dried under air. The cocrystallized samples were investigated with a “Bruker FLEX III” 
(Bruker Daltronics, Leipzig). 
4.4.3 HPLC-MS  
High Performance Liquid Chromatography (HPLC) was used to characterize substrate and 
product by retention time on a chromatography column and by mass. Reversed phase 
chromatography is based on hydrophobic interactions with the unpolar stationary phase (C18 
or C8 coated silica gel). Elution is mediated by the unpolar organic solvent acetonitrile which 
concurs with the adsorbed analytical compound for binding positions. The retention time of 
the analytical compound is monitored by UV-detection. An electrospray-ionization mass 
detector allows the mass analysis of liquid compounds at atmospheric pressure. Ionization of 
the analytical compound was achieved by adding 0.1 % TFA. Experiments were carried out 
on a “Agilent 1100” system (Agilent, Waldbronn). Experimental details are listed in section 
4.3.  
All substrates and products were confirmed by HPLC-MS or MALDI-MS: 
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Table 4.3. Characterization of surfactin SNAC substrates and products by mass. 
N/A = not applicable; N/D = no product detected. 
observed mass (calculated mass) (Da) compound species 
Substrate cyclized product hydrolyzed product 
SLP-wt [M-H]- 999.7 (999.5) 880.7 (880.5) 898.6 (898.5) 
SLP-1 [M+H]+ 959.4 (958.6) N/A 857.4 (857.5) 
SLP-2 [M+H]+ 973.9 (974.5) 855.5 (855.5) 873.5 (873.5) 
SLP-3 [M+H]+ 974.8 (974.5) 854.9 (855.5) 873.0 (873.5) 
SLP-4 [M+H]+ 989.1 (988.5) 869.6 (869.5) 887.6 (887.5) 
SLP-5 [M+H]+ 972.3 (972.6) 853.0 (853.5) 871.0 (871.5) 
SLP-6 [M+H]+ 974.4 (974.5) N/D N/D 
SLP-7 [M+H]+ 974.1 (974.5) N/D N/D 
SLP-1/2 [M+H]+ 871.9 (872.5) 752.8 (753.5) 771.0 (771.5) 
SLP-3/4 [M+H]+ 901.8 (902.5) 783.3 (783.4) 800.8 (801.5) 
SLP-5/6 [M+H]+ 885.9 (886.5) 767.0 (767.5) 785.0 (785.5) 
SLP-wt 
cycle 
[M-H]- 880.7 (880.5) N/A 898.1 (898.5) 
SLP-ONAC [M-H]- 983.8 (983.5) 880.6 (880.5) 898.6 (898.5) 
SLP-εOH [M+H]+ 1002.6 (1002.5) 883.5 (883.5) 901.5 (901.5) 
Table 4.4. Characterization of peptidyl-coenzyme A substrates by mass. 
compound species ionization 
method 
observed mass (calculated mass) (Da) 
SLP [M+H]+ ESI 1620.4 (1620.6) 
MLP [M+H]+ ESI 1613.5 (1613.5) 
FLP [M+H]+ ESI 2018.5 (2018.7) 
FLP(Phe) [M+H]+ ESI 2003.6 (2003.7) 
FLP(2) [M-H]- MALDI 2016.6 (2016.7) 
FLP(4) [M-H]- MALDI 2016.6 (2016.7) 
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Table 4.5. Characterization of peptidyl-PCP and cyclic fengycin products by 
mass. N/D = no product detected. 
compound species ionization 
method 
observed mass (calculated mass) (Da) 
apo-PCP [M+H]+ MALDI 9876.0 (9877.3) 
SLP-PCP [M+H]+ MALDI 11069.0 (11068.9) 
MLP-PCP [M+H]+ MALDI 11063.0 (11061.7) 
FLP-PCP [M+H]+ MALDI 11467.0 (11466.9) 
   cyclized product hydrolyzed product 
FLP [M+H]+ ESI 1251.2 (1251.6) 1269.4 (1269.6) 
FLP (Phe) [M+H]+ ESI N/D 1253.4 (1253.6) 
FLP (2) [M+H]+ ESI 1251.2 (1251.6) 1269.4 (1269.6) 
FLP (4) [M+H]+ ESI N/D 1269.4 (1269.6) 
Table 4.6. Characterization of thiophenol substrates by mass. 
compound species ionization 
method 
observed mass (calculated 
mass) (Da) 
FLP-tp [M+H]+ ESI 1361.4 (1361.6) 
SLP-tp [M+H]+ ESI 965.4 (965.5) 
MLP-tp [M+H]+ ESI 1055.5 (1055.5) 
SyLP-tp [M+H]+ ESI 1175.6 (1175.5) 
SLP-tc [M+H]+ ESI 979.4 (979.5) 
SLP-mb [M+H]+ ESI 995.4 (995.5) 
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Table 4.7. Characterization of thiophenol products by mass. 
compound species ionization 
method 
observed mass (calculated mass) (Da) 
cyclized product      hydrolyzed product 
Cy/Hy 
ratio 
FLP-tp [M+H]+ ESI 1251.4 (1251.6) 1269.4 (1269.6) 0.85 
SLP-tp [M+H]+ ESI 855.4 (855.5) 873.4 (873.5) 0.78 
MLP-tp [M+H]+ ESI 945.4 (945.4) 963.4 (963.5) 1.13 
SyLP-tp [M+H]+ ESI 1065.3 (1065.5) 1083.6 (1083.5) 0.65 
SLP-tc [M+H]+ ESI 855.4 (855.5) 873.4 (873.5) 0.73 
SLP-mb [M+H]+ ESI 855.4 (855.5) 873.4 (873.5) 0.64 
Table 4.8 Characterization of tyrocidine substrates and products by mass. 
observed mass (calculated mass) (Da) compound species 
Substrate cyclized product hydrolyzed product 
TLP [M+H]+ 1389.6 (1389.7) 1270.5 (1270.6) 1288.6 (1288.7) 
TLP-Ala [M+H]+ 1313.6 (1313.6) 1194.5 (1194.6) 1212.5 (1212.6) 
allyl-TLP [M+H]+ 1339.6 (1339.7) 1220.6 (1220.6) 1238.7 (1238.6) 
Ala-Ala-TLP [M+H]+ 1304.4 (1304.6) 1185.4 (1185.6) 1203.6 (1203.6) 
Ala-Leu-TLP [M+H]+ 1346.4 (1346.6) 1227.4 (1227.6) 1245.6 (1245.6) 
 
4.5 Solid Phase Peptide Synthesis (SPPS) 
Synthesis of peptide chains on an insoluble support has benefits like easy separation of 
intermediate peptides by filtration and washing with savings in time and labour. However, 
there are also limitations in this approach: By-products from incomplete reactions, side 
reactions, or impure reagents will accumulate on the resin during chain assembly and 
contaminate the final product. In this work Fmoc-based SPPS was used in a batch 
process[121]. The resin used was cross-linked polystyrene with an attached 2-
chlorotritylchloride linker (Novabiochem, Darmstadt). Amino acid building blocks were side 
chain protected to prevent side reactions (Bachem, Novabiochem). Protecting groups 
included: tert-butyl (tBu), trityl (trt) and Boc. 
4 Methods 
4.5.1 SPPS: Initiation, Elongation and Termination   
4.5.1.1 Initiation: Coupling of the First Amino Acid to the Resin 
The first step in the process of solid phase peptide synthesis is the loading of the resin linker 
2-chlorotritylchloride with the C-terminal amino acid. This step is very important because the 
extend of this reaction will determine the yield of the final product and also sites on the resin 
not reacted in this initial process can potentially be acylated in subsequent cycles leading to 
truncated products. For this reason the resin was incubated in dry DCM with 2 equivalents of 
Fmoc-protected amino acid and 8 equivalents of the weak base DIPEA (N,N-
diisopropylethylamine) which ensures complete deprotonation of the carboxy-group. The 
carboxy-group carries out a nucleophilic attack onto the labile carbon-chlorine bond of the 2-
chlorotrityl linker, attaching the first amino acid to the resin. After 2 h incubation the solvent 
was removed by filtration and the resin washed with DCM (Fig. 4.1). 
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Figure 4.1. Coupling of first amino acid onto solid support. 
4.5.1.2 Elongation 
Elongation of the peptide chain requires deprotection of the N-terminal Fmoc-protecting 
group of the resin bound amino acid. The removal is usually achieved by treatment with 20 % 
piperidine in DMF for 5 – 10 min. The key step is initial deprotonation of the flourene ring to 
generate the aromatic cyclopentadiene-type intermediate. This rapidly eliminates to form 
dibenzofulvene, which is scavenged by piperidine (Fig. 4.2).  
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Figure 4.2. Deprotection of Fmoc protected amino acid. 
Chemical methods to form peptide bonds require activation of the carboxy-group of the 
Fmoc-protected amino acid. In this work only in situ coupling methods were applied by using 
the coupling reagent HBTU with its additive HOBt in DMF. The carboxy-group is 
deprotonated by a 10 fold excess of DIPEA and attacks in the second step the electrophilic 
carbenium ion of HBTU. A very reactive N,N,N,N-tetramethylurea intermediate is formed 
which is attacked by the nucleophile HOBt leading to a reactive benzotriazole ester. The free 
amine of the resin bound amino acid attacks this intermediate releasing benzotriazol and 
giving rise to an elongated peptide chain (Fig. 4.3). Quantitative reactions are observed when 
a high excess of amino acids (3 times) is used. 
An analytical method to monitor the qualitative success of each coupling step can be carried 
out with the Kaiser-test[121]. The reaction of ninhydrin with primary amines leads to intense 
blue color. No color is observed with Fmoc-protected amines, which allows to distinguish 
between success of deprotection and coupling. 
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Figure 4.3. Amino acid activation and peptide elongation. 
4.5.1.3 Termination 
Cleavage of the mature peptide off the resin was carried out with a mixture of acetic 
acid/trifluoroethanol/DCM (1:2:7). The acid labile 2-chlorotritylchloride-linker releases the 
peptide while all other acid labile protecting groups are stable under these conditions. The 
peptide is washed in hexane. 
4.6 Chemical Synthesis 
4.6.1 Synthesis of SNAC and Thiophenol Thioesters 
Activation of the peptide C-terminus was carried out in situ by using 2 eq of 
dicyclohexylcarbodiimide (DCC) and the additive HOBt in THF. K2CO3 was also added to 
ensure deprotonation of the carboxy-group which forms O-acylisourea with the C=N-double 
bond of DCC. This intermediate was labile and transformed into a benzotriazol-ester by 
nucleophilic attack of HOBt. The benzotriazol-ester leaving group of this active ester was 
finally replaced by SNAC or thiophenol, which were added in a 10 times excess. Therefore 
the reaction was stirred for 3 h at room temperature. 
Acid labile side chain protecting groups were cleaved under strong acidic conditions. In this 
work a mixture of TFA/H2O/triisopropylsilane 95:2.5:2.5 (v/v) was used. The peptide was 
incubated for 3 h and precipitated in cold ether. The deprotected peptides were purified by 
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preparative high performance liquid chromatography (HPLC) on a Äkta Purifier (Amersham 
Biosciences) HPLC-System with a reversed phase C18 Nucleodur (Macherey and Nagel) 
column. The identities of peptide thioesters were verified by high performance liquid 
chromatography-mass spectrometry (HPLC-MS) and matrix-assisted laser desorption 
ionization-time-of-flight (MALDI-TOF) MS. 
4.6.2 Synthesis of Peptidyl-CoA 
The general procedure for the synthesis of peptidyl-CoA substrates was based on a synthesis 
described previously[57]. To 1 eq of protected peptide 1 – 2 eq Coenzyme A, 1.5 eq PyBOP 
and 4 eq potassium carbonate were added and dissolved in a 1:1 THF/water mixture. The 
mixture was agitated for 2 h at rt and the solvent was removed. Side chain deprotection and 
purification were carried out as described in section 4.6.1. To confirm the thioester linkage all 
product peaks, identified by their mass, were additionally incubated with 0.1% KOH to 
hydrolyse the thioester bond which was again verified by LC-MS. 
4.6.3 Synthesis of Cyclosporin A SNAC 
Acetylation of Cyclosporine A - 1 g of cyclosporin A extracted from tablets (Novartis) was 
dissolved in 40 ml acetanhydride/pyridine 1:1 and 1.47 mg DMAP was added. The mixture 
was agitated for 2 h at 45°C. The solvent was removed by rotary evaporation, 40 ml 
chloroform was added and washed 3 times with water. After purification on silica gel 
(CHCl3/CH3OH, 98:2), 0.61g acetylcyclosporin was isolated and identified by NMR and 
MALDI based on literature data[122]. 
 Synthesis of Acetylcyclosporin 7-thioamidate – 1 g of acetylcyclosporin was dissolved in 20 
ml xylene and heated to 30 °C internal temperature. 0.12 g Lawesson reagent was added 
stepwise. After 30 min the reaction was cooled to room temperature and evaporated. The 
product was isolated by flash chromatography in diethylether/water 4:1 and identified by 
NMR[122]. 
Synthesis of Acetylcyclosporin 7-(benzyl thioamidate) – A solution of 251.7 mg 
acetylcyclosporin 7-thioamidate in 10 ml DCM, 0.3 ml DBU and 0.2 ml benzylbromide was 
kept at room temperature for 2 h. Tert-butyl methyl ether was added and washed 3 times with 
water. After flash chromatography with saturated diethylether the product was identified by 
NMR[122]. 
Synthesis of Acetylcyclosporin carboxylic acid S-benzylester – 46.5 mg Acetylcyclosporin 7-
(benzyl thioamidate) in 1 ml acetonitrile was added within 2 min to a mixture of 0.25 ml 6 N 
HCl in 1 ml acetonitrile. The mixture was stirred for 20 min and the reaction was monitored 
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by TLC. The pH was adjusted to 11 and the product extracted with tert-butyl methyl ether. 
The product was confirmed by MALDI.  
Subsequent conversion of the benzyl-thioester into the SNAC thioester was carried out 
according to standard procedures for SNAC synthesis. 
5 Results 
5 Results 
The exceptional biological and pharmacological activities of cyclic natural peptides produced 
by NRPS make them interesting targets for drug discovery efforts. In order to identify 
therapeutics with improved or altered activities, structural diversity has to be introduced into a 
selected molecular scaffold. The generation of such a library can be achieved by two different 
approaches: 
1. Domain and module exchange in the multienzymatic machinery.  
2. Chemical synthesis of linear peptides and enzymatic cyclization. 
Protein engineering requires knowledge of the topology and architecture of NRPS 
multienzyme complexes in order to reprogram the enzymatic synthesis machinery by module 
or domain swapping. Data about the quaternary organization of NRPSs will be presented in 
the first part of the results section. 
An alternative route to increase the diversity of cyclic peptide products can be achieved by a 
chemoenzymatic approach. In this approach the whole enzymatic machinery required for 
peptide elongation is replaced by chemical SPPS, which allows the easy and fast synthesis of 
diverse linear peptide analogues. Subsequently regio- and stereoselective peptide cyclization 
is catalysed by unique NRPS peptide cyclases. In the second part of the results section, 
mechanism, tolerance and activity of various peptide cyclases will be presented. 
5.1 Protein Architecture: The Quaternary Structure of NRPS 
The objective of this research effort was to explore the quaternary structure of NRPS with 
strategies similar to those, that have been successfully applied to discover the structure of 
PKS and FAS (chapter 2.8). Investigations were carried out with several representative NRPS 
systems different in size and assembly line organization: GrsA (domains A-PCP-E) [123], 
TycB1 (domains C-A-PCP) [124], the dimodular enzyme TycB2-3 (domains A-PCP.C-A-PCP-
E) [71] and EntF (domains C-A-PCP-TE) [84, 125] (Fig. 5.1).  
 
Figure 5.1. NRPS enzymes investigated. GrsA (127 kDa), TycB1 (119 kDa), TycB2-3 
(237 kDa) and EntF (143 kDa). 
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The first part of the strategy focused on the chemical and biophysical properties of the 
enzymes. Gel filtration, ultracentrifugation and chemical cross-linking are useful methods to 
gain general information about size and molecular weight of a protein. The second part 
investigated the functional complementation between subunits carrying inactivated domains, 
which would additionally give a biochemical proof of a dimeric structure. In order to 
complete the biochemical part of the strategy, enzymes with two different affinity tags were 
constructed. Only a putative heterodimer with two different tags should be able to bind to two 
successive affinity columns. Parts of these investigations were already described in a previous 
diploma thesis and will therefore only be summarized here[126].  
5.1.1 Gel Filtration, Chemical Crosslinking and Equilibrium Analytical 
Ultracentrifugation 
First attempts to elucidate the quaternary structure of NRPS modules were carried out 
utilizing gel filtration experiments (Tab. 5.1). Each NRPS enzyme, GrsA (127 kDa), TycB1 
(119 kDa) and TycB2-3 (237 kDa), eluted with an apparent monomeric weight. No protein 
elution at a corresponding dimeric or higher mass was observed. In contrast, gel filtration of 
the mixed NRPS-PKS hybrid enzyme HMWP1 (350 kDa) carried out under the same 
conditions revealed significant formation of a monomer (424 kDa) and an additional elution 
peak of a protein with the approximate weight of a dimer (721 kDa). 
Table 5.1. Results of size exclusion chromatography. The table shows the 
theoretical (mt) and obtained (mo) molecular weights of all four applied proteins 
gained under the conditions as described in materials and methods. The quotient m0/mt 
is a measure how much the obtained weight exceeds the theoretical monomeric weight 
of the proteins (a value of 1 is obtained for monomers and a value of 2 for dimers).  
enzyme theoretical mass mt  
(kDa) 
obtained mass mo  
(kDa) 
quotient 
mo/mt
GrsA 127 167 1,31 
ProCAT 119 162 1,36 
TycB2-3 237 364 1,53 
HMWP1 350 721; 424 2.06; 1.21 
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Figure 5.2. Results of cross-linking experiments. (A) 7.5 % polyacrylamide gel of 
GrsA (line 1) and GrsA after incubation with a 3-fold excess of BMH (line 2). A new 
protein species after incubation with BMH can be obtained corresponding to an 
electrophoretic mobility of ~140-160 kDa. (B) 7.5 % polyacrylamide gel of TycB1 
(line 1) and TycB1 after incubation with a 3-fold excess of BMH. Also in case of 
TycB1 a similar shift in electrophoretic mobility from ~120 before to ~140-160 kDa 
after incubation with cross-linker can be observed. (C) 5 % polyacrylamide gel of 
TycB2-3 (line 1), TycB2-3 after incubation with a 30-fold excess of DBP (line 2) and 
after incubation with a 6-fold excess of BMH (line 3). DBP as well as BMH lead to 
the formation of a new protein species corresponding to an electrophoretic mobility of 
~290 kDa. (D) MALDI-TOF mass spectra of GrsA without BMH treatment. The 
molecule ion peak was obtained at 127608 Da. (E) MALDI-TOF mass spectra of GrsA 
after treatment with BMH. The molecule ion peak is shifted towards a higher mass 
(128214 Da) in comparison with the spectra of the untreated sample. Peaks 
corresponding to the masses of a dimer were not observed.  
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Bifunctional cross-linking reagents such as 1,3-dibromopropanone (DBP) and 
bismaleimidohexane (BMH) have been shown to cross-link PKS modules as homodimers 
[100, 127]. DBP and BMH covalently connect thiol groups within a distance of 5 Å and 16 Å, 
respectively. The same cross-linking experiments were applied to these NRPS modules. The 
molecular weights of any cross-linked proteins were investigated using SDS-PAGE and 
MALDI-TOF mass spectrometry. To avoid non-specific linkages the cross-linkers were used 
only up to a 3-10 fold molar excess according to the manufacturers protocol (ICN, Pierce). 
After incubation with BMH, the electrophoretic mobilities of GrsA and TycB1 proteins 
decreased marginally, resulting in a shift to higher molecular weights (from ∼120 kDa to 
∼140-160 kDa) on SDS gels (Fig. 5.2), whereas in case of DBP no change of migration was 
observed (data not shown). On the basis of these results there is no indication for the 
existence of a dimer since the electrophoretic mobilities of the new bands (∼140-160 kDa) are 
in between the monomeric (∼120 kDa) and dimeric weight (∼240 kDa) of GrsA and TycB1. 
Similar results were obtained for the larger dimodular enzyme TycB2-3 (237 kDa) which 
revealed one new protein band after reaction with both BMH and DBP, corresponding to an 
electrophoretic mobility of a protein of ~290 kDa (Fig. 5.2). The determination of the 
electrophoretic mobility of the new protein band was carried out in direct comparison with a 
parallel cross-linking of phosphorylase b (97-582 kDa)[127]. Again, for the larger dimodular 
enzyme the electrophoretic mobility of the new protein band does not represent a dimer (474 
kDa). Analogous experiments were carried out with dimethyl suberimidate (DMS), a cross-
linker which connects primary amines in a distance of about 11 Å. None of these cross-
linking reactions revealed altered protein patterns on SDS gels (data not shown). The cross-
linking results were confirmed by application of MALDI-TOF mass spectrometry. Direct 
comparison of cross-linker treated and untreated samples revealed neither peaks for GrsA and 
TycB1 corresponding to the singly charged molecular ions (∼250 kDa) nor to odd multiply 
charged species (M3+ ∼85 kDa and M5+ ∼50 kDa) of the dimers (MALDI-TOF spectra of 
GrsA are shown in figure 2D and 2E). The differences of the molecular masses of treated and 
untreated samples, observed were “only” ∼1500 Da for TycB1 and ∼600 Da for GrsA larger 
than the monomer molecular weights, indicated the reaction of 5 and 2 molecules of BMH 
(276 Da), respectively. TycB2-3 was too large for MALDI-TOF investigations. 
Analytical ultracentrifugation was applied to determine the native molecular weight for the 
dimodular enzyme fragment TycB2-3 and the monomodular enzyme EntF. 
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Figure 5.3. Sedimentation equilibrium analysis of TycB2-3 and EntF. (A) Overlay 
of 8 wavelength scans and (B) residuals from the global fit of the data of TycB2-3 as 
described in Materials and methods. The Monte Carlo distribution of the molecular 
weight (C) and the association constant (D) (ln Ka) are shown to establish an 
experimental Mr = 238.07 ± 18.21 kDa (the protein sequence predicted molecular 
weight is 237.69 kDa) for the monomer and a dissociation constant of Kd = 3.489 ± 
0.186 µM for the TycB2-3 enzyme. (E) Overlay of 4 wavelength scans and (F) residuals 
from the global fit of the data of EntF as described in Materials and methods. The 
Monte Carlo distribution of the molecular weight (not shown) establishes an 
experimental Mr = 137.17 ± 8.17 kDa for the monomer which is in agreement with the 
protein sequence predicted molecular weight (142.97 kDa). 
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To establish the association properties of TycB2-3, sedimentation equilibrium experiments 
were conducted at several protein concentrations (Fig. 5.3). For the global equilibrium 
analysis, 8 scans (Fig. 5.3A) of speeds ranging from 5,000 to 12,500 r.p.m. and 0.39 and 0.57 
O.D. loading concentrations were fit to a monomer-dimer model. Monomer molecular weight 
and the association constant were floated global parameters and were forced to be the same 
for all the included data sets. The system could be well described with this monomer-dimer 
model, which resulted in random residuals (Fig. 5.3B) and a monomer molecular weight of 
238.07 ± 18.21 kDa (Fig. 5.3C), which is in agreement with the protein sequence predicted 
molecular weight (237.69 kDa). The dissociation constant of 3.489 ± 0.186 µM suggests the 
presence of dimer only at unphysiologically high concentrations, which were required for 
ultracentrifugation experiments (Fig. 5.3D). 
Sedimentation equilibrium analysis of EntF was conducted at a single protein concentration 
(Fig. 5.3E and 5.3F). For the global equilibrium analysis, 4 scans (Fig. 5.3E) of speeds 
ranging from 8,000 to 17,000 r.p.m. and a 0.40 O.D. loading concentration were fit to a one-
component (monomer only) model. Molecular weight was a floated global parameter and was 
forced to be the same for all the included data sets. The system could be well described with 
this monomer only model, which resulted in random residuals (Fig. 5.3F) and a molecular 
weight of 137.17 ± 8.17 kDa, which is in agreement with the protein sequence predicted 
molecular weight (142.97 kDa). The data fitting did not improve with a monomer-dimer 
model for EntF, and the experimentally fit dissociation constant (not shown) was many orders 
of magnitude larger than the loading concentration. Therefore, neither gel filtration, analytical 
ultracentrifugation, nor cross-linking supported a strong dimeric interaction of the 
investigated tyrocidin synthetase and enterobactin synthetase components.  
5.1.2 Dissociation and Reassociation of Subunits of a Putative Dimer 
In this study, two different biochemical methods were applied to address the quarternary 
structure of NRPS enzymes. Similar experiments were carried out previously to verify the 
dimeric structure of FAS and PKS [99, 109, 110, 113, 128]. Both methods were designed to 
detect heterodimeric enzymes, and give negative results for monomeric enzymes. The critical 
step, which is necessary for both methods is the dissociation and reassociation (scrambling) of 
putative homodimers to form heterodimers with different affinity tags or different domain-
inactivating point mutations.  
Two different approaches to perform scrambling were utilized. Anion exchange 
chromatography was applied in the same way as described previously for PKS-systems [127]. 
Dissociation is induced by a strong interaction of putative dimer subunits with the matrix 
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material and reassociation can occur by increasing the salt concentration resulting in the 
elution of the proteins. The aminoacylation activity of the tested enzymes did not drop after 
application on the anion exchange column. The aminoacylation activities before and after 
application to the anion exchange column of GrsA-ATE and of TycB2-3-AT.CATE with [14C]-
phenylalanine increased from 20% to 25% and from 60% to 65%, respectively, that of TycB1-
CAT with [14C]-proline decreased negligibly from 15% to 13%, with all differences being in 
the margin of error (5%) of the method. A second approach to perform dissociation and 
reassociation of putative dimers was carried out with the zwitterionic detergent CHAPS. One 
advantage of CHAPS is its non-denaturating character, which typically only directs the 
inhibition of protein-protein interactions leaving the tertiary structure intact. The attachment 
of CHAPS molecules onto the unpolar protein residues leads to the dissociation of putative 
dimers and to the formation of monomers covered in micelles [129]. Subsequent dialysis 
induces the destruction of micelles and allows the formation of putative heterodimers. To 
demonstrate the favoured properties of CHAPS some preliminary experiments were 
implemented. To allow micelle formation CHAPS was used at a concentration of 15 mM, 
which is well above the critical micellar concentration. The aminoacylation activities of GrsA 
and TycB1 with their dedicated [14C]-marked amino acids did not change during and after 
incubation with 15 mM CHAPS indicating a functioning tertiary structure. The 
aminoacylation activity of GrsA with [14C]-phenylalanine changed only negligibly from 15% 
to 17% after addition of 15 mM CHAPS and remained at 12% after dialysis. Aminoacylation 
activity of TycB1-CAT with [14C]-labeled-proline as substrate resulted in a minor decrease 
from 21% to 16% after addition of 15 mM CHAPS and remained at 20% after dialysis.  
The interaction of GrsA-ATE with TycB1-CAT in trans leads to the formation of a linear 
dipeptide, which is cleaved by a non-catalyzed cyclization reaction resulting in the release of 
D-Phe-L-Pro-diketopiperazine (DKP-assay) [123]. This assay was applied to demonstrate that 
in the presence of 15 mM CHAPS the D-Phe-L-Pro-DKP (1,3-diketopiperazine) formation 
decreased by greater than 80 % in comparison with the untreated sample. The in trans 
reaction between GrsA and TycB1 is conducted via protein-protein interactions and was 
effectively inhibited by CHAPS. These two experiments showed that CHAPS interrupts 
protein-protein interactions for Grs and Tyc proteins and therefore has the necessary 
prerequisite to perform scrambling. 
5.1.2.1 Two Affinity Tag System 
The specific and reversible binding of proteins with two different affinity tags to 
corresponding affinity columns was used to test for heterodimer formation. In this experiment 
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two different affinity tags were utilized. Affinity chromatography on immobilized Ni-ions 
allows the rapid purification of proteins with a fused hexahistidine-(His6-)tag. The strep-tag is 
a small peptide with a high affinity to genetically modified streptavidin. The dimeric character 
of a protein can be demonstrated by scrambling of two identical homodimers, which only 
differ from their affinity tag. The resulting heterodimer consists of two subunits with two 
different affinity tags. This heterodimeric protein has the unique ability to bind with its 
hexahistidine tag first on a Ni-NTA column and subsequently with its strep-tag on a 
streptavidin column or the other way round. The detection of a protein after the second 
column would be a proof for a dimer. Similar experiments with two affinity tags were carried 
out with dimeric FAS previously [128].  
In this work both scrambling methods were applied to conduct putative his6-tag/strep-tag-
heterodimer formation of GrsA and TycB1, respectively. The scrambled protein samples were 
loaded on both affinity columns successively under conditions optimized to prevent non-
specific binding, and all elution fractions were investigated with specific hexahistidine-tag 
and strep-tag antibodies. However, in all cases it was not possible to detect any protein in the 
elution fraction of the second column, (data not shown) indicating that no heterodimers 
existed in solution. 
5.1.2.2 Complementation 
Heterodimers of fatty acid synthases and polyketide synthases carrying mutations in distinct 
domains are able to balance their loss of activity by mutual complementation of the remaining 
active domains [99, 109, 110, 113]. The success of the mutual complementation was 
visualized by the ability to form product, which was a direct proof of a dimeric behaviour. In 
this work the same complementation strategy for NRPS was used and the cooperation of PCP- 
and C-domains from TycB2-3 after scrambling was investigated (Fig. 5.4). Both scrambling 
methods were applied to conduct the formation of the putative heterodimers TycB2-
3(PCP)(S560A)/TycB2-3(C-domain)(H741R) and TycB2-3(PCP)(S1593A)/TycB2-3(C-domain)(H741R). 
The phenotypes of the single mutants are the following: S560A, inactivation of the first PCP 
by mutation of the cofactor binding invariant serine residue resulting in the loss of the ability 
to covalently bind substrates to module one; H741R, inactivation of the C-domain resulting in 
the breakdown of condensation activity; S1593A inactivation of the second PCP by mutation 
of the cofactor binding invariant serine residue resulting in the loss of the ability to covalently 
bind substrates to module two. 
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Figure 5.4. Complementation systems. For the complementation assays three 
different mutants of TycB2-3 were used with mutations in the first PCP (S560A, 
resulting in the loss of the ability to covalently bind substrates to module one), the C-
domain (H741R, resulting in the breakdown of condensation activity of the enzyme) 
and in the second PCP (S1593A, resulting in the loss of the ability to covalently bind 
substrates to module two) leading to two complementation systems. The putative 
heterodimeric systems would either allow the interaction of the upstream T-domain 
with the C-domain or the interaction of the C-domain with the downstream T-domain 
(indicated by red lines). In case of real heterodimers, product formation should be 
observed although all three mutated enzymes show no activity by themselves.  
 
Figure 5.5. HPLC trace of the tripeptide product formation assay on the example 
of the S560A/H741R TycB2-3 complementation system. Only the wild type enzyme 
is able to produce the tripeptide. The mutated enzymes S560A, H741R did not show 
any detectable activity alone. Also the mixture of S560A/H741R as well as a mixture 
of S1593A/H741R with and without Source Q scrambling did exhibit any activity 
above background. The same results were gained for the other complementation 
system and scrambling method. 
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Subsequently their ability for product formation was investigated via a tripeptide assay 
described previously [71]. Control reactions under the same conditions were carried out using 
the wild-type enzyme without mutations, the mutants alone, and a mixture of both mutants 
without the process of scrambling. As shown in figure 5.5, no product formation was 
observed in all experiments except in the case of the wild-type enzyme, indicating that there 
was no functional complementation between the enzymes inactivated in distinct domains. 
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5.2 Natural Product Architecture: Chemoenzymatic Peptide Cyclization 
A common structural feature of nonribosomally produced peptides is the constrained structure 
which ensures precise functionality important for the interaction with the dedicated cellular 
receptor. In many cases rigidity is achieved by cyclization strategies of the peptide backbone 
leading to diverse macrolactams and macrolactones. Because peptide cyclization can be a 
difficult task in chemical synthesis there has been a significant interest in exploring enzymatic 
cyclization mechanisms to develop new synthesis routes for the production of modified 
natural cyclic peptides. Nature achieves the synthesis of linear peptide precursors by using the 
NRPS machinery and subsequent cyclization is catalysed by associated peptide cyclase 
domains (TE).  
In order to use these enzymes for the cyclization of synthetic peptides, the autonomous 
activity of Tyc TE, Srf TE and Grs TE had been shown before[80, 90, 91]. The results 
presented here follow up on these initial findings and further investigate enzyme tolerated 
substrate variations on the example of Srf TE in order to evaluate its utility as a valuable 
cyclization tool for organic synthesis. This section then concentrates on investigations of the 
underlying mechanism of cyclization by mutational analysis of catalytically important 
residues of Srf TE based on its crystal structure. In the course of these studies peptide 
cyclases from various other systems were investigated. Their lack of activity with 
conventional SNAC substrates indicated an unsufficient translation between the language of 
biology and the language of chemistry by the small natural substrate surrogates. New methods 
to retain activity with all these enzymes will be presented here in order to generate a catalytic 
tool set of enzymes capable of cyclizing various precursors. Another approach to catalyse 
cyclization of various precursors is the generation of custom made peptide cyclases by protein 
evolution. The last part of this section focuses on initial results of such a protein evolution 
approach to engineer new peptide cyclases with altered substrate specificities.  
5.2.1 Biochemical Characterization of Surfactin TE 
All peptide substrates were characterized by mass spectrometry (table 4.3) and mutations 
confirmed by DNA sequencing. The work was carried out in cooperation with Claire Tseng. 
5.2.1.1 Incubation of SrfTE with the Native SNAC Substrate 
It was previously reported that Srf TE catalyzed the stereospecific cyclization of a linear 
surfactin precursor peptidyl-SNAC (N-acetylcysteamine) thioester that was a mimic of the 
acylheptapeptide sequence of authentic surfactin[80] and SNAC a mimic of the natural 
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cofactor ppan. To improve water solubility, the sequence of this substrate differed from that 
of the wild type substrate in that D-ornithine replaced D-Leu3 and (R)-3-hydroxybutyric acid 
replaced the β-hydroxy C13-C15 fatty acid (SLP-Orn). Reactions of SLP-Orn with Srf TE, in 
the presence of 1% glycerol as an enzyme stabilizer, produced a 1:1:1 ratio of the products of 
cyclization, hydrolysis, and glycerolysis, with similar kcat (15-22 min-1) and KM (4.0-5.6 mM) 
values for all three products[80]. 
 
Figure 5.6. Cyclization and
hydrolysis of  a peptide-SNAC
thioester substrate by Srf TE.
(A) Structure of SLP-wt. (B)
HPLC traces of 2 h reaction
initially containing 2.5 µM Srf
TE, 250 µM SLP-wt, and 25
mM MOPS, at pH 7.0 and 24
°C. The peaks corresponding to
the cyclic (C) and hydrolyzed
(H) product are labeled. 
As a baseline to study a substrate more similar to the wild type substrate, a peptidyl-SNAC 
was synthesized that included the native surfactin heptapeptide sequence, but retained the β-
hydroxy-C4 fatty acid substitution of SLP-Orn (SLP-wt, Fig. 5.6A). SLP-wt was soluble in 
water to 2 mM, and in DMSO to 50 mM. Reactions of SLP-wt (250 µM, 0.5% DMSO, 25 
mM MOPS, pH 7.0) with Srf TE (2 µM) in the absence of glycerol produced a 2.5:1 ratio of 
the cyclic:hydrolyzed products, with a kcat/KM of 0.86 mM-1min-1 for cyclization and 0.35 
mM-1min-1 for hydrolysis (Fig. 5.6B). The kcat and KM values could not be deconvoluted, 
because KM concentrations of substrate could not be reached due to the low solubility of SLP-
wt in water. These solubility limitations are expected to be exacerbated with the C13-C15 acyl 
chains in the wild type heptapeptide sequence of surfactin. Nonetheless, product analysis of 
SLP-wt showed that Srf TE could direct about 70% of the flux of β-hydroxy-acyl-
heptapeptidyl-O-enzyme intermediate to the macrolactone ring of the natural product. 
5.2.1.2 Dap Scan of the Heptapeptide Sequence 
To evaluate enzymatic recognition elements in the heptapeptidyl substrate chain, a systematic 
alteration of each of the side chains of the substrate was considered. It was anticipated that an 
alanine scan would not improve the hydrophobic constraints on solubility; instead, a 2,3-
diaminopropionic acid (Dap) residue with an ionizable 3-amino group was introduced at each 
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of the seven residue positions of SLP-wt, with the stereochemistry of each residue maintained 
(Fig. 5.7A). The resulting seven peptides, SLP-1 to SLP-7, were assessed as substrates for Srf 
TE by determining the kinetic parameters and cyclization:hydrolysis ratio of Srf TE on each 
substrate, with the results summarized in Fig. 5.7. The solubilities of the Dap-containing 
substrates in water were much improved (25-50 mM) over SLP-wt, except when the Dap 
replaced an acidic residue, as in SLP-1 and SLP-5, which displayed solubility properties 
similar to SLP-wt. However, separate kcat and KM values could still not be measured for those 
substrates with improved solubility, because severe substrate inhibition was observed at 
concentrations greater than 3 mM. This inhibition could be related to the critical micellar 
concentration (CMC) of these substrates[130], which were measured to be in the 0.6-2.0 mM 
range (data not shown). 
 
Figure 5.7. Results of Dap scan. (A) Cyclic product of SLP-wt. The residues for 
which replacement by Dap results in neither cyclization nor hydrolysis are highlighted 
by red ovals. The residue for which replacement results in only hydrolysis is 
highlighted by a red square. The grey squared residues can be both cyclized and 
hydrolyzed when replaced by Dap. (B) HPLC traces of 1 hr reactions initially 
containing 2 µM Srf TE, 500 µM indicated substrate, and 25 mM MOPS, at pH 7.0 
and 24°C. The peaks corresponding to the cyclic (C) and hydrolyzed (H) products, 
substrate (S) and enzyme (E) are labeled. The trace corresponding to SLP-5 (labeled 
with asterisk) was run on a slower gradient than the other traces in order to achieve 
good peak separation. The identities of the substrates and products were verified by 
MALDI-TOF MS. (C) C/H ratios and kcat/KM values of cyclization and hydrolysis for 
each substrate (standard deviation ±10%). N/D = activity not detected. 
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Nonetheless, the Dap scan allowed to determine which residues were tolerant to a significant 
change of both size and charge. The residues at the N- (Glu1) and C-terminus (D-Leu6 and 
Leu7) of the substrate were not tolerant for the Dap substitution, resulting in either no product 
formation or only hydrolysis (Fig. 5.7). On the other hand, the residues in the middle of the 
substrate (Leu2, D-Leu3, Val4, and Asp5) were tolerant to Dap substitution to varying degrees, 
with each forming measurable amounts of both cyclized and hydrolyzed products. 
Unexpectedly, the kcat/KM of Srf TE for the cyclization of SLP-3 was almost four times 
greater than that for SLP-wt, although the kcat/KM for hydrolysis increased even more, with a 
cyclization:hydrolysis ratio of 0.54:1 (Fig. 5.7C). Qualitatively, this increase appeared to be 
due mainly to an increase in kcat. SLP-3 was therefore used as scaffold for further 
experiments. 
5.2.1.3 Spacer Scan 
A residue scan orthogonal to the Dap scan was also performed, in which two adjacent 
residues at a time, from Glu1 to D-Leu6, were replaced by the flexible spacer ε-aminohexanoic 
acid (ε-Ahx), in order to address which residue side chains are necessary for productive 
substrate positioning in the enzyme active site (Fig. 5.8). Kinetic parameters and 
cyclization:hydrolysis ratios of Srf TE on each substrate were determined, and found that, 
unlike in the Dap scan, the removal of residue side chains towards the N- (SLP-1/2) and C-
terminus (SLP-5/6) of the substrate did not dramatically affect the cyclization:hydrolysis 
ratios of the resulting substrates. In contrast, the removal of residue side chains in the middle 
of the substrate (SLP-3/4) resulted in significantly decreased cyclization by Srf TE, with a 
cyclization:hydrolysis ratio of 0.057:1 (Fig. 5.8). These divergent results highlight the 
different substrate recognition properties probed in the two scans. 
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Figure 5.8. Results of spacer scan. (A) Cyclic product of SLP-wt. The residues for 
which replacement by ε-Ahx results in cyclization and hydrolysis are highlighted by 
grey squares. The residues for which replacement results in only hydrolysis and little 
cyclization are highlighted by a red square. (B) HPLC traces of 2 hr reactions initially 
containing 2 µM Srf TE, 500 µM indicated substrate, and 25 mM MOPS, at pH 7.0 
and 24°C. The peaks corresponding to the cyclic (C) and hydrolyzed (H) products and 
substrate (S) are labeled. The identities of the substrates and products were verified by 
LC-MS. (C) C/H ratios and kcat/KM values of cyclization and hydrolysis for each 
substrate (standard deviation ±10%). FA = (R)-3-hydroxybutyric acid. 
5.2.1.4 Reverse Reaction: Hydrolysis of the Macrolactone 
The cyclic macrolactone product of SLP-wt was also a substrate for Srf TE with the enzyme 
reopening the macrolactone at the ester bond and catalyzing the formation of the linear acid 
through water attack (Fig. 5.9). A time course shows enzyme mediated conversion of cyclic 
substrate into linear hydrolysed product. In addition, the acyl-enzyme intermediate could also 
be captured through nucleophilic attack by ONAC (N-acetylethanolamine), SNAC, or NNAC 
(N-acetylethylenediamine), with the resulting formation of linear esters, thioesters, or amides 
of the substrate, respectively (Fig. 5.9C). As expected, the presence of exogenously added 
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macrolactone inhibited the cyclization of SNAC substrates in a concentration-dependent 
manner (data not shown). The kcat/KM for the hydrolysis of the macrolactone was 0.4 mM-
1min-1. 
 
Figure 5.9. Enzymatic opening of macrolactone by Srf TE with different 
nucleophiles. (A) Mechanism of macrolactone opening. Srf TE can catalyze the attack 
of water or competing nucleophiles such as SNAC, ONAC, or NNAC to open the 
cyclic ester bond. (B) 14 hr time course of hydrolysis of the cyclic product of SLP-wt 
by Srf TE, with time points taken every 2 hr. (C) HPLC traces of 2 hr reactions 
initially containing 2 µM Srf TE, 250 µM cyclic product of SLP-wt, 25 mM MOPS, at 
pH 7.0 and 24 °C. Each reaction also contained 250 mM of the following nucleophile: 
1) none, 2) SNAC, 3) ONAC, 4) NNAC. The peaks corresponding to the cyclic 
substrate (C), the hydrolyzed product (H), and the product resulting from attack by the 
added nucleophile are labeled. The structures of the substrate and products were 
verified by MALDI-TOF MS. 
5.2.1.5 Alterations to Leaving Group, Nucleophile, and Length of Substrate 
The ability of Srf TE to reopen the macrolactone product suggested that it might cyclize linear 
peptides with an ester leaving group. The thioester of SLP-wt was therefore changed to an 
ester through the replacement of the SNAC with ONAC. Srf TE was able to both cyclize and 
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hydrolyze the resulting substrate (SLP-ONAC), with a cyclization:hydrolysis ratio of 0.6:1 
(Fig. 5.10), although the reaction occurred 5-10 times more slowly (data not shown). These 
results showed that Srf TE is able to tolerate a less active hydroxyl leaving group in addition 
to the native thiol leaving group. Assays with other thioester leaving groups will be presented 
below. 
 
Figure 5.10. Cyclization and
hydrolysis of peptide-ONAC
substrate by Srf TE domain.
(A) Structure of SLP-ONAC.
(B) HPLC traces of 4 hr
reaction initially containing 2
µM Srf TE, 250 µM SLP-
ONAC, and 25 mM MOPS, at
pH 7.0 and 24 °C. The peaks
corresponding to the cyclic (C)
and hydrolyzed (H) products are
labeled. The structures of the
substrate and products were
verified by MALDI-TOF MS. 
 
Variations were also made to the nucleophile-containing fatty acid of SLP-3, as summarized 
in Figure 5.11. The heptapeptide of SLP-3 was used instead of that of SLP-wt, because its 
greater solubility in water allowed for easier synthesis and purification of the multiple 
alternate substrates. A substrate in which a secondary β-hydroxyl group was substituted for 
the secondary β-amino group of the fatty acid (SLP-NH2) was not cyclized by Srf TE, 
although it was hydrolyzed (data not shown). Similar results were obtained on (R)- and (S)-
SLP-αOH, which have a fatty acid containing a secondary α-hydroxyl group rather than a β-
hydroxyl group, and also on a substrate in which the fatty acid was replaced by a serine (SLP-
Ser), which contains a primary β-hydroxyl group. On the other hand, a substrate with a fatty 
acid containing a primary ε-hydroxyl group (SLP-εOH) was accepted as a substrate for both 
cyclization and hydrolysis, with a cyclization:hydrolysis ratio of 1.5:1 (Fig. 5.11). These 
initial data indicate altered macrolactone ring size is possible. To further test this possibility, a 
nonapeptide version of SLP-wt was synthesized, with a Leu inserted between Leu2 and D-
Leu3 and another between Val4 and Asp5. However, similar to SLP-NH2, this substrate was 
hydrolyzed but not cyclized by Srf TE (data not shown). In addition, structurally-unrelated 
peptidyl-SNAC substrates, including those with the peptide sequences of mycosubtilin 
(heptapeptide), fengycin (decapeptide), and tyrocidine (decapeptide), also showed substantial 
hydrolysis but no cyclization with Srf TE, indicating the enzyme’s broad tolerance for 
hydrolysis but not cyclization of these substrates (data not shown).  
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Figure 5.11. Variations to the nucleophilic attacking group of SLP-3. (A) The (R)-
3-hydroxybutyric acid group was replaced by those shown. The altered substrate that 
could be cyclized by Srf TE, SLP-eOH, is boxed. (B) HPLC traces of 2 hr reaction 
initially containing 2.5 µM SrfTe, 250 µM SLP-εOH, and 25 mM MOPS at pH 7.0 
and 24 °C. The peaks corresponding to the cyclic (C) and hydrolyzed (H) products are 
labeled. The structures of the substrate and products were verified by MALDI-TOF 
MS. Additionally the cyclic product was characterized by ESI-ion trap mass 
spectrometry. 
5.2.1.6 Mutations of Catalytically Important Residues of Surfactin TE 
Six point mutations were individually introduced into Srf TE based on analysis of the crystal 
structure[96]. All Srf TE mutants were heterologously expressed in E. coli and subsequently 
purified by Ni-NTA affinity chromatography. The yields of all proteins ranged from 2-5 mg 
per one liter of cell culture and their purity was evaluated by SDS-PAGE analysis (Fig. 5.12). 
The presumed catalytic serine, Ser80, was changed to cysteine, and the other two residues of 
the proposed catalytic triad, Asp107 and His207, were each changed to alanine as confirmed 
by DNA sequencing.  
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Figure 5.12. SDS-PAGE of purified mutant Srf TE proteins. The calculated mass 
(28 kDa for all mutants) corresponds to the observed mass. MM = molecular marker. 
The catalytic triad mutants were inactive with SLP-wt as substrate, indicating that all three 
residues are critical for enzymatic activity and they can indeed be ascribed to a catalytic triad 
(slight hydrolysis activity was observed with the D107A mutant in overnight incubations) 
(Fig. 5.13). Two prominently placed basic residues in the largely hydrophobic active site of 
Srf TE, Lys111 and Arg120, were each changed to alanine. The K111A mutant was inactive 
on SLP-wt (slight hydrolysis activity was observed in overnight incubations), while the 
R120A mutant catalyzed the formation of decreased levels of the hydrolyzed, but not 
cyclized, product (Fig. 5.13B). In comparison with the wild type Srf TE, the R120A mutant 
showed a 11-fold decrease in kcat/KM for cyclization (0.078 mM-1min-1), and a comparable 
kcat/KM for hydrolysis (0.40 mM-1min-1) (Fig. 5.13C). 
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Figure 5.13. Characterization of Srf TE mutants. (A) Binding pocket of Srf TE 
with sites of mutations highlighted. (B) HPLC traces of 2 hr reactions initially 
containing 2 µM indicated enzyme, 250 µM SLP-wt, and 25 mM MOPS, at pH 7.0 
and 24 °C. The peaks corresponding to the cyclic (C) and hydrolyzed (H) products, 
and substrate (S) are labeled. (C) C/H ratios and kcat/KM values of cyclization and 
hydrolysis for each mutant with SLP-wt and SLP-3 (standard deviation ±10%). N/D = 
activity not detected. 
A P26G mutant was made based on the sequence alignment of Srf TE with other TE domains 
and lipases (data not shown), which are also members of the α,β-hydrolase enzyme family 
that catalyze only hydrolysis of ester/lactone substrates[131]. A proline conserved among TE 
domains, Pro26 in Srf TE, is instead conserved as a glycine in lipases, and the position of this 
residue near those responsible for the formation of the oxyanion hole in the active site (Val27 
and Ala81) indicates that it may have an effect on product-determining catalysis of cyclization 
vs. hydrolysis by the enzyme (Fig. 5.13A). Indeed, reactions of SLP-wt with the P26G 
mutant produced two observations of note. One was a 12-fold change in product ratio to favor 
hydrolysis, down to a cyclization:hydrolysis ratio of 0.2:1 (Fig. 5.13C). The other was a net 
increase in catalytic flux to 15.7 mM-1min-1, up from 1.2 mM-1min-1 in wildtype Srf TE; of 
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this 13-fold increase in overall flux, 80% of SLP-wt underwent hydrolysis. P26G was also 
able to reopen the macrolactone with a kcat/KM of 0.21 mM-1min-1. 
5.2.1.7 Cocrystal Structure of Srf TE with a Dipeptidyl Boronate Inhibitor 
 
Figure 5.14. Crystal structure of Srf TE bound to a dipeptide boronic acid 
analogue. (A) Structure of N-acetyl-D-Leu-Leu-B(OH)2 complexed to Srf TE. The 
dipeptide analogue is shown in pink, the catalytic triad in yellow, and additional active 
site chains in green. (B) Surface repesentation of the active site in the same orientation 
as in part A. (C) Model of the cyclizing conformation of the surfactin linear peptide. 
Superposition of the NMR structure of surfactin onto the structure of N-acetyl-D-Leu-
Leu-B(OH) in the active site. (C) Structure of N-acetyl-D-Leu-Leu-B(OH) 
coordinated by His and Ser. 
In order to further characterize the binding mode of surfactin linear peptides, Steve Bruner 
examined X-ray crystal structures of Srf TE bound to designed inhibitor molecules. A variety 
of linear peptides containing the surfactin heptapeptide sequence and a C-terminal boronic 
acid in place of the carboxyl group were synthesized[79]. Boronic acid-based inhibitors are 
widely used as potent inhibitors of serine proteases, and function by alkylating the catalytic 
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serine, forming a tetrahedral boronate that closely mimics the tetrahedral intermediate in the 
reaction pathway. Peptides were soaked into crystals of Srf TE, and the structures solved by 
molecular replacement using the structure of Srf TE[96]. Peptide electron density was only 
clearly present for D-Leu6, Leu7, and the boronic acid group, irrespective of the length of the 
peptide used in the soaking experiment. Figure 5.14 shows the structure of the enzyme bound 
to the dipeptide analog N-acetyl-D-Leu-Leu-B(OH)2 (Ki = 50 µM), and is representative of 
the observed electron density with full-length heptapeptide boronic acid analogs. The 
structure shows a tetrahedral boron atom bound both to the hydroxyl side chain of Ser80 and 
the N3 of His270, a bidentate binding mode sometimes observed in serine protease/boronic 
acid complexes[132, 133]. The C-terminal Leu (corresponding to Leu7) is bound specifically 
in a pocket adjacent to the triad, forming contacts with residues Tyr156, Tyr159, and Leu129. 
The D-Leu residue (corresponding to D-Leu6) is also well ordered in the density maps, bound 
in a hydrophobic pocket consisting of Tyr109, Leu187, and Phe 181. The remaining residues 
of the substrate peptide are not well ordered in the maps. 
5.2.2 Loading Peptidyl-CoA onto PCPs: A Novel Approach to Characterize 
Macrocyclization by TEs 
To expand the set of cyclization catalysts also genes encoding peptide cyclases from other 
NRPS systems like mycosubtilin, and fengycin from B. subtilis and syringomycin from P. 
syringae were cloned and overexpressed. Contrary to surfactin and tyrocidine cyclases, no 
activity was observed for those of mycosubtilin, fengycin and syringomycin cyclases with 
synthetically made peptidyl-SNAC substrates, indicating a limitation in the chemoenzymatic 
potential of the latter cyclases. The inability to recognize or bind the SNAC substrates in the 
active site of the excised peptide cyclase could be affected by the way of presenting the short 
SNAC mimic to the enzyme. To overcome this limitation the cyclase domain (TE) can be 
excised with the preceeding cofactor binding PCP-domain as a PCP-TE didomain. 
Recombinant apo PCP-TE cyclases can then be loaded in vitro with chemically synthesized 
peptidyl-CoA using the 4´-phosphopantetheine (ppan) transferase Sfp. The resulting peptidyl-
ppan-PCP-TE holo cyclase carries the covalent cofactor bound substrate in a way that mimics 
the natural substrate presentation in the NRPS assembly line (Fig. 5.15). A prerequisite of this 
method is the promiscuity of the B. subtilis ppan transferase Sfp for loading chemically 
synthesized peptidyl-CoA substrates onto apo PCP which was investigated first. 
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Figure 5.15. Natural substrate interaction. Synthetic fengycin-CoA is loaded onto 
apo Fen PCP-TE by Sfp to give the holo enzyme. The substrate is transferred onto the 
TE and subsequently released by cyclization and hydrolysis. 
5.2.2.1 Overexpression of the Proteins and Synthesis of Peptidyl-CoAs 
To investigate loading of peptidyl-CoA substrates with Sfp onto apo proteins, gene fragments 
encoding a PCP domain from module 7 of the surfactin synthetase in its apo form as well as 
an apo PCP-TE didomain from the fengycin synthetase and a TE active site Ser to Ala mutant 
of this didomain were cloned and overexpressed in E. coli. The proteins were purified by Ni-
NTA affinity chromatography and the purity was evaluated by SDS-PAGE analysis (Fig. 
5.16). 
 
 Figure 5.16. SDS-PAGE of purified Fen
PCP-TE and Srf PCP7. The calculated
mass of wt Fen PCP-TE (37 kDa) and Srf
PCP7 (10 kDa) correspond to the observed
mass. The Ser to Ala Fen PCP-TE mutant
was obtained in the same yield and purity.
MM = molecular marker. 75
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Three different N-acyl-peptidyl-CoA substrates derived from surfactin (SLP), fengycin (FLP) 
and mycosubtilin (MLP) were synthesized. The structures of all peptidyl-CoA substrates are 
shown in figure 5.17. In comparison with all three wild type sequences the long fatty acid 
moiety was replaced with shorter acyl-chain mimics to increase solubility. In the surfactin 
sequence Asp at position 5 was replaced with 2,3-diaminopropionic acid as described 
before[79] and in the mycosubtilin sequence Asn at position 7 was replaced by Ala for 
synthetic reasons. The subsequent coupling with CoA yielded 50 – 60 % product[57]. The 
peptidyl-CoAs were characterized by mass analysis as shown in Table 4.4. 
 
Figure 5.17. Structures of all CoA substrates. Residues important for 
regioselectivity experiments are highlighted in red. For amino acid sequences, please 
see also the appendix section. 
5.2.2.2 Loading Peptidyl-CoAs onto PCP 
Incubation of apo PCP with the three peptidyl-CoA substrates and Sfp revealed a substantial 
conversion into peptidyl holo PCPs (Fig. 5.18). The KM values of the loading reactions were 
higher for SLP-CoA (17.2 µM), FLP-CoA (18.1 µM) and MLP-CoA (11.3 µM) than that of 
CoASH alone (0.7 µM) described previously[55]. Also a strong reduction of the kcat values 
for the loading of the three peptidyl-CoAs was observed (SLP-CoA: 0.92 min-1, FLP-CoA: 
0.94 min-1, MLP-CoA: 0.69 min-1) (Fig. 5.19) when compared with CoASH alone (102 
min-1)[55]. Sfp is promiscuous enough to tolerate dramatically larger derivatives of CoA with 
a reduced kinetic efficiency but preparatively useful. It is now possible to convert an apo PCP 
into peptidyl holo PCP and study its interaction with TE domains in cis or in trans. Products 
were identified by MS (Table 4.5). 
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Figure 5.18. Loading peptidyl-CoA on PCP and interaction of peptidyl-PCP with 
the TE domain. HPLC traces of 14 min Sfp (2µM) loading reactions of apo PCP (50 
µM) with surfactin-CoA (SLP), fengycin-CoA (FLP) and mycosubtilin-CoA (MLP) in 
25 mM Hepes and 50 mM NaCl, pH 7.0. The peaks corresponding to the apo PCP 
(apo) and peptidyl-PCP (holo) are labeled. Sfp catalyses the nucleophilic attack of the 
invariant serine residue of apo PCP onto the phosphodiester bond of fengycin-CoA 
(FLP) to give peptidyl-holo PCP. 
 
Figure 5.19. Lineweaver-Burk plots of MLP-CoA, SLP-CoA and FLP-CoA.  
5.2.2.3 Autonomous Cyclization Activity of FenPCP-TE 
Fengycin is a potent antifungal branched cyclic lipopetide which inhibits filamentous fungi 
but does not act on yeast and bacteria[15]. In order to understand principles of cyclization, the 
gene fragment coding for fengycin TE was cloned and overexpressed as an apo PCP-TE 
didomain. The PCP-TE didomain should first ensure a proper folding of the TE and secondly 
allow the loading of FLP-CoA substrate onto apo PCP to mimic the natural substrate for the 
TE (Fig. 5.15). Pure PCP-TE was first incubated with a linear fengycin SNAC substrate for 
several hours but did not show any cyclization or hydrolysis (data not shown). In contrast, 
using the new FLP-CoA substrate, PCP-TE and Sfp, cyclization and hydrolysis were 
observed while a PCP-TE mutant enzyme with a Ser to Ala mutation in the TE active site did 
not show any activity under the same conditions (Fig. 5.20, Table 4.5). Also a control reaction 
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with substrate and apo PCP-TE but without Sfp treatment did not reveal activity indicating 
that the covalent loading of the lipopeptidyl substrate onto the PCP is required for both 
cyclization and hydrolysis reactions. The observed cyclization to hydrolysis ratio was 2:1 
validating that the TE in this PCP-TE didomain retains cyclase activity. A time course 
showed maximum cyclization after approximately one hour. With increasing time the amount 
of cyclic product decreased while hydrolysed product increased. Incubation of isolated cyclic 
peptide with PCP-TE showed progressive hydrolysis to linear lipopeptide. Thus the fengycin 
TE can like Srf TE also run backwards to a linear peptidyl-O-TE that can be captured by 
water. 
  
5.2.2.4 Regioselectivity of Cyclization 
The identity of the cyclic FLP peptidolacto
5.2). Masses of 2 characteristic cyclic fragm
proposed cyclization position and (b) frag
calculated for all possible nucleophiles and c
 Figure 5.20. Results of the cyclization
reaction with Fen PCP-TE. Peaks corres-
ponding to the substrate (Su), hydrolysed
product (Hy) and cyclic product (Cy) are
labeled. LC-MS traces (TIC) of 30 min
reactions containing 60 µM fengycin PCP-TE,
60 µM FLP-CoA and 5 µM Sfp in 25 mM
Hepes and 50 mM NaCl, pH 7.0. Trace 1
shows the reaction with FLP-CoA and a
mutated enzyme (Ser to Ala in the active site
of the TE). Trace 2 shows the same reaction
with the wild type enzyme. ne was confirmed by MS-MS sequencing (Table 
ents ((a)fragmentation of the peptide bond at the 
mentation of the adjacent NH-CH bond) were 
ompared with the observed fragments. 
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Table 5.2. (a) Fragmentation of the peptide bond at the proposed cyclization position 
and (b) fragmentation of the adjacent NH-CH bond. *The observed mass belongs to a 
peptide fragment which carries Orn but is cyclized via Tyr. If cyclization would occur 
via Orn, no cyclic fragment would have been obtained with the apparent mass of Tyr 
cyclization. N/D = not detected. 
observed mass of fragments (calculated mass) (Da) Compound Species 
cyclization 
via Orn 
Cyclization 
via Tyr 
cyclization 
via Thr 
FLP cycle [M+H]+ 1080.538* (1080.537)
N/D (1063.510) 
966.459 (966.457) 
949.443 (949.431) 
N/D (803.394) 
N/D (786.367) 
FLP(2) 
cycle  
[M+H]+ N/D (917.473) 
N/D (900.447) 
1080.542 (1080.537) 
1063.502 (1063.510)  
N/D (803.394) 
N/D (786.367) 
(a) 
(b) 
(a) 
(b) 
 
The results show that cyclization occured regioselectively via nucleophilic attack of Tyr at 
position 3, discriminating two other nucleophiles at position 2 (Orn) and 4 (Thr). This high 
selectivity raised the question if the TE specifically recognizes position 3 or if the identity of 
the amino acid residue (Tyr) is important. To answer this question three new fengycin-CoA 
substrate analogs were synthesized (Fig 5.17). The first carried a Phe residue instead of Tyr at 
position 3 (FLP-Phe). The enzymatic reaction with PCP-TE showed only hydrolysis but no 
cyclization as judged by LC-MS, indicating that none of the other two nucleophiles could 
replace tyrosine. In additional reactions substrates with an exchange of positions Tyr 3 and 
Orn 2 (FLP-2) as well as Tyr 3 and Thr 4 (FLP-4) were used. The relocation of Tyr at 
position 4 revealed only hydrolysis but Tyr relocation at position 2 showed hydrolysis and 
cyclization (Fig. 5.21, Table 4.5). The identity of Tyr 2 as the nucleophile for this cyclization 
was again confirmed by MS-MS sequencing (Table 5.2). These results show that fengycin TE 
specifically recognizes Tyr as the nucleophile in position 3 and 2 and an increase of the 
peptidolactone ring size by one residue (from 29 to 32 atoms) is possible. 
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Figure 5.21. Cyclization of FLP-2. Peaks
corresponding to the substrate (Su),
hydrolysed product (Hy) and cyclic product
(Cy) are labeled. LC-MS traces of 30 min
reactions containing fengycin PCP-TE and
a fengycin-CoA derivative (FLP-2) with
Tyr at position 2 and Orn at postion 3
without Sfp (Trace 1) and in presence of
Sfp (Trace 2).  
5.2.3 Peptidyl-Thiophenols as New Substrates for Peptide Cyclases 
The previous PCP-TE approach is limited to single turnover reactions, since after product 
release the cofactor ppan remains attached to the PCP-TE didomain cyclase, which blocks 
further Sfp catalyzed transfer of additional peptidyl-CoAs onto ppan-PCP. In order to force 
multiple rather than single turnover cycles a new strategy to expand the utility of this method 
was developed. This strategy is based on a thioester exchange reaction between the free ppan-
PCP thiol and a soluble thiophenol-peptide substrate which should ensure chemical reloading 
of substrate onto the ppan-PCP-TE didomain[134, 135]. 
5.2.3.1 Cloning and Overexpression of the Proteins 
The mycosubtilin (ATCC 6633) and syringomycin (DSMZ B-301D) gene fragments encoding 
Myc PCP-TE and Syr TE were amplified from chromosomal DNA and cloned into a pET37b 
expression plasmid. The proteins were heterologously expressed in E. coli and subsequently 
purified by Ni-NTA affinity chromatography. The yields of the proteins ranged from 2-5 mg 
per one liter of cell culture and their purity was evaluated by SDS-PAGE analysis (Fig. 5.22). 
 
Figure 5.22. SDS-PAGE of purified Myc
PCP-TE and Syr TE. The calculated mass of
Myc PCP-TE (37 kDa) and Syr TE (32 kDa)
correspond to the observed mass. MM =
molecular marker. 
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5.2.3.2 Activity Based Enzyme Acylation with Thiophenol Substrates 
 
Figure 5.23. Activity based enzyme acyclation. The active site serine of the fengycin 
peptide cyclase (TE) is selectively acylated by a reactive peptidyl-thiophenol 
substrate. The acyl-enzyme intermediate is then captured by an intramolecular 
nucleophilic attack of tyrosine3 to give the cyclic peptidolactone fengycin. 
The initial aim was to achieve a thioester exchange reaction between the ppan free thiol group 
of fengycin bidomainal fragment ppan-PCP-TE[59] and synthetic fengycin-thiophenol (FLP-
tp). Surprisingly, control reactions of FLP-tp with apo PCP-TE, lacking the free thiol group, 
revealed hydrolysis and cyclization activity, which was not observed with SNAC substrates 
(Fig. 5.24 and Fig. 5.25A). A control reaction with a Ser to Ala mutant in the fengycin cyclase 
active site abolished activity. Identities of all substrates (Table 4.6) and products (Table 4.7) 
were verified by HPLC-MS. In turn, no increased product turnover was observed with holo 
PCP-TE, indicating that the thiophenol substrate directly acylates the TE active site serine 
efficiently (Fig. 5.23). Kinetic data for the cyclization of FLP-tp (kcat = 0.33 min-1 and KM = 
461 µM, Cy/Hy ratio = 0.85) show saturation kinetics and suggest sufficient catalytic 
efficiency for preparative scale reactions.  
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Figure 5.24. Structures of peptidyl-aryl thioester substrates. Leaving groups are 
indicated by squares and nucleophiles for enzymatic intramolecular cyclization are 
indicated by circles. For amino acid sequences, please see also the appendix section. 
 
Figure 5.25. HPLC traces of peptide cyclases (SNAC inactive) incubated with 
peptidyl-thiophenol substrates. (A). Fengycin cyclase incubated with FLP-tp for 1.5 
h (Trace 2). Trace 1 shows incubation of substrate with an active site Ser to Ala 
mutated cyclase. (B). Mycosubtilin cyclase incubated with MLP-tp for 5 min (Trace 
2). Trace one shows substrate incubation without enzyme. Uncatalyzed cyclization via 
tyrosine3 [Cy(Tyr)] is observed. (C) Syringomycin cyclase incubated with SyLP-tp for 
30 min (Trace 2). Trace 1 shows substrate incubation without enzyme. Su = substrate, 
Hy = hydrolysed product, Cy = cyclized product, Gy = glycerol adduct. 
5.2.3.3 Tuning the Reactivity of the Thiophenol Leaving Group 
To evaluate the general utility of thiophenol leaving groups for other peptide cyclases, 
surfactin cyclase (Srf TE), which was previously characterized with SNAC substrates[79], 
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was incubated with surfactin-thiophenol (SLP3-tp) (Fig. 5.24). HPLC analysis revealed 
enzyme catalysed cyclization and hydrolysis activity with a KM of 126 µM and a kcat of 5.66 
min-1 and 11.33 min-1 for cyclization and hydrolysis, respectively (Fig. 5.26A). Comparison of 
the catalytic cyclization efficiency of SLP3-tp (kcat/KM 44.9 mM-1 min-1) with SLP3 (2.9 
mM-1 min-1)[79] revealed a 15 fold increased activity for the thiophenol substrate, with a 
Cy/Hy ratio of 0.78 for thiophenol and 0.54 for SNAC, consistent with a common acyl-
enzyme intermediate for both substrates whose breakdown may now have become rate-
determining with SLP3-tp. However, the better peptide activation by thiophenol seems to 
facilitate non-enzymatic catalysed cyclization as observed in the surfactin control reaction 
without enzyme (Fig. 5.26A). MS-MS sequencing of the cyclic species obtained in the 
absence of Srf TE revealed uncatalyzed cyclization via a diaminopropionic acid (Dap) residue 
at position three which was introduced due to solubility reasons and is not present in the 
natural sequence (Table 5.3). Such non-enzymatic peptide cyclization is an intrinsic property 
of some peptide sequences as has been reported before in the tyrocidine series[92]. Note that 
the Srf TE directs cyclization to the β-OH of the fatty acyl chain rather than the Dap amide 
formation seen nonenzymatically. 
 
Figure 5.26. HPLC traces of surfactin cyclase (SNAC active) incubated with 
aromatic thioester substrates. (A). Incubation of surfactin cyclase with SLP-tp for 
10 min (Trace 2). Trace one shows substrate incubation without enzyme. Uncatalyzed 
cyclization via diaminopropionic acid3 [Cy(Dap)] is observed. (B) Incubation of 
surfactin cyclase with SLP-tc for 10 min (Trace 2). Trace one shows substrate 
incubation without enzyme. (C) Incubation of surfactin cyclase with SLP-mb for 10 
min (Trace 2). Trace one shows substrate incubation without enzyme. Su = substrate, 
Hy = hydrolysed product, Cy = cyclized product. 
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Table 5.3. (a)Fragmentation of the peptide bond at the proposed cyclization position 
and (b) fragmentation of the adjacent NH-CH bond. N/D = not detected. 
observed mass of fragments (calculated mass) (Da) Compound species 
Cyclization 
via Dap 3 
 
SLP3 cycle [M+H]+ 527.316 (527.319) 
N/D (510.293) 
 
 
 Cyclization 
via Tyr 2 
cyclization 
via Ser 6 
MLP cycle  [M+H]+ 704.278 (704.300) 
687.254 (687.274)  
N/D (202.083) 
N/D (185.056) 
(a) 
(b) 
(a) 
(b) 
 
To suppress the limitation of unspecific nonenzymatic cyclization of thiophenol-peptides via 
side chains, the reactivity of the leaving group was decreased by changing ligands. 
Substituents with a positive inductive or mesomeric effect such as methyl and methoxy 
groups were introduced into the aromatic thiophenol-ring at ortho, meta and para positions. 
All six new aryl thiol leaving groups were coupled to the free carboxylic acid of the surfactin 
peptide and subsequently incubated with the surfactin cyclase. Replacement of thiophenol 
with o-thiocresol (SLP3-tc) and p-methoxybenzenethiol (SLP3-mb) gave best results for 
suppression of unspecific background cyclization, while enzyme catalysed substrate 
cyclization and hydrolysis remained constant (Table 4.8, Fig. 5.24, Fig. 5.26B and C). The 
attachment of ligands onto the aromatic ring can therefore adjust the desired activity for any 
peptidyl thioester substrate. Ortho and para positions seem to be preferred, probably due to 
their impact in destabilization of the thiophenolate anion. 
5.2.3.4 Characterization of New Peptide Cyclases 
The observed catalytic activity of peptidyl thiophenol substrates with fengycin and surfactin 
peptide cyclases encouraged to investigate other peptide cyclases with this new technology. 
Therefore mycosubtilin PCP-TE and syringomycin TE were investigated because of their 
interesting structures and bioactivities[23, 136]. Both enzymes failed to show any activity 
with peptidyl-SNAC substrates (data not shown). Therefore thiophenol was attached to 
peptide sequences derived from mycosubtilin (MLP-tp) and syringomycin (SyLP-tp) (Fig. 
5.24). In comparison to the syringomycin wild type sequence[81] the peptide analogue used 
here differs for synthetic reasons: 4-Cl-threonine at position 9 was replaced by threonine, 
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dehydrobutyrine by aminobutyric acid, β-hydroxy aspartate by aspartate and the long fatty 
acid moiety was replaced with a shorter β-hydroxy fatty acyl chain for solubility reasons. In 
contrast to syringomycin where cyclization occurs via a serine side chain, the fatty acid chain 
in the mycosubtilin sequence seems to be important since macrolactamization occurs via the 
β-amino fatty acid moiety (Fig. 5.24). The natural fatty acid chain was replaced by a C7-β-
aminoacyl chain, provided by chemical synthesis[137]. Incubation of mycosubtilin peptide 
cyclase with MLP-tp revealed enzyme catalysed hydrolysis and cyclization (Fig. 5.25B). 
Cyclization occured with a kcat of 2.16 min-1 and a KM of 3991 µM and a Cy/Hy ratio of 0.85. 
The high KM value could be due to missing enzymatic recognition elements of the artificial 
cofactor thiophenol. Similar to the surfactin derived autocatalytic peptidyl-thiophenol self-
cyclization of MLP-tp was also observed in a control reaction without enzyme. The identity 
of this new species was investigated by MS-MS sequencing and identified to be cyclized via 
tyrosine at position two (Table 5.3), again a regiospecificity distinct from that imposed during 
enzymatic cyclization. Incubation of syringomycin peptide cyclase with SyLP-tp revealed 
both cyclized and hydrolysed products (Fig. 5.25C). Also a glycerol adduct was observed due 
to the fact that 5 % glycerol were necessary to stabilize syringomycin peptide cyclase. 
Saturation behaviour was observed and kcat and KM of cyclization determined  (kcat = 0.32 
min-1 and KM = 28 µM, Cy/Hy ratio = 0.65). Previous data shows that in vivo cyclization of 
syringomycin occurs via L-serine at position one[81]. Interestingly, an adjacent D-serine 
residue at position two is not used, raising the question if a change in stereochemistry at 
position one and two could alter product outcome. Therefore two new thiophenol substrates 
were made with D-serine at position one and L-serine at position two as well as L-serine at 
position one and two. Incubation of these substrates with syringomycin cyclase revealed only 
hydrolysis in both cases emphasizing the importance of Ser1,2 stereochemistry for enzymatic 
cyclization (data not shown). 
5.2.4 Directed Protein Evolution to Provide “Custom Made” Peptide Cyclases 
Peptide cyclases presented here catalyse the chemo-, regio- and stereoselective cyclization of 
linear peptide chains of their dedicated substrates. The relaxed enzymatic specificity in 
defined parts of the peptide backbone as seen for surfactin TE and tyrocidine TE[90] make 
these enzymes valuable tools for the cyclization of related compounds.  
However, if cyclization of a structurally unrelated linear compound is desired only synthetic 
chemical cyclization techniques with all their disadvantages can be applied so far. Therefore, 
in order to provide “custom made” catalytic tools for enzymatic peptide cyclization of nearly 
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any desired compound, in vitro protein evolution is the method of choice. By introducing 
random mutations into the protein sequence, mutants with altered activities should be 
generated and those with improved activity would be identified by a screening method. 
Subsequent rounds of random mutagenesis with an identified hit could further improve 
catalytic activity.  
 
Figure 5.27. Task: Cyclization of cyclosporin SNAC either by cognate C-domain 
or engineered TE domain. 
The objective of the project presented in this chapter was to provide an enzymatic catalyst for 
the cyclization of linear cyclosporin, which would allow to create libraries of new cyclosporin 
variants starting from linear compounds. Two different approaches have been tried (Fig. 
5.27): 
1. Cloning and overexpression of the putative natural cyclase, the cyclosporin C-domain. 
2. Protein evolution of Tyc TE. 
5.2.4.1 Cloning and Overexpression of the Cyclosporin C-Domain 
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The cyclosporin synthetase gene fragment encoding the C-terminal C-domain was amplified 
from chromosomal DNA and cloned into a pBAD202/D-TOPO expression plasmid. This 
plasmid facilitated C-terminal fusion of a His6-tag and N-terminal fusion of a thioredoxin 
domain onto the recombinant protein. Thioredoxin is a 12 kDa protein which helps to increase 
the solubility of the recombinant protein. Induction of the araBAD promotor was facilitated 
by adding arabinose in concentrations ranging from 0.01% to 0.0005%. Cultures were grown 
at 22°C. Figure 5.28 shows a SDS-PAGE of a cyclosporin C-domain test-expression. 
Induction with 0.01% arabinose clearly reveals the formation of a new protein band with an 
observed weight of about 75 kDa (calculated: 74 kDa). Uninduced growth overnight does not 
lead to any protein production of the same size. After Ni-NTA purification only very little 
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protein with the expected size was eluted together with impurities. Mass spectrometry of this 
protein fraction failed so far so that His6-tag antibodies will help to further clarify the identity 
of this species. The insoluble fraction shows a big protein band of the expected C-domain size 
which indicates that almost all of the desired protein was insoluble and therefore not suitable 
for cyclization studies. 
 
5.2.4.2 Synthesis of Cyclosporin SNAC 
The chemical synthesis of linear cyclosp
problematic due to the formation of ma
different strategy starting with a ring open
5.29). The ring opening reaction of cyc
protocol[122].  
Figure 5.29. Synthesis of linear cyclo
 Figure 5.28. SDS-PAGE of cyclosporin C-
domain test-expression. In comparison with
the uninduced sample (t0), the induced (t1)
sample as well as the pellet show a new
protein band with the size of the C-domain
(74 kDa) indicated by an arrow. The fraction
after elution from a Ni-NTA column (100
mM imidazole) does not show specific
binding of an individual protein. MM =
molecular marker.orin starting from amino acid building blocks is 
ny N-methylated peptide bonds[35]. Therefore a 
ing of the cyclic compound was selected here (Fig. 
losporin was carried out according to a previous 
 
sporin A-SNAC.  
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In the first step of synthesis cylosporin A was converted into cyclosporin A acetate by adding 
acetanhydride to protect the free hydroxyl group (60 % yield). The acetate was treated with 
Lawesson´s reagent at 130 °C for 30 min. A mixture of only three products was observed due 
to steric repulsion of the folded peptide. Acetyl cyclosporin 4,7-bis(thioamidate), acetyl 
cyclosporin 7-thioamidate and acetyl cyclosporin 4-thioamidate were isolated and used 
without purification for the next reaction step. The thioamidate mixture was incubated with 
benzylbromide for 2 h at room temperature. Extensive column chromatography on silica gel 
yielded 20% of the desired acetylcyclosporin A 7-(benzyl thioamidate) as identified by NMR 
and MALDI-MS. Subsequent hydrolysis of the benzyl thioamidate formed 98 % 
acetylcyclosporin A carboxylic acid S-benzylester. Cleavage of the acetyl-group, N-terminal 
Boc protection as well as C-terminal SNAC synthesis were carried out according to standard 
protocols. Pure cyclosporin A SNAC (CLP) was obtained after reversed phase HPLC 
purification with an observed mass (M+H+) of 1321.81 Da (theoretical 1321.80). The overall 
yield was about 10 %. 
5.2.4.3 Cyclization of Cyclosporin A SNAC by TycTE? 
Alternatively to the C-domain derived from the cyclosporin biosynthesis cluster, Tyc TE 
represents a promising enzyme for the cyclization of CLP since the structures of tyrocidine A 
and cylosporin A feature striking similarities. Both have similar ring sizes and it is well 
known, that Tyc TE also tolerates larger rings for cyclization[90]. Moreover it is known, that 
Tyc TE is very selective for the stereochemistry at the cyclization position which is in both 
cases the same (D,L). A major difference of both compounds is the identity of the residue at 
position one which is D-Ala in case of cyclosporin A and D-Phe in case of tyrocidine. 
Previous studies revealed that Tyc TE is not tolerant for a change of D-Phe into D-Ala[90] 
(Fig. 5.30).  
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Figure 5.30. Can Tyc TE cyclize linear cyclosporin SNAC? Comparison of 
cyclosporin and tyrocidine peptides. Residues at position 1 are indicated by red circles.  
Incubation of Tyc TE with CLP revealed complete hydrolysis after 30 min but no cyclization 
(Fig. 5.31). A control reaction without enzyme revealed no hydrolysis indicating that the 
substrate was stable under assay conditions. The identity of the hydrolysed species was 
confirmed by mass spectrometry (M+H+) (1220.96 Da observed; 1220,80 theoretical). 
 
Figure 5.31. HPLC traces of tyrocidine cyclase incubated
with CLP. Peaks corresponding to the substrate (CLP) and
hydrolysed product (Hy) are labeled. Trace one shows  1 hr
substrate incubation without enzyme and trace two with 5 µM
tycTE. 
5.2.4.4 Directed Protein Evolution of Tyc TE 
The previous result indicated that Tyc TE can recognize CLP to form an acyl-enzyme 
intermediate which is released only by hydrolysis probably due to D-Ala at position one. The 
initial aim was therefore to identify a new species of Tyc TE by directed protein evolution 
which is capable of cyclizing a tyrocidine A SNAC with D-Ala (TLP-Ala) instead of the D-
Phe at position one. A new species could then be further refined by protein evolution to 
finally cyclize the desired substrate CLP. 
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Figure 5.32. Selected sequence for random mutagenesis. The Lid region of the Srf 
TE crystal structure (grey circle) is highlighted by grey shade in the sequence 
alignment of Tyc TE, Grs TE and Srf TE. 
In the approach selected here, random mutations were introduced by error prone PCR only 
into a defined part of the Tyc TE which is thought to be important for substrate recognition. 
Figure 5.32 shows a sequence alignment between Srf TE, Grs TE and Tyc TE together with 
the crystal structure of Srf TE. By comparison of the structure with the alignment one can see 
that the least conserved region of all three sequences is located in the lid region of the enzyme 
indicating that this region is likely to comprise the highest flexibility for substrate recognition. 
This observation is further supported by studies of Reetz and co-workers[138] who found 
mutations improving the stereoselectivity of a structurally related lipases to be located in this 
lid region. Previous investigations on the lid regions of hepatic and lipoprotein lipases 
supported their relevance for substrate interaction[139]. Therefore in order to minimize the 
size of an initial library, this 93 amino acid comprising region of Tyc TE was selected for 
random mutagenesis (Fig. 5.32).  
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Figure 5.33. High troughput screen methodology. Any species which would cyclize 
linear TLP-Ala could be identified by a quantitative mass screen. 
The strategy of the directed protein evolution approach is summarized in figure 5.33. Random 
mutations of 2-3 per 273 bp are introduced into the DNA fragment coding the lid region. 
These fragments are then ligated into a pASK IBA2 vector which allows periplasmatic 
expression of the protein. After transformation of cells the proteins are expressed in 96 well 
plates. The cells are harvested by centrifugation and EDTA treatment which permealize the 
cell wall and release the periplasmatic proteins into solution. Subsequent incubation with 
TLP-Ala would then reveal active species identified by high throughput mass spectrometry. 
An alternative screen could be based on the antibiotic activity of cyclic TLP-Ala, which 
inhibits the growth of B. subtilis. The MIC of cyclic TLP-Ala was experimentally determined 
to be 1.5 µM. Cyclic TLP-Ala was provided by a chemical cyclization method under high 
dilution conditions (data not shown). 
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5.2.4.5 Error Prone PCR and Periplasmatic Expression 
Tyc TE was cloned into a pASK IBA2 vector with a C-terminal strep-tag and a N-terminal 
OmpA-sequence for periplasmatic expression. Two new unique restriction sites (XhoI and 
SacI) were incorporated by silent mutations before and after the 273 bp lid region and 
confirmed by DNA sequencing. Error prone PCR of this DNA region was performed with the 
GeneMorph mutagenesis kit (Invitrogen). A mutation rate of 2-3 on DNA level was selected 
leading to 1-2 mutations on protein level on average which were confirmed on randomly 
picked colonies by DNA sequencing (Fig. 5.34). According to the formula N = 19M X!/(X-
M)! M![140] the number of colonies (N) which have to be screened in order to obtain a single 
amino acid exchanges at all 93 positions (X) by a mutation rate of 1 (M) is 1767. This number 
of colonies is reasonable to screen by the method described here. Error prone PCR helps to 
identify hot spot regions of the enzyme amino acid sequence. Identified hits will be further 
refined by saturation mutagenesis which introduces all other 19 amino acids at the identified 
position and can therefore help to select the best amino acid for this position.  
 
Figure 5.34. Control sequencing at selected mutation rate. 1-2 mutations on protein 
level are observed. 
Activity of Tyc TE in the periplasmatic cell extract was confirmed by incubation with TLP 
which revealed cyclization and hydrolysis activity. In a negative control TLP was stable with 
an extract of cells, which carried an expression vector lacking the tyc TE insert (data not 
shown). Tyc TE was also purified by strep-tag affinity chromatography (Fig. 5.35). 
  
 Figure 5.35. SDS-PAGE of Tyc
TE* with new restriction sites in
the lid region and strep tag. The
expected mass (30 kDa)
corresponds to the observed mass.
MM = molecular marker. 92
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5.2.4.6 High Throughput Mass Analysis 
About 1700 mutant colonies of Tyc TE were overexpressed in 96 well plates and screened for 
cyclization activity by high throughput mass spectrometry together with Uwe Linne. Hits 
were manually identified by integration over the mass signals of the cyclic (1194.5 Da) and 
hydrolytic (1212.5 Da) peaks. Figure 5.36 shows mass signal and integration for a hit 
compared with a background signal. The cut-off for a hit identification was a 4-fold signal 
intensity increase of cyclization over background. The screen of about 1700 colonies revealed 
6 hits in total (10B6, 10C12, 10E5, 6C10, JH1, and 9E2). 
 
Figure 5.36. Mass spectra of an identified hit. All relevant mass signals are labled. 
Integrals over the cyclic mass peaks are shown for a background sample (no hit) and 
an identified hit (identified as hit). 
 93
5 Results 
5.2.4.7 Biochemical Characterization of Hits 
 
Figure 5.37. DNA sequnence alignment of the six selected hits with the wild type 
enzyme. Consensus sequences are indicated in red color and the lid region is 
highlighted by blue shade. The OmpA signal peptide is indicated in yellow shade. 
All hits were first characterized by DNA sequencing and an alignment of the protein 
sequences in comparison with the wild type enzyme is shown in figure 5.37. Interestingly all 
6 mutants carry stop codons in the lid region leading to shorter enzyme fragments. In 5 of the 
mutants these stop codons were derived from frame shifts due to a single nucleotide deletion. 
Stop mutations occurred in a region of residues 141 – 178 of the TE domain leading to 
enzyme mutants lacking 74 – 111 residues (30 – 40 %). According to the manufacture´s 
protocol (Invitrogen) these deletion mutants occur with a frequency of 1.1%. Since the shorter 
enzymes did not carry a C-terminal strep-tag anymore, all mutant inserts and the wild type 
insert were recloned into a pASK IBA4 vector, which carries a N-terminal strep-tag in order 
to perform biochemical characterization of purified proteins. A testexpression revealed 
induction of all proteins according to their predicted size except the 10C12 mutant, which did 
not show protein production (Fig. 5.38). Subsequent purification of wild type Tyc TE (29.1 
kDa) and three selected mutants (9E2, 19.8 kDa; 10B6, 20.6 kDa; JH1,18.7 kDa) allowed for 
initial biochemical investigations of these shorter enzymes. The SDS-PAGE of the 4 enzymes 
shows double bands, which are probably due to incomplete splicing of the 2 kDa OmpA 
signal sequence (Fig. 5.38). 
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Figure 5.38. SDS-PAGE of testexpression and purification with selected Tyc TE 
variants. The testexpression shows protein fragments (boxed) which are smaller in 
comparison with the wild type enzyme. The second gel shows proteins which were 
purified on a strep tag affinity column. Observed masses of purified proteins fit well 
with theoretical masses: 9E2, 19.8 kDa; 10B6, 20.6 kDa; JH1,18.7 kDa, wt, 29.1 kDa 
(including the strep-tag and OmpA sequence). MM = molecular marker. 
 
Figure 5.39. Incubation of TLP-Ala with mutant fragment JH1 and wild type Tyc 
TE (wt). HPLC traces of 1 hr incubation with 5 µM enzyme and 100 µM substrate in 
25 mM Hepes and 50 mM NaCl, pH 7. Hy = hydrolysis product, Su = substrate, and 
(Cy) = trace amounts of cycle. The D-Ala residue of the substrate is indicated by a 
blue box in the peptide structure. 
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Surprisingly, none of the mutants showed increased cyclization activity of TLP-Ala in 
comparison with wild type Tyc TE. Traces of cyclic product were observed in the same range 
as produced by wild type Tyc TE (Fig. 5.39, Table 4.8). By changing the standard assay 
buffer to buffer P (containing 250 mM sucrose), which was used for the periplasmatic screen, 
a small increase of cyclic product was observed for the mutants as well as for the wild type.  
Hydrolysis of substrate was also detected for the mutants indicating that they were still able to 
form acyl-enzyme intermediates although lacking substantial parts of the wild type protein 
sequence including the catalytic triad His. In order to further characterize the activity of these 
short enzymes, substrate incubations with allyl-TLP and TLP were carried out. In 
comparison with TLP, allyl-TLP carries an allyl-glycine instead of phenylalanine at position 
3 (allyl-TLP was used in a different study to investigate post-cyclization modifications on the 
functionalised allyl group). Interestingly, the assays revealed cyclization and hydrolysis 
activities for all mutants in varying amounts (Fig. 5.40, Table 4.8, Table 5.4). 
 
Figure 5.40. Incubation of TLP-wt and allyl-TLP with mutant fragment JH1 and 
wild type Tyc TE (wt). HPLC traces of 1 hr incubation with 5 µM enzyme and 100 
µM substrate in 25 mM Hepes and 50 mM NaCl, pH 7. Hy = hydrolysis product, Su = 
substrate, and Cy = cyclic product. The allyl-Gly residue of allyl-TLP is indicated by a 
blue box in the peptide structure. 
The best cyclization/hydrolysis ratios for allyl-TLP and TLP were observed for JH1 with 3.5 
and 0.8 respectively (Table 5.4).  
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Table 5.4. Cyclization to hydrolysis ratios for stop fragments with TLP-wt and allyl-TLP.  
 
  
 
 
 
 
 
TLP-wt allyl-TLP 
 Cy/Hy  Cy/Hy 
wt 7 (6 [90]) wt 3,2 
10B6 0,24 10B6 0,5 
JH1 0,8 JH1 3,5 
9E2 0,13 9E2 0,03 
Kinetic data for the cyclization of TLP (kcat = 0.06 min-1 and KM = 25.2 µM) catalysed by 
JH1 shows saturation kinetics. Compared to wild type Tyc TE with strep tag (kcat = 55 min-1 
and KM = 29.5 µM) the catalytic efficiency is drastically reduced. Differences in protein-
tagging, purification strategy, as well as buffer system may account for the slightly increased 
KM value in comparison with his-tagged Tyc TE[90].  
In order to evaluate the influence of reduced protein size on catalytic activity, two new 
substrates (Ala-Leu-TLP and Ala-Ala-TLP) lacking C-terminal recognition elements (Orn 9 
in case of Ala-Leu-TLP and Orn 9, Leu 10 in case of Ala-Ala-TLP) were synthesized (Fig. 
5.41). In contrast to wild type Tyc TE, which was able to cyclize both substrates, none of the 
other mutants revealed cyclization but only hydrolysis activity. Figure 5.41 shows the 
incubation of the wild type enzyme and JH1 with the substrate variants (Table 4.8).  
 
Figure 5.41. Incubation of Ala-Leu TLP and Ala-Ala-TLP with mutant fragment 
JH1 and wild type Tyc TE (wt). HPLC traces of 1 hr incubation with 5 µM enzyme 
and 100 µM substrate in 25 mM Hepes and 50 mM NaCl, pH 7. Hy = hydrolysis 
product and Su = substrate. The Ala residue of Ala-Leu-TLP and both Ala residues of 
Ala-Ala-TLP are indicated by blue boxes in the peptide structure. 
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6 Discussion 
One of the current challenges in NRPS research is to reengineer natural products in order to 
increase or alter their biological activities. Research of the last years revealed that NRPS as 
well as NRPS-PKS hybrids can produce biologically active compounds with an outstanding 
potential for new drug discovery. A prominent example is the mixed NRPS-PKS product 
epothilone which is a promising candidate to combat cancer [141-143]. One goal is to 
improve and alter natural product based drugs by rational protein engineering of these 
enzymes (e.g. by module and domain swapping). Therefore understanding of any oligomeric 
structure of these enzymes might be crucial and was subject of investigations in the first part 
of the research presented here. Recently a second strategy has evolved which uses a 
combination of chemistry and enzymology to create libraries of novel compounds. Solid 
phase peptide chemistry is a well established method to provide linear peptides in sufficiently 
good yields. The critical part is cyclization which requires much effort in chemical 
synthesis[38] but can be overcome by enzymatic means. Therefore the chemoenzymatic 
approach presented in the second part utilizes chemistry and biology and concentrates on the 
strength of the individual discipline. Both approaches also aimed to contribute to the global 
understanding of NRPS natural product assembly in general, or for an individual domain, 
which would help for further biological or chemical engineering. 
6.1 Quaternary Architecture of NRPS 
The study addressed the question of whether NRPS need a higher-order quaternary structure 
to function or if they work as monomers. Several strategies, which were already successfully 
applied to FAS and PKS systems previously and which elucidated several independent 
aspects of protein-protein interactions were used.  
Results gained from gel chromatography showed a monomeric behaviour of each of the 
NRPS enzymes. The experimental masses were slightly higher than the theoretical masses 
which is likely due to the structure of the proteins differing from the ideal globular shape 
[144]. The results obtained from gel filtration therefore indicate a monomeric structure of 
NRPS which is predominantly consistent with the literature [84, 96, 106, 114, 145]. A control 
experiment with NRPS-PKS hybrid HMWP1 subunit of yersiniabactin synthetase revealed 
dimers and monomers during gel filtration indicating an association. This shows that the 
method is robust enough to detect dimers and that the PKS/NRPS hybrid enzyme HMWP1 
seems to be dimeric.  
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Analytical equilibrium ultracentrifugation is a reliable method to determine the molecular 
weight and detect oligomerization of solutes in the native state. Unlike gel filtration this 
method is independent of calibration or shape assumptions and is therefore a good supplement 
to the gel filtration results.  
Ultracentrifugation experiments with the PKS enzyme 6-deoxyerythronolide B synthetase 1 
(DEBS1) have substantially contributed to the finding of an overall dimeric structure for PKS 
[100]. Analytical ultracentrifugation experiments carried out to obtain the quaternary structure 
of NRPS are very rare in the literature. In a sedimentation velocity analysis experiment with 
cyclosporin synthetase (1.4 MDa) a sedimentation coefficient of 26.3 S was observed, which 
led to a reasonable structural interpretation only in case of a monomer with an oblate overall 
shape [146]. Here analytical equilibrium ultracentrifugation was applied to TycB2-3 and EntF, 
peptide synthetases involved in the production of a cyclic decapeptide and a siderophore, one 
from a gram-positive B. brevis, one from a gram-negative E. coli. Results for EntF clearly 
indicate a monomeric structure and no aggregation at even high concentrations which is in 
agreement with results from gel filtration carried out previously [84]. The dissociation 
constant of TycB2-3 (3.5 µM) calculated from the ultracentrifugation data indicates 
oligomerization at higher non-physiological concentrations. Assays described here were 
carried out at concentrations of about 0.17 µM which would correspond to 92 % monomer. 
Unlike dimeric PKS, these results from ultracentrifugation suggest a predominantly 
monomeric structure of the two investigated NRPS modules at assay and physiological 
concentrations. 
The cross-linkers BMH and DBP differ in the length of their spacers and therefore in 
specificity. All three enzyme modules (GrsA, TycB1 and TycB2-3) reacted with BMH at low 
molar excess and one new protein species with an electrophoretic mobility in between 
monomeric and dimeric molecular weights appeared on the SDS gel. Witowski and 
coworkers already observed a similar phenomenon with cross-linked FAS [113]. They 
demonstrated that the new band belongs to a monomer which is intramolecular cross-linked, 
where altered protein shape explains the changed electrophoretic mobility of the internally 
cross-linked product. In consideration of the quantity of thiol groups available in the proteins 
(GrsA 8, TycB1 11, TycB2-3 13) multiple reactions with the cross-linker seem to be reasonable 
and support the assumption of an intramolecularly linking. This finding is supported by the 
results of MALDI-TOF mass spectrometry. The M+ peaks of GrsA and TycB1 were shifted to 
higher molecular masses indicating the reaction of 2 molecules of BMH with GrsA and 5 
molecules with TycB1. Signals belonging to a dimer were not observed. In contrast to FAS 
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and PKS no reaction with DBP occurred with GrsA and TycB1, which could be explained by 
the short spacer of this cross-linker. In the case of FAS, DBP was able to connect the active 
site cysteine of the KS-domain with the closely located thiol group of the phosphopantetheine 
cofactor of the ACP inter- and intramolecularly [100, 113]. Such an active site cysteine does 
not exist in the C-domain of NRPS [65] which is consistent with lack of successful DBP 
cross-linking in TycB1 while GrsA does not have a C-domain. However, the intramolecular 
reaction between DBP and the dimodular enzyme TycB2-3 indicates that the flexibility of two 
modules may allow the approach of thiol groups into close proximity. All results gained from 
cross-linking did not show any dimer formation but demonstrated an intramolecular linking 
within a monomer. 
A biochemical approach to test for oligomerization utilized a two affinity tag system which 
was adopted from investigations with FAS [128]. Neither GrsA nor TycB1 demonstrated the 
ability to build heterodimers containing both the strep-tag and hexahistidine-tag, and thereby 
the capacity to bind on both affinity columns successively. The specificity of the columns and 
of the applied antibodies were investigated and confirmed by separate experiments. Provided 
that the two scrambling methods were sufficient to allow dissociation and reassociation of 
putative dimers, the results clearly demonstrate a monomeric character of the enzymes. 
Complementation experiments between C- and PCP-domains were also adapted from 
previous investigations of an analogous KS and ACP complementation in FAS and PKS 
enzymes. The dimodular NRPS system TycB2-3 used for these studies had the advantage to 
provide C-PCP interactions in cis compared to in trans in a monomodular system. None of the 
complementation experiments revealed any product formation, indicating that no functioning 
heterodimers were formed, presuming a sufficient scrambling process. Based on the results 
from ultracentrifugation, a maximum population of 4% heterodimers would have been 
possible. Product formation catalyzed by them could have been detected within the limit of 
the HPLC assay.  
The critical step to conduct the biochemical experiments is the scrambling of homodimeric 
subunits to form heterodimers. Positive results would have proved unequivocally the dimeric 
nature of the investigated enzymes. In contrast the negative results obtained may have two 
explanations: the enzymes are monomeric or the scrambling procedure was not sufficient. The 
zwitterionic detergent CHAPS associates with nonpolar protein residues and therefore 
disrupts hydrophobic interactions. The tertiary structure, at least of the A-domain, is not 
influenced by this process which was demonstrated by an unchanged aminoacylation activity 
of the enzymes (GrsA, TycB1 and TycB2-3) in presence of CHAPS and after dialysis. 
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Furthermore it was possible to show that CHAPS is in position to interrupt functional protein-
protein interactions in trans between GrsA and TycB1. Whether CHAPS would also be able to 
interrupt protein-protein interactions in a putative NRPS dimer is speculative. The application 
of source Q anion exchange chromatography was adapted from PKS experiments [127]. The 
principle of this method is the dissociation of proteins induced by the strong interaction with 
the matrix and the subsequent reassociation by an increasing salt gradient (David Cane, 2000, 
personal communication). Scrambling of dimeric PKS and FAS worked very well with anion 
exchange chromatography. 
 
Do NRPS have an oligomeric quaternary structure? 
The related organization and chain elongation logic of PKS and NRPS as well as the 
existence of naturally occurring PKS-NRPS hybrids led to the assumption of a similar 
quaternary structure of both enzymes.  
Enzymes of physiological oligomeric significance other than NRPS vary greatly in degree and 
strength of interaction. Examples for strongly interacting enzymes are pyruvate 
dehydrogenase (PDH) systems with 24-mer or 60-mer cores [147]. The complex oligomeric 
organization of these systems is important for the channeling of intermediates, and stiff 
linkers between domains of each subunit allow motion without excessive degrees of freedom 
[147]. In contrast to these strong interactions, FAS dimers are able to dissociate in monomers 
at low temperatures whereas an equivalent behaviour has never been observed for related 
PKS. The observed tendency of NRPS to dimerize at higher concentrations can therefore be 
an evolutionary relic and does not appear to have functional significance.  
Crystallographic data from the PKS thioesterase domain shows a hydrophobic leucine-rich 
dimer interface and a 2-fold symmetry axis of the dimer [148]. Such an interface has not been 
observed for any NRPS domain based on crystallographic data [96, 104, 105] indicating that 
one necessary prerequisite to form dimers does not exist for NRPS.  
In the case of FAS and PKS the functional dimeric interaction takes place between the 
ketosynthase domains and the ACPs. Covalent intermediates can be isolated where the 
substrates are bound to a conserved cysteine residue of the ketosynthases and it is 
mechanistically necessary that this cysteine interacts with substrates bound to the ppan-
cofactors of ACPs of the second polypeptide chain of the dimer [99]. For C-domains of NRPS 
systems, recently a reaction mechanism was suggested by the results of a mutational analysis 
that does not involve covalent acylenzyme intermediates [65]. There may be no such 
mechanistic need for NRPS to function as dimers. In a recent publication of Smith and 
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coworkers it was shown that there is contrary to previous believe also no mechanistic need for 
FAS to work as dimers[111]. Full inactivation of one polypeptide chain in a dimer did not 
abolish activity indicating that one functional subunit in a heterodimer is sufficient for 
product assembly.  
In conclusion, although there is no direct experimental proof for the efficacy of the two 
methods for scrambling subunits between possible NRPS oligomers, the results from gel 
chromatography, analytical equilibrium ultracentrifugation and cross-linking demonstrate no 
indication of NRPS dimers for these NRPS subunits. A monomeric structure is also supported 
by recent studies of cyclosporin synthetase with transmission electron microscopy which 
demonstrates that nearly all 11 modules of one synthetase are not interacting with a second 
synthetase in a dimer [149]. It is also important to note that in a recent publication by Hillson 
et al. the dimeric structure of the unusual NRPS system VibF was demonstrated by analytical 
ultracentrifugation and complementation studies[150]. In contrast to cold labile FAS the VibF 
dimers did dissociate at elevated temperatures which suggestes a different pattern in dimer 
breakdown and re-formation. Crystallographic data of the accompanying free standing C-
domain VibH revealed a monomeric structure which indicates two oligomeric states in the 
vibriobactin system. This is similar to the proposed difference in aggregation of PKS and 
NRPS systems with regard to the existence of hybrid enzymes. A possible structure for these 
hybrid enzymes could be a dimeric PKS core with monomeric NRPS loops. This structure is 
similar to the postulated PKS structure where optional domains are separated from the 
dimeric core in monomeric loops [44]. 
 
Figure 6.1. Quaternary architecture of
multienzyme complexes. In contrast to
PKS and FAS, NRPSs investigated here are
monomeric. 
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6.2 Enzymatic Peptide Cyclization 
6.2.1 Characterization of Surfactin Thioesterase 
Previous studies with the tyrocidine thioesterase domain revealed its activity with synthetic 
SNAC substrate analogues and allowed to characterise enzymatic substrate tolerance[80, 90]. 
In contrast to Tyc TE, which catalyses head to tail cyclization, only little was known about 
branched chain cyclizing enzymes like the TE domains of surfactin, fengycin and 
syringomycin synthetases. Srf TE catalyzes the cyclization of linear β-hydroxy-acyl-
heptapeptidyl thioesters to produce cyclic macrolactones through the capture of the Leu7 
carbonyl by the fatty acyl β-hydroxyl nucleophile (Fig. 2.2). This is representative of the 
terminal step in the biosynthesis of other cyclic peptidolactones, including globomycin[151] 
and tripropeptin[152], and analogous peptidolactams, such as the iturins[153]. The related 
nonribosomal peptidolactones in the fengycin and syringomycin classes of antibiotics are 
similarly macrocyclized at the end of the NRPS assembly line by TE domains that use as the 
cyclization nucleophile a β-hydroxyl group of an amino acid side chain instead of a fatty acid. 
To evaluate the catalytic capacity of these cyclic depsipeptide synthases, active site mutants 
of Srf TE were characterized for cyclization and thioester hydrolysis activity. An assessment 
of the contributions of the fatty acyl group, heptapeptide backbone, and SNAC leaving group 
to substrate recognition for both cyclization and hydrolysis was carried out. 
6.2.1.1 Structure and Mechanism 
The superfamily of serine esterases generally uses a catalytic triad of active site residues, with 
serine as nucleophile, histidine as acid/base catalyst, and aspartate to orient the histidine and 
serine residues optimally[154]. Mutational analysis on the chicken FAS TE domain[155] and 
enterobactin synthetase TE domain[97] validated the roles of the active site serine and 
histidine. In the enterobactin system, the Ser to Cys mutant showed a 1000-fold decrease in 
activity compared with the wild type enzyme, and the His to Ala mutant showed a 10,000-
fold decrease[97]. The X-ray structure of the Srf TE domain indicated that Ser80, His207, and 
Asp107 were architecturally disposed to be such a catalytic triad[96]. Mutagenesis results 
reported here verify that the Ser80 to Cys and His207 to Ala mutants were without detectable 
activity in both cyclization and hydrolysis assays, with the Asp107 to Ala mutant also 
showing no cyclization activity and only a trace amount of hydrolysis activity. The lack of 
catalytic activity with the Ser80 to Cys mutant could be explained by the steric crowding in 
the active site due to the large sulfur atom which was also reported for a mutant version of 
subtilisin[156]. In acyl-O-Ser enzyme intermediate formation and breakdown, anionic 
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tetrahedral adducts are predicted, and electrostatic stabilization via oxyanion hole interaction 
is a general tenet of the superfamily catalytic mechanism[154]. For Srf TE, the backbone 
amides of Ala81 and Val27 are thought to serve this function (Fig. 5.13A)[96]. This work 
focused on Pro26 just adjacent to Val27, since it is a conserved residue in NRPS TE domains, 
but is instead conserved as a glycine in the lipase subfamily of serine esterases, which carry 
out acyl transfer exclusively to water as the nucleophilic cosubstrate. In fact, the Pro26 to Gly 
Srf TE mutant had a 13-fold increase in kcat/KM, with a 12-fold change in product partition 
ratio away from intramolecular cyclization in favor of intermolecular hydrolysis. The change 
from a rigid proline to a flexible glycine may increase the conformational freedom in this 
region of the active site, and create more access for water to capture the acyl-heptapeptidyl-O-
Ser enzyme intermediate. In turn, it may be that mutation of lipase active sites to introduce the 
proline may enhance intramolecular cyclization outcomes. The active site pocket adjacent to 
the catalytic triad has the attributes of a hydrophobic bowl, likely a good match for the 
generally hydrophobic nature of the acyl-heptapeptidyl chain to be cyclized to the 
biosurfactant product[96]. There are two prominent cationic side chains in the bowl, Lys111 
and Arg120; to evaluate whether removal of these side chains altered catalytic efficiency, the 
Lys111 to Ala and Arg120 to Ala mutants were prepared. The Lys111 to Ala mutant was 
inactive for cyclization of substrate thioesters and displayed only a low level of hydrolysis 
activity, while the Arg120 to Ala mutant retained a higher fraction of activity with product 
ratio now skewed towards hydrolysis. A prediction for such charged active site residues to be 
involved in the recognition of peptide backbone carbonyl groups in the substrate was made 
for the PKS DEBS TE domain[148]. 
6.2.1.2 Substrate Tolerance 
One of the goals of this study was to evaluate features in substrates that allow the excised Srf 
TE to carry out the chemo-, regio-, and stereospecific macrocyclization to the lariat type of 
peptidolactone, as prelude to evaluation of its catalytic potential for biogenesis of novel 
macrocyclic products. A significant limitation in an initial study was the poor aqueous 
solubility of the fatty acyl-heptapeptidyl-SNACs[80]. As a result, the acyl chain from the 
natural C13-C15 length was shortened down to C4. In this work, β-hydroxybutyric acid was 
used for the ease of synthesis, purification, and assay, but it will be necessary to explore how 
longer fatty acyl chains may affect catalytic efficiency. Recent data suggests that CDA 
peptide cyclase catalyses cyclization of a CDA analogue with a natural hexanoic acid more 
efficiently with only trace amounts of hydrolysis. By contrast CDA analogues with shorter 
fatty acids show little regioselectivity and increased hydrolysis[157]. This indicates the 
6 Discussion 
existence of a hydrophobic fatty acid binding pocket in the enzyme which will be discussed 
below. Even with the C4 acyl chain, the surfactin substrates showed CMCs in the 0.6-2.0 mM 
range, creating problems in kinetic assays. Solubility was increased by systematically 
introducing a Dap residue at each of the seven positions of the heptapeptide sequence of 
surfactin. The substrate with Dap at the third position (SLP-3) was more tractable than the 
substrate with the wild type heptapeptide sequence (SLP-wt), but was still not optimal for 
deconvolution of kcat and KM values. 
Nonetheless, HPLC assays could be performed on all of  the substrates and relative rates of 
both cyclization and hydrolysis determined (Fig. 5.7C). Both the intermolecular hydrolysis 
and the intramolecular cyclization reactions were enzyme-mediated and are presumed to 
reflect competing fates for deacylation of the acyl-heptapeptidyl-O-TE enzyme intermediate 
(Fig. 2.2). Some structure/activity data for TE action were acquired on the nucleophile (X) in 
the acyl moiety, determinants in the heptapeptide chain (Y), and leaving group (Z), as 
highlighted in figure 6.2. 
 
Figure 6.2. Summary of alternate substrates tolerated by SrfTE. In this study, 
different parts (X, Y, and Z) of a peptidyl-SNAC substrate (SLP-wt) were altered. X: 
Nucleophilic attacking group of fatty acid, Y: heptapeptide sequence, Z: leaving 
group. The substrates listed could be cyclized by Srf TE. 
For the C4 acyl chain, when X = OH, the peptidolactone could be formed by 
macrocyclization, while when X = NH2, only hydrolysis occurred. It is possible this outcome 
may be altered for longer acyl chains, since the β-NH2 of a C14-17 acyl chain is the cyclizing 
nucleophile in the closely related iturin peptidolactam antibiotic[153]. When the attacking 
hydroxyl of the acyl chain was moved from the β- to α-position, only hydrolysis occurred, 
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suggesting misalignment or steric barriers to intramolecular lactonization. However, the 
straight ε-hydroxycaproyl chain was cyclized to generate a peptidolactone with three more 
carbon atoms, suggesting further exploration of ω-hydroxy-acylpeptidyl substrates may be 
useful. In terms of alteration of the heptapeptide backbone, lengthening to the nonamer gave 
hydrolysis but no cyclization, as though a cyclizing conformer in the active site was 
disfavored. Previous in vivo experiments by Mootz et al. who deleted the leucine activating 
module 2 of the surfactin synthetase showed, that a shorter substrate was tolerated by Srf 
TE[158].  
The Dap scan, in which each side chain was replaced with one that differed in both size and 
charge, indicated tolerance of Dap in the middle of the peptidyl chain, but not at the N- and C-
terminus, in some analogy with tolerance of the tyrocidine synthetase TE domain to treat 
internal residues in a cyclizing chain as substitutable cargo (Fig. 5.7)[80, 91]. With regards to 
the NMR structure of surfactin it is important to note that the two acidic residues Glu 1 and 
Asp 5 form a polar domain by pointing in an opposite direction as the other hydrophobic 
residues[159]. This "claw" configuration of acidic residues gives important clues for the 
cation binding and transporting ability of surfactin. Replacement of Asp 5 by Dap or other 
residues could therfore likely alter the bioactivity of surfactin analogues.  
On the other hand, the results of the spacer scan, which replaced pairs of adjacent residues 
with a minimal linker containing no peptide bonds or side chains, indicated that, while the 
residues toward the N- and C-terminus of the substrate are not tolerant to significant side 
chain changes, the presence of sidechains at either end is not necessary for cyclization. In 
contrast, the removal of the residues in the middle of the substrate had a marked effect on 
cyclization (Fig. 5.8). In combination with the findings from the Dap scan, this suggests that 
the peptide backbone of the middle residues is an important feature for substrate placement 
and orientation for cyclization. 
The leaving group, Z, is a ppan chain covalently tethered to the PCP of the seventh module of 
surfactin synthetase in the native environment of the surfactin synthetase assembly line (Fig. 
2.2). This macromolecular portion of the substrate can be replaced by SNAC in case of the 
surfactin and tyrocidine cyclases. Changing from a thiol to hydroxyl leaving group still 
retained sufficient thermodynamic activation in the substrate for Srf TE-mediated cyclization. 
In the cognate Tyc TE case, such oxoester chemistry was used to make peptide libraries on 
beads to allow screening of libraries that can be enzymatically cyclized[95]. In addition, Srf 
TE domain also catalyzes the reverse reaction, the peptidolactone ring opening, where the 
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leaving group is the β-hydroxyl of the acyl chain. The influence of other leaving groups on 
Srf TE mediated cyclization will be discussed below. 
6.2.1.3 Substrate Recognition - Cocrystallization 
While the expected acylheptapeptidyl-O-TE intermediate has yet to be isolated, e.g., in rapid 
quench studies, the cocrystallization of the D-Leu-L-Leu-boronate with the boron bridging 
Ser80 and His207 is consistent with the mechanistic prediction for the catalytic pathway (Fig. 
5.14A). In agreement with biochemical data, only the peptide side chains of D-Leu6 and L-
Leu7 show specific binding in the active site pocket, each bound tightly in a well-defined 
hydrophobic pocket. These two amino acids fill up most of the active site, with the remainder 
of the peptide chain jutting out of the pocket (Fig. 5.14). Starting from this orientation of 
residues 6 and 7 of the heptapeptidyl chain and the NMR structure of the cyclic surfactin 
product[159], one can model the full heptapeptidyl chain in a product-like conformer as 
prelude to subsequent structure-activity-engineering mutagenesis on Srf TE and, by extension, 
other macrocyclizing NRPS TE domains. This model sets the surfactin linear peptide in a 
twisted β-sheet structure pointing away from the active-site pocket into solution (Fig. 5.14C). 
Consistent with the substrate tolerance of Srf TE, the enzyme makes specific contacts only 
with the two termini of the linear peptide. The proximity of the fatty acid of the natural 
surfactin linear lipopeptide to the nucleophilic hydroxy-group may suggest that it is a 
necessary determinant for cyclization. A pronounced hydrophobic pocket is present in the 
active site close to the predicted fatty acid position and may assist in increasing cyclization to 
hydrolysis product distribution. 
6.2.1.4 Comparison with Tyrocidine Cyclase 
Further comparison of Srf TE to Tyc TE and other macrolactonizing and macrolactamizing 
TE domains, excised from both NRPS and PKS assembly lines, is warranted to sort out the 
determinants of intramolecular cyclization vs. intermolecular hydrolysis for the acyl-O-TE 
intermediates. For example, Srf TE makes a branched chain peptidolactone, utilizing a D-
hydroxyl stereocenter in the intramolecular nucleophile. Tyc TE also uses a D-stereocenter in 
the attacking nucleophile, but it is an amine nucleophile and the product is a head-to-tail 
cyclized macrolactam. Minimal substrate recognition by Tyc TE appears to consist only of a 
N-terminal D-phenylalanine and the potential of the substrate to preorganize into an 
antiparallel β-sheet, with multiple residue substitutions and length variations is well 
tolerated[90, 91, 93, 95]. In contrast, the analysis of Srf TE indicates that it is optimized for its 
naturally dedicated substrate, with catalysis of cyclization only retained by conservative 
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changes to the substrate sequence. This might be also explained by the fewer β-sheets 
displayed in surfactin, which limit substrate preorganization in comparison to tyrocidine. 
Deciphering the productive folding of acyclic conformers of the acyl chain in the binding 
pockets of acyl-O-TE intermediates will be crucial in future studies to understand cyclization 
outcomes. 
6.2.2 Characterization of Fengycin Thioesterase by Natural Substrate Presentation 
In order to expand the scope of macrocyclization catalysts, thioesterases form other NRPS 
systems were cloned and overexpressed. Surprisingly, no activity was observed for fengycin 
TE, mycosubtilin TE and syringomycin TE upon incubation with SNAC substrates, which 
indicated a limitation in the chemoenzymatic potential of these cyclases. There were two 
possible reasons for the observed inactivity: First, it could be that the enzymes are misfolded 
and unable to reconstitute their activity after heterologous expression. Alternatively, substrate 
presentation by the short leaving group SNAC might be insufficient because of problems to 
find the right way into the enzyme´s active site by diffusion. In order to rule out the second 
possibility, a new strategy was employed which allowed Sfp catalysed loading of peptidyl-
CoAs onto apo PCPs mimicking the natural substrate presentation as close as possible. 
Remarkably Sfp is promiscous enough to tolerate peptidyl-CoA substrates instead of CoA and 
acetyl-CoA. This can be explained by the crystal structure which shows specific interactions 
with the adenine base but leaving the ppan arm pointing out of the enzyme (Fig. 2.6). This 
ensures enough space and freedom for the attached peptide chain which is accomodated in the 
solvent. Loading fengycin-CoA onto the fengycin PCP-TE didomain revealed indeed 
cyclization and hydrolysis activity which was not observed with SNACs before. The result 
demonstrates that the PCP tethered ppan arm is necessary to direct the substrate into the 
enzyme active site and ensures appropriate alignment for the nucleophilic attack of the active 
site serine.  
Contrary to surfactin and tyrocidine, the fengycin peptide sequence carries two competing 
nucleophiles (Orn2 and Thr4) directly next to Tyr3, which is the naturally dedicated 
nucleophile. Since the hydroxy-group of tyrosine is less nucleophilic in comparison with Orn 
and Thr[47], it raises the question if one of these competing nucleophiles can complement Tyr 
if it is exchanged to Phe. Such an exchange in the peptide substrate did only reveal hydrolysis 
which shows that Tyr is specifically recognized and activated by the TE. Relocation of Tyr at 
position 2 and 4 did only reveal little cyclization outcome in case of Tyr2 which indicates that 
an increase of the peptidolactone ring size is possible by one residue. Fengycin is the first 
cyclic branched chain peptidolactone where regioselectivity of enzymatic macrocyclization 
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has begun to be explored. By contrast, recent studies on CDA cyclase revealed relaxed 
regioselectivity between Thr2 and Ser1[157]. This regioselectivity was dramatically increased 
by using longer N-terminal fatty acyl chains, which correlates to specific binding in a putative 
hydrophobic pocket in the CDA cyclase and induces correct alignment for the nucleophilic 
attack of Thr2. Such a pocket was also reported for surfactin TE. In case of fengycin TE, 
regiochemistry seems to be triggered by specific recognition of the nucleophile Tyr rather 
than fatty acyl chain length, which was acetate in the substrates investigated. 
Fengycin TE is one example for a successful application of the new peptidyl-CoA loading 
method. Recently this approach was also used to characterize C- and R-domains in order to 
bypass NRPS specificity by directly loading peptidyl-CoA on any apo PCP within an 
assembly line[60, 78]. However, a limitation of the method is the single turnover (Fig. 6.3). 
After product release the cofactor ppan remains attached to the PCP-TE didomain cyclase, 
which blocks further Sfp catalyzed transfer of additional peptidyl-CoAs onto ppan-PCP. 
 
Figure 6.3. Limitation of natural substrate interaction approach: Single turnover. 
Once the peptide is released, the ppan moiety stays covalently attached to the PCP 
which blocks the enzyme for subsequent reloading of peptidyl-CoA. 
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6.2.3 Novel Thiophenol Based Leaving Groups 
In order to force multiple rather than single turnover cycles a new strategy was developed to 
expand the utility of peptidyl-CoA loading. It is known that amino acid thioesters undergo 
transthioesterification reactions when exposed to thiol-containing compounds[135]. The 
strategy was initially based on a thioester exchange reaction between the free ppan-PCP thiol 
and a soluble thioester-peptide substrate which should ensure both chemical reloading of 
substrate onto the ppan-PCP-TE didomain[134, 135] and natural substrate presentation by the 
ppan arm. Inspired by expressed protein ligation[134], thiophenol was selected as thioester 
compound due to its good leaving group properties. In the course of studies it became obvious 
that soluble fengycin thiophenol did directly acylate the cyclase active site serine rather than 
the free ppan thiol. It indicates that the serine hydroxyl-group is a much better nucleophile for 
the attack onto the thiophenol-peptide thioester in comparison with the thiol of the ppan. This 
is just the opposite of what is expected from chemical predictions since thiols are better 
nucleophiles than hydroxy-groups because of their better polarizability[47]. If serine is 
embedded in a functional catalytic triad as observed for peptide cyclases its hydroxyl group 
proton is in conjugation with the neighbouring histidine which makes it much more 
nucleophilic compared to serine in solution[160]. The rapid direct acylation of the active site 
serine therefore makes sense and further confirms the autonomous activity of the excised 
enzyme. Moreover, this result shows that in contrast to previous believe no natural cofactor 
recognition elements as displayed in SNAC or CoA substrates are necessary for enzyme 
acylation but only the potency of the leaving group. After acyclation of the enzyme, 
thiophenol can delocalize the negative charge across the aromatic ring system while there is 
no such stabilization for SNAC or CoA substrates (Fig. 6.4). 
 
Figure 6.4. Mesomeric stabilization by electron delocalisation of the 
thiophenolate anion.  
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The results further suggest that nature has developed peptide cyclases with different catalytic 
activities. While tyrocidine TE and surfactin TE showed activity directly with SNAC 
substrates, mycosubtilin TE, fengycin TE and syringomycin TE appeared to be completely 
inactive. A 15 fold increase in catalytic activity was observed for Srf TE when the SNAC 
leaving group was exchanged by thiophenol. Recently, a similar increase of activity was also 
reported for comparison of CDA-SNAC with CDA-thiophenol for CDA cyclase[157]. The 
thiophenol leaving group increases the velocity of the acylation step. While the first step of 
acylation depends on substrate presentation, as seen in the peptidyl-CoA experiments, 
deacylation is an intrinsic property of the enzyme, visualized by comparable cyclization to 
hydrolysis ratios for SLP3 and SLP3-tp which is consistent with a common acyl-enzyme 
intermediate for both substrates. By contrast, comparison of in cis experiments with PCP-TE 
bound FLP-CoA and in trans experiments with FLP-tp, the cyclization:hydrolysis ratio 
decreased from 2:1 to 0.85:1, respectively. This change in ratio could indicate that the ppan 
arm in the enzyme entrance excludes water from the active site and therefore reduces 
hydrolysis outcome. As expected, undesired hydrolytic by-products are observed in 
thiophenol based in vitro systems, since substrate presentation and enzyme environment are 
unnatural. The ratio of cyclization to hydrolysis could be increased by providing natural 
unmodified thiophenol substrates, that fit precisely into the enzyme active site. In contrast, not 
much is known about the hydrolysis rate of natural NRPS systems but it is likely that also the 
multienzyme complexes produce hydrolysed by-products to a certain extend. In general, 
selective enzyme acylation can now be achieved for many peptide cyclases by a variety of 
leaving groups (Fig. 6.5). 
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Figure 6.5. Leaving groups used in this study. 
6.2.4 Protein Evolution 
The previous studies on peptide cyclases revealed that cyclization depends on both, substrate 
preorganization and specific interaction with the enzymatic binding pocket. Within the 
cyclases investigated so far, tyrocidine TE exhibits the greatest tolerance for substrate 
variations in length, side chains, nucleophiles and leaving groups. This high tolerance makes 
Tyc TE an interesting candidate for cyclizing other substrates than tyrocidine analogues, 
which has been shown for NRPS-PKS hybrids as well as an intergrin inhibitor variant[93, 94]. 
Drastic changes, as observed for the integrin inhibitor substrate with 7 new residues in the 
decapeptide sequence, decrease the cyclization:hydrolysis ratio by reduction of productive 
substrate preorganization. Only two residues were identified to be specifically recognized by 
Tyc TE, D-Phe1 and Orn9 while changes in the rest of the peptide seemed to be tolerated[90]. 
Results of this study showed that Orn at position 9 could be exchanged by alanine under 
reconstitution of cyclization activity which shows that Tyc TE in contrast to Srf TE tolerates 
changes at the C-terminal end. Major limitations in cyclization ability of Tyc TE will 
therefore predominantly arise from changes at the N-terminal end and any alterations in the 
peptide sequence which lead to unproductive substrate preorganization or repulsion. Since 
problems in expression of soluble cyclosporin C-domain could not be solved, Tyc TE was a 
promising alternative possible candidate to facilitate cyclization of linear cyclosporin A. This 
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application would be very interesting in order to create libraries of cyclosporin A variants 
with improved or altered activities. Incubation with linear cyclosporin SNAC (CLP), which 
carries D-Ala instead of D-Phe at position 1, indicated only productive enzyme acylation but 
no release via cyclization. Therefore directed protein evolution was applied to change enzyme 
specificity of D-Phe1 towards D-Ala1. In order to minimize the number of mutant peptide 
products to screen by mass spectrometry, only the lid region was selected for random 
mutagenesis for several reasons. First, sequence alignments show very little conservation 
among TE domains in this region which could reflect individual optimisation for different 
substrates[96]. Second, Reetz and coworkers demonstrated that many mutations which 
increased the stereoselectivity in a related lipase were located in this lid-region[138]. The 
most evident support that the lid contributes to substrate binding was reported by Dugi et al., 
who showed that the lids of hepatic lipase and lipoprotein lipase are critical for the interaction 
with the lipid substrates[139]. The Srf TE crystal structure revealed that the lid surrounds the 
peptide binding pocket[96]. It can exist in an open and a closed conformation and in analogy 
to lipases it was suggested that the closed conformation represents the ground state without 
bound substrate. Together, these findings support the initial idea to concentrate random 
mutagenesis on one part of the enzyme which seems to be involved in substrate recognition. 
The mass screen of about 1700 mutants revealed several hits, which did correlate with 
putative new enzyme species with increased TLP-Ala cyclization activity. DNA sequence 
analysis of 6 mutants showed that all of them carried stop codons within the lid region which 
led to shorter enzyme fragments. Most of the stop codons were derived from deletion mutants 
with corresponding frame shifts which occur during epPCR with a frequency of 1.1 % 
(Invitrogen). Since biochemical characterization of these purified stop fragments with TLP 
and allyl-TLP still revealed enzyme catalysed cyclization and hydrolysis activity, one can 
conclude that the lid region and subsequent parts of the enzyme are not essential for catalytic 
activity. This is specially intriguing since 30 – 44 % of the enzymes were missing in active 
stop fragments. Kinetic data of mutant JH1 revealed a drastic reduction in kcat (1000 fold) but 
only very little deviation in KM in comparison with wild type Tyc TE which suggests the 
relevance of the C-terminal enzyme part for catalytic efficiency. This is also supported by a 
drop in the cyclization:hydrolysis ratio from 6 to 0.8. Sequence alignments of several TEs 
show conserved regions for the N-terminal end up to the lid region. The lid region itself and 
the C-terminal part reveal high flexibility and almost no conserved regions which might 
explain why the short fragment mutants have been selected in this screen since they represent 
the shortest possible enzyme versions for productive cyclization (Fig. 6.6).  
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Figure 6.6. Sequence alignment of several TE domains. The C-terminal part of the 
enzymes show little homology, while the N-terminal part shows conserved regions. 
Also differences in length of the lid region can be observed. 
It is also interesting to note that all mutant fragments lack the putative triad member His213 
which may suggest that this residue is not essential for Tyc TE catalysis. Mutational exchange 
of the catalytic triad His to Ala in the serine protease subtilisin revealed drastic drop in 
activity but demonstrated still 1000 fold catalytic rate enhancement in comparison with the 
uncatalysed reaction[156]. This was explained by stabilization of the negative tetrahedral 
intermediate by the oxyanion hole similar to catalytic antibodies.  
Previous research on hepatic lipase (HL) and lipoprotein lipase (LPL) suggested a crucial role 
of the lid region in substrate recognition for these TE related enzymes[139]. More detailed 
investigations revealed later that their substrate specificity can be altered. Characterization of 
chimeric enzymes in which LPL and HL lids have been exchanged demonstrated that the LPL 
core enzyme with the HL lid had an increased activity for the HL dedicated phospholipide 
substrates while HL with the LPL lid showed activity on triglyceride substrates which were 
only processed by LPL before[161]. This method could be applied to peptide cyclases and 
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would allow for directed protein engineering of Tyc TE by introduction of several lids or C-
terminal fragments from other TE domains.  
Since there is no crystal structure of Tyc TE available so far, the fragment JH1 was modeled 
by sequence homology into the crystal structures of Srf TE and Fen TE[162] (Fig. 6.7). Both 
structural models indicate a very rigid and stable N-terminal fold for the putative JH1 
fragment which would explain why this part is sufficient for enzyme activity. 
 
Figure 6.7. Structures of Srf TE and Fen TE to visualize JH1 fragment fold. 
Based on Srf TE and Fen TE[162] crystal structures, the short fragment was modeled 
into these structure based on sequence alignments. The green structure represents JH1 
and the red part is the lid plus C-terminal regions which are missing in JH1. 
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However, although the selected hits demonstrated increased cyclization of TLP-Ala during 
the screen, no such behaviour could be detected with purified enzymes under standard assay 
conditions which raises the question why they were selected. All selected mutants revealed 
only 4 times the intensity of background cyclization during the screen which represents the 
lower detection limit. One possible answer could therefore be increased expression rates and 
better solubility of the shorter fragments in comparison with wild type Tyc TE, which is 
supported by the rigid and stable fold of the small fragment. This would lead to higher 
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enzyme concentrations during the screen and therefore explain the slightly increased substrate 
to product conversion. In order to obtain real hits with improved cyclization catalysis, a 
higher mutation rate in combination with other mutagenesis methods, such as DNA shuffling, 
cassette mutagenesis, could be applied[163].  
Tyc TE and mutant fragment JH1 were both capable of cyclizing TLP and allyl-TLP, but 
surprisingly did not show activity for the N-terminal substrate variant TLP-Ala. Besides these 
similarities, a major difference was observed for the C-terminally modified substrates Ala-
Leu-TLP and Ala-Ala-TLP. In contrast to Tyc TE, cyclization activity of the fragment JH1 
was completely abolished for these substrates while trace amounts of hydrolysis were still 
observed. Substrate preorganization is limited in these two new tyrocidine variants since Orn9 
is replaced by Ala which inhibits productive intramolecular H-bonds and complicates 
cyclization. This shows that the short C-terminal enzyme fragment is most likely involved in 
substrate recognition and coordination in the active site, especially if Orn9 is missing. 
Acylation and deacylation activity itself is probably contributed predominantly by the N-
terminal region. This result would therefore encourage the exchange of C-terminal parts form 
other cyclases to explore new chimeric enzymes with putative altered substrate specificities as 
previously carried out with related lipases[161] (Fig. 6.8). 
 
Figure 6.8. Engineering of hybrid TE domains by lid exchange. The lid of Tyc TE 
will be replaced by several lids from other TE domains. 
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6.2.5 General Utility of Peptide Cyclases: Chemical vs. Enzymatic Cyclization 
In order to evaluate utility and potential of enzyme catalysed cyclization reactions, a 
comparison with established chemical methods is necessary. In principal, the chemical 
formation of macrocyclic rings is difficult, because of energetically disfavored ecliptic and 
transannular interactions[47]. If heteroatoms are present, as for example in macrocyclic 
natural products, the disfavored interactions are minimized[164] but ring closure proceeds 
still more slowly compared to normal peptide bond formations. In solution, only a few 
conformers have the right geometry to intramolecularly attack the C-terminal carboxy group. 
The entropic costs of populating these few productive conformations by several C-C-bond 
rotations are high and therefore disfavoured. To ensure regioselective cyclization, competing 
undesired nucleophiles such as hydroxy- or amino-groups have to remain protected, while the 
desired nucleophile needs to be deprotected which requires orthogonal protecting group 
strategies. Side reactions such as intermolecular peptide bond formation and subsequent 
cyclo-oligomerization may predominate since peptide bonds are usually trans-configured and 
favor a higher population of linear precursors. To minimize intermolecular reactions, high 
dilution conditions are applied with 10-4-10-5 M solutions which make larger scale reactions 
difficult. Alternatively, cyclization of a peptide can also occur while it is still attached to the 
resin. This pseudo-dilution is a kinetic phenomenon and favors intramolecular reactions[121]. 
By contrast, turn inducing elements such as D-amino acids, proline, glycine, or N-alkyl amino 
acids also populate cis peptide bonds and are therefore easier to cyclize in solution. This 
emphazises that preorganization of the linear precursor by H-bonding is an important 
precondition for ring closure which was also observed for some peptide cyclases[91]. Another 
problem of chemical cyclization is the activation of the C-terminal carboxy-group without 
amino acid racemization. Coupling reagents like BOP and TBTU permit rapid cyclization but 
suffer from C-terminal racemization[121]. Less reactive coupling reagents minimize 
racemization but prolong reaction times. Better results were achieved with HOAt and 
DPPA[165-168]. Typically, with the above mentioned chemical cyclization methods 30-40 % 
yield of cyclic peptide products can be obtained[35, 164-166]. Reaction times range from 
several hours to days. 
By contrast, enzymatically catalysed cyclization reactions do not require protecting groups 
and high dilution conditions due to enzymatic specificity. In literature, predominantly head to 
tail cyclizing enzymatic methods are reported. Cyclization of linear peptide esters was first 
reported for the subtilisin mutant subtiligase[169]. Subtiligase cyclizes peptide esters longer 
than 12 residues with yields of 30 - 88  % in a regioselective head to tail fashion. Hydrolysis 
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and dimerization are observed by-products. Head to tail cyclization without by-products was 
reported for an intramolecular version of an expressed protein ligation and split- intein 
approach which allow the generation of backbone cyclized peptides in vitro and in vivo[170].   
In the work presented here, several enzymes such as surfactin TE, mycosubtilin TE, fengycin 
TE and syringomycin TE were shown to regiospecifically catalyse branched chain 
circularization between one dedicated nucleophile and the activated C-terminal peptide 
residue by discrimination of other unprotected competing nucleophiles. No oligomerization 
and C-terminal racemization were observed. The advantage of enzymatic vs. chemical 
cyclization illustrates the example of tyrocidine A synthesis. While chemical on resin 
cyclization reveals only 30 % yield, enzymatic cyclization yields 85 % product[90, 171]. 
However, the yield of enzymatically catalysed ring formation suffers from linear hydrolytic 
by-products due to competing nucleophilic attacks of water molecules. Typical yields of TE 
mediated cyclization range from 40-91 % and observed reaction times are several minutes to 
hours (Table 6.1). 
Table 6.1. Cyclization yields and catalytic efficiency of several TE domains. 
Enzyme Substrate % Yield  kcat/KM (min-1mM-1) 
Tyc TE[90] TLP-SNAC 85 19700 
Srf TE SLP3-SNAC  
SLP3-tp 
35  
44 
2.9 
44.9 
Fen PCP-TE FLP-CoA 
FLP-tp 
67 
46 
N.A. 
0.71 
Myc PCP-TE MLP-tp 46 0.54 
Syr TE SyLP-tp 40 11.4 
CDA TE[157] CDA-tp 91 29.8 
SnbDE PCP-TE[172] PLP-SNAC 67 0.77 
 
Since these recombinant peptide cyclases are usually embedded in a hydrophobic 
multienzyme complex, their unprotected modification as a single TE or PCP-TE may enhance 
the exposure of the active site to water. Moreover, substrate analogues used in in vitro studies 
lack for the ease of synthesis some structural features like long chain fatty acyl chains which 
are important for a perfect fit into the enzyme binding pocket as seen for CDA[157]. This is 
also supported by in vivo studies with a genetically engineered surfactin synthetase lacking 
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module 2[158]. While it was not possible to detect hydrolysed surfactin product in the 
supernatant of the wild type producer cells, hydrolysis was observed for the shorter surfactin 
variant produced by the engineered strain. This indicates that hydrolysis can also occur in 
vivo, where the TE domain is embedded in a functional multienzyme complex. Therefore the 
presentation of the dedicated substrate seems to be a key determant to minimize hydrolysis by 
TE domains. Moreover, artificial thioester leaving groups like SNAC and thiophenol are short 
mimics of the natural cofactor ppan-PCP and may therefore be more suceptible for the entry 
of water into the active site rather than blocking it. The nucleophilic side reaction by water 
can further be eliminated by enzyme catalysis in organic solvents[173]. The high enzymatic 
selectivity for cognate substrates can also be a disadvantage when the cyclization of substrate 
analogues is desired. Changes of residues specially at the C- and N-terminal ends of the 
peptide sequence decrease or completely abolish cyclization yields and are subject of protein 
evolution. With the current set of active peptide cyclases described here, diverse cyclization 
reactions such as head to tail and branched chain lactamization and lactonization of various 
substrates can already be performed.  
In comparison to organic synthesis the chemoenzymatic approach presented here minimizes 
time and side reactions and maximizes purity and yield of cyclic peptide production. 
Biochemical prerequisites such as enzyme characterization and leaving group technology 
have been solved which will now allow for applications such as formation of various cyclic 
peptide libraries[95]. In future, further exploration of structurally diverse peptide cyclases will 
help to generate a tool set of cyclization catalysts which in combination with protein evolution 
are likely to broaden the applications and increase the utility of enzymatic peptide cyclization 
similar to the use of lipases in stereochemistry today. 
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Name Peptide sequence 
SLP wt FA-Glu-Leu-D-Leu-Val-Asp-D-Leu-Leu 
SLP-1 FA-Dap-Leu-D-Leu-Val-Asp-D-Leu-Leu 
SLP-2 FA-Glu-Dap-D-Leu-Val-Asp-D-Leu-Leu 
SLP-3 FA-Glu-Leu-D-Dap-Val-Asp-D-Leu-Leu 
SLP-4 FA-Glu-Leu-D-Leu-Dap-Asp-D-Leu-Leu 
SLP-5 FA-Glu-Leu-D-Leu-Val-Dap-D-Leu-Leu 
SLP-6 FA-Glu-Leu-D-Leu-Val-Asp-D-Dap-Leu 
SLP-7 FA-Glu-Leu-D-Leu-Val-Asp-D-Leu-Dap 
SLP-1/2 FA-ε-Ahx -D-Leu-Val-Asp-D-Leu-Leu 
SLP-3/4 FA-Glu-Leu-ε-Ahx -Asp-D-Leu-Leu 
SLP-5/6 FA-Glu-Leu-D-Leu-Val-ε-Ahx -Leu 
MLP FA-Asn-D-Tyr-D-Asn-Gln-Pro-D-Ser-Ala 
FLP FA-Glu-D-Orn-Tyr-D-Thr-Glu-D-Ala-Pro-Glu-D-Tyr-Ile 
FLP(Phe) FA-Glu-D-Orn-Phe-D-Thr-Glu-D-Ala-Pro-Glu-D-Tyr-Ile 
FLP(2) FA-Glu-D-Tyr-Orn -D-Thr-Glu-D-Ala-Pro-Glu-D-Tyr-Ile 
FLP(4) FA-Glu-D-Orn-Thr-D-Tyr-Glu-D-Ala-Pro-Glu-D-Tyr-Ile 
SyLP FA-Ser-D-Ser-Dab-D-Dab-Arg-Phe-Abu-Asp-Thr 
TLP D-Phe-Pro-Phe-D-Phe-Asn-Gln-Tyr-Val-Orn-Leu 
allyl-TLP D-Phe-Pro-allyl-Gly-D-Phe-Asn-Gln-Tyr-Val-Orn-Leu 
Ala-Leu-TLP D-Phe-Pro-Phe-D-Phe-Asn-Gln-Tyr-Val-Ala-Leu 
Ala-Ala-tlp D-Phe-Pro-Phe-D-Phe-Asn-Gln-Tyr-Val-Ala-Ala 
TLP-DAla D-Ala-Pro-Phe-D-Phe-Asn-Gln-Tyr-Val-Orn-Leu 
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